VAERS Reports #057M21A

VAERS 2728892

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 29.12.2023
Impfdatum: 04.05.2022
Beginn: 18.11.2023
Tage bis Beginn: 563,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Acute respiratory failure Atelectasis Blood creatinine increased Blood lactic acid Blood pH normal Brain natriuretic peptide increased COVID-19 Cardiomegaly Chest X-ray abnormal Chronic kidney disease Computerised tomogram thorax abnormal Condition aggravated Dyspnoea Echocardiogram abnormal Ejection fraction decreased Glycosylated haemoglobin increased Hypokinesia

Symptomtext

Patient is a 80 y.o. male patient of MD with history of HFrEF, HTN, HLD, T2DM, BPH, anxiety, and depression Patient presented to with shortness of breath and mild changes mental status. Acute on chronic hypoxic respiratory failure Mild metabolic encephalopathy, resolved COVID-19 infection Sepsis, POA Patient presented with preceding history of upper respiratory tract infection symptoms since 2-3 days back. He was sent from assisted living with mild change in his mental status and shortness of breath, tested positive for COVID-19 11/18 Patient is vaccinated for COVID-19 infection. He is also up to date with his booster. He had temperature of 100.3 with pulse rate of 107 respirations of 22. VBG done in ER showed pH of 7.39 with PCO2 42.7 WBC was 14.34 with lactic acid of 2.7 BNP of 6001 CXR: Moderate cardiomegaly with slight to mild bibasilar atelectasis. CT chest without contrast: Bibasilar atelectasis Empirically started on antibiotics, switched to ceftriaxone and azithromycin Procalcitonin normal, suspect symptoms more due to COVID-19 infection as opposed to bacterial pneumonia Stopped antibiotics and monitor off of them, patient improving Continue decadron, for total of 10 days, LDT 12/3 On RA as 11/24 with sats between 88-91% Discharge home with remainder of decadron RX, IS/flutter. AKI on CKD stage 3 baseline creatinine is between 1.56?1.8, worsened up to 2.8 Home torsemide held on admission Cr was back to baseline and torsemide resumed 11/22 Continue to monitor renal function Chronic HFrEF Ischemic cardiomyopathy s/p ICD HTN and HLD Does not appear to be in acute exacerbation at this time 2D echo done on 9/13/2023 showed EF of 30% with moderate hypokinesis of the apex, interventricular septum and anterior wall of the left ventricle Continue home Plavix, isosorbide, metoprolol and pravachol Resume torsemide but at half dose 11/22, and full dose 11/23 Continue to hold entresto, BP well within normal range, will need to address resumption in the outpatient setting once acute illness has resolved. Paroxysmal atrial fibrillation Continue Eliquis and metoprolol Hypothyroidism Continue Synthroid. Diabetes mellitus type 2 A1c of 7.6 Can resume metformin on discharge however will need to monitor renal function closely as he is at the lower limit of creatinine clearance cutoff. May benefit from changing to alternative agent however will defer this to PCP BPH Continue home flomax Anxiety and depression Continue home Effexor. Obesity BMI >41 kg/m2 Dietary and lifestyle modifications

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2652517

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 057M21A

kritisch

Staat: PA
Alter: 74,0
Geschlecht: F
Eingang: 05.07.2023
Impfdatum: 22.12.2022
Beginn: 01.12.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Antiphospholipid antibodies Bladder mass Dizziness Expired product administered Feeling abnormal Influenza like illness Laboratory test Nausea Near death experience Pulmonary embolism Vaccination site warmth

Symptomtext

blood clots/The patient had 6 blood clots removed from her lungs late at night on January 15; feel the second bivalent booster dose vaccine in her body/feels like there is water crashing on rocks in her body/was very foggy/unstable; almost died after these blood clots; dizzy; nauseous; She also was found that the patient had a growth on her bladder. The patient had a surgical procedure to find that the growth was benign; The patient received her second Moderna bivalent booster dose on December 22, 2022 lot number 057M21A expiration date August 13, 2022 patient received in her left arm; flu like symptoms; injection site was warm to the touch; This spontaneous case was reported by a patient and describes the occurrence of PULMONARY EMBOLISM (blood clots/The patient had 6 blood clots removed from her lungs late at night on January 15), NEAR DEATH EXPERIENCE (almost died after these blood clots) and FEELING ABNORMAL (feel the second bivalent booster dose vaccine in her body/feels like there is water crashing on rocks in her body/was very foggy/unstable) in a 74-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057M21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No medical history information were reported by the reporter. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication. On 22-Dec-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In December 2022, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and VACCINATION SITE WARMTH (injection site was warm to the touch). On 22-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received her second Moderna bivalent booster dose on December 22, 2022 lot number 057M21A expiration date August 13, 2022 patient received in her left arm). In 2023, the patient experienced NEAR DEATH EXPERIENCE (almost died after these blood clots) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced PULMONARY EMBOLISM (blood clots/The patient had 6 blood clots removed from her lungs late at night on January 15) (seriousness criteria hospitalization and medically significant), FEELING ABNORMAL (feel the second bivalent booster dose vaccine in her body/feels like there is water crashing on rocks in her body/was very foggy/unstable) (seriousness criterion hospitalization), DIZZINESS (dizzy), NAUSEA (nauseous) and BLADDER MASS (She also was found that the patient had a growth on her bladder. The patient had a surgical procedure to find that the growth was benign). The patient was treated with MECLIZINE HCL at a dose of 25mg in the Morning, and 25mg dose 8 hours later and HEPARIN at an unspecified dose and frequency. At the time of the report, PULMONARY EMBOLISM (blood clots/The patient had 6 blood clots removed from her lungs late at night on January 15), DIZZINESS (dizzy) and NAUSEA (nauseous) had not resolved, NEAR DEATH EXPERIENCE (almost died after these blood clots), FEELING ABNORMAL (feel the second bivalent booster dose vaccine in her body/feels like there is water crashing on rocks in her body/was very foggy/unstable), EXPIRED PRODUCT ADMINISTERED (The patient received her second Moderna bivalent booster dose on December 22, 2022 lot number 057M21A expiration date August 13, 2022 patient received in her left arm) and BLADDER MASS (She also was found that the patient had a growth on her bladder. The patient had a surgical procedure to find that the growth was benign) outcome was unknown and INFLUENZA LIKE ILLNESS (flu like symptoms) and VACCINATION SITE WARMTH (injection site was warm to the touch) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antiphospholipid antibodies: tests were false positive. On an unknown date, Laboratory test: found that the patient had a growth on her bladder. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. The patient called an ambulance and was taken to the emergency room. The ambulance immediately put the patient on oxygen and the oxygen was continued in the hospital. The patient had 6 blood clots removed from patient lungs late at night on 15-JAN-2023 or early morning of 16-JAN-2023. The patient said that she almost died after these blood clots. The patient was rushed from the ED to the Operating room. Since 15-JAN-2023, the patient had several lab tests. She also was found that the patient had a growth on her bladder. The patient had a surgical procedure to find that the growth was benign. The patient was worked up for antiphospholipid syndrome or Hughes syndrome the first two tests were positive. Because the patient takes Eliquis her Doctor ordered a separate test in addition to the 3rd antiphospholipid test and found out that the ingredients in Eliquis had caused false positives for antiphospholipid syndrome. The first two antiphospholipid tests were false positives. Metaphorically like a war going on in patient body between the technology and patient antibodies. This started once came home from the hospital. Patient was on a Heparin drip in the hospital and then when patient was discharged from the hospital the vibration was there. The patient used an oxygenator device to measure the amount of oxygen in her body. Patient can visualize a war going on in patient's body between the new technology and patient antibodies. This whole thing had been a nightmare for patient. Company Comment: This is a spontaneous case concerning a 74-year-old female patient with a history of use of Eliquis for unknown indication, who experienced the serious (due to medically significant and hospitalization) unexpected, events of pulmonary embolism (AESI) and near-death experience, and the serious (due to hospitalization) event of feeling abnormal, which occurred approximately 1 month after a dose of mRNA-1273 Bivalent .222 (original and omicron BA.4/BA.5), received as the fourth dose of COVID-19 vaccination schedule. It was reported that the patient had 6 blood clots removed from lungs. The patient said that she almost died after these blood clots. Patient was on a Heparin drip in the hospital and then when patient was discharged from the hospital. Concomitant use of Eliquis could suggest a risk factor for event Pulmonary embolism. The benefit-risk relationship of Bivalent .222 (original and omicron BA.4/BA.5) is not affected by this report. This case was linked to MOD-2023-731715 (Patient Link).; Sender's Comments: Company Comment: This is a spontaneous case concerning a 74-year-old female patient with a history of use of Eliquis for unknown indication, who experienced the serious (due to medically significant and hospitalization) unexpected, events of pulmonary embolism (AESI) and near-death experience, and the serious (due to hospitalization) event of feeling abnormal, which occurred approximately 1 month after a dose of mRNA-1273 Bivalent .222 (original and omicron BA.4/BA.5), received as the fourth dose of COVID-19 vaccination schedule. It was reported that the patient had 6 blood clots removed from lungs. The patient said that she almost died after these blood clots. Patient was on a Heparin drip in the hospital and then when patient was discharged from the hospital. Concomitant use of Eliquis could suggest a risk factor for event Pulmonary embolism. The benefit-risk relationship of Bivalent .222 (original and omicron BA.4/BA.5) is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Near death experience
Hospital-Tage: -
Labordaten: Test Name: antiphospholipid syndrome or Hughes syndrome; Result Unstructured Data: tests were false positive; Test Name: several lab tests; Result Unstructured Data: found that the patient had a growth on her bladder
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: No medical history information were reported by the reporter.
Andere Medikamente: ELIQUIS
Allergien: -
Vorherige Impfungen: -

VAERS 2651450

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 30.06.2023
Impfdatum: 16.11.2021
Beginn: 18.04.2023
Tage bis Beginn: 518,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction

Symptomtext

ACUTE NON ST ELEVATION MI 4/19/2023 ACUTE NON ST ELEVATION MI ACUTE NON ST ELEVATION MI 4/19/2023 ACUTE NON ST ELEVATION MI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2634516

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: IL
Alter: 71,0
Geschlecht: M
Eingang: 19.05.2023
Impfdatum: 09.02.2021
Beginn: 09.04.2023
Tage bis Beginn: 789,0
Dosis: 4
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Coagulopathy Death Embolism

Symptomtext

He received the last COVID Moderna vaccine on 04/26/2022. He was very healthy, active individual with no signs of illness found dead at home. His cause of death is surmised to be a thromboembolic event due to coagulopathy. He has no known history of coagulopathy, nor any known in his family. Of note, his family is characterized by longevity. The coagulopathy is suspect to be secondary to the COVID vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: none.
Aktuelle Erkrankungen: none
Vorgeschichte: Hypertension GERD
Andere Medikamente: Carvedilol naproxen lisinopril timolol omeprazole
Allergien: none
Vorherige Impfungen: -

VAERS 2618317

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: -
Alter: 59,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578871

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: KY
Alter: 73,0
Geschlecht: M
Eingang: 09.02.2023
Impfdatum: 23.06.2022
Beginn: 08.10.2022
Tage bis Beginn: 107,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Infection

Symptomtext

Patient had a breakthrough infection and passes away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2604569

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 24.01.2023
Impfdatum: 06.05.2022
Beginn: 15.01.2023
Tage bis Beginn: 254,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute respiratory failure Allen's test Anion gap Atrial fibrillation Base excess Basophil count decreased Basophil percentage decreased Blood bicarbonate increased Blood calcium decreased Blood chloride normal Blood creatinine increased Blood glucose normal Blood pH increased Blood potassium decreased Blood sodium normal Blood urea normal Body temperature increased

Symptomtext

Narrative: 1/15/23 at 10:33 - Pt presented to ED c/o SOB worsening since diagnosis of COVID on 1/10/23. Pt states he has been increasing his oxygen use. In ED, Pt with oxygen sats of approx. 80% in room. He normally wears oxygen overnight and has a hx of COPD and CHF. Pt also has hx of atrial fibrillation as well, he does have some increased lower extremity edema. He has been continuing oxygen 24/7 instead of just at night, and still feels SOB. Pt administered Lasix 40mg IV, labs and x-rays obtained. Troponin is 0.02. Pt had no chest pain complaint, just dyspnea. EKG showed a-fib with no new changes. Pt to be admitted with diagnosis = COVID +, CHF, CAD AD, A-fib, dyspnea. (Admission 1/15 - 1/18/2023) PRINCIPAL DIAGNOSIS (Reason for admission after study): #Acute Hypoxic Resp Failure #HFrEF Decompensation: AKI, hypovolemia: Resolved #Hypokalemia: Resolved #COVID Infection ADDITIONAL DIAGNOSES - Chronic Problems: #afib on Xarelto #Chronic Hypoxic Resp Failure (on home nightly O2) #Interstitial lung dz (2/2 textiles factory work, pulm fibrosis, PFTs 2/2022 showing no airway obstruction, lung volumes consistent with restrictive lung dz) #OSA - CPAP #CAD #Aortic Root Dilation (mild to mod) #Previous CVA #HTN #T2DM on insulin HOSPITAL COURSE: #Acute Hypoxic Resp Failure - Pt has been off bumex 4mg BID since 12/2022 hospitalization for hypotension, - O2 sats 85% on RA - Home O2 adjusted to 2L/NC continuously #HFrEF Decompensation: - TTE 11/2022: LVEF 50-55%, RV mild-mod dilated w/mild-mod decresed fxn/ - Lasix 40mg IV bid - return to outpatient Bumex dose. - CXR: bilateral increased interstitial opacities with small right pleural effusion (concerning for pulmonary edema although worsening Covid pneumonia cannot be excluded). - BNP: 273 (was 168 on 12/3/2022) AKI, hypovolemia: Resolved - S/P 1 Liter NS - Cr 1.2 #Hypokalemia - K 2.8 -> 3.8 -> 3.4 - KCL 40meq x 2 ordered - will monitor K closely daily, especially in setting of aggressive diuresis #COVID Infection -Clinically, patient appears to be having heart failure decompensation and suspect less contribution from Covid towards patient's dyspnea and hypoxia -Remdesivir ordered: day #3 -Holding off dexamethasone for now due to concern for possibly worsening heart failure decompensation Discharge date = 1/18/23

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Pt tested COVID + on 1/10/23. Vital Signs * Temperature 97.9 F (36.6 C) Pulse 84 Respirations 18 Blood Pressure 159/50 Pain scale recorded: 6 Pulse Oximetry 85 Room Air PHYSICAL EXAM: Current Vitals: T: 97.9 F [36.6 C] (01/15/2023 10:33) P: 84 (01/15/2023 10:33) R: 18 (01/15/2023 10:33) BP: 159/50 (01/15/2023 10:33) Pain: 6 (01/15/2023 10:33) Height: 69 in [175.3 cm] (03/17/2022 21:20) Weight: 211.6 lb [95.98 kg] (12/22/2022 08:29) BMI: 31.3 (12/22/22) Pulse Oximetry: 94% on 2L The patient appeared well nourished and normally developed. Vital signs as documented. Head exam is unremarkable. No scleral icterus or corneal arcus noted. Neck is without jugular venous distension, thyromegaly, or carotid bruits. Lungs are clear to auscultation and percussion. Cardiac exam reveals the PMI to be normally sized and situated. Rhythm is regular. First and second heart sounds normal. No murmurs, rubs or gallops. Abdominal exam reveals normal bowel sounds, no masses, no organomegaly and no aortic enlargement. Extremities are edematous 2+. LABS: FIO2 (L. OR %): 21 O2CT.: 10.9 PCO2: 40 PO2: 43 L* BASE EXCESS: 6.3 H PT. TEMP: 37.0 PCO2 AT PT. TEMP: 40 PO2 AT PT. TEMP: 43 PH {ARTERIAL}: 7.49 H HCO3: 30.1 H SAT: 79.5 L* ALLENS TEST: + ctCO2(B)c: 27.7 TROP-I iSTAT: 0.02 BNPS: 273 H SODIUM: 137 POTASSIUM: 2.8 L CHLORIDE: 98 CO2: 30 H ANION GAP (CALCULATED): 9 GLUCOSE: 160 H CREATININE: 1.0 CALCIUM: 8.4 EGFR: 74 UREA, BUN: 14 WBC: 7.6 RBC: 3.30 L HGB: 10.5 L HCT: 31.6 L MCV: 95.8 H MCH: 31.8 MCHC: 33.2 RDW: 15.3 PLT: 218 MPV: 9.7 EOSINO, ABSOLUTE: 0.1 BASO, ABSOLUTE: 0.0 GRAN % (SS): 75.0 H LYMPH % (SS): 14.4 L MONO % (SS): 8.9 EOS% (SS): 1.4 BASO% (SS): 0.3 GRAN# (SS): 5.7 LYMPH# (SS): 1.1 MONO# (SS): 0.7 MDW: 22.36 H* IMAGING: Findings: Chest portable AP projection has been received for interpretation. There is diffusely increased interstitial markings involving bilateral lungs with redistribution of flow to the upper lobe vasculature keeping with pulmonary venous congestion. Small right pleural effusion is suspected. Cardiac silhouette remains enlarged. Trachea is midline. Impression: Diffusely increased interstitial opacities involving bilateral lungs and small right pleural effusion. In the setting of cardiomegaly differential diagnosis includes interstitial pulmonary edema, although superimposed worsening Covid pneumonia cannot be excluded. EKG: Patient EKG shows an atrial fibrillation with a rate of 82 left axis deviation with a low voltage incomplete right bundle branch block with a QTC of 488 there is no change in this EKG from the one from August 2022 he has no STEMI present
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2493224

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: TX
Alter: 60,0
Geschlecht: F
Eingang: 28.10.2022
Impfdatum: 28.04.2022
Beginn: 02.09.2022
Tage bis Beginn: 127,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Blindness unilateral COVID-19 Cerebrovascular accident Cough Dizziness Eye haemorrhage Eye inflammation Eye swelling Feeling of body temperature change Influenza like illness Ophthalmic artery thrombosis Ophthalmological examination abnormal SARS-CoV-2 test positive Secretion discharge Sleep disorder Throat irritation

Symptomtext

On 9/2/2022, my throat was scratchy, but I also had mucous, I had severe flu-like symptoms, a bad cough, and I was weak, and I was hot and cold. On 9/3/2022, I took a COVID-19 home test and it was positive. My cough got worse that I could not sleep. I called the doctor's nurse; I told her I was very light-headed, and she thought it could be my multiple sclerosis. She advised me to go to the ER and to check my lungs. There was a very long wait at the emergency room, so I did not want to wait, so I went home. I started taking over-the-counter cough medication and doing everything I could think of. I started to feel better a little over a week. I tested negative about 10 or 11 days after I contacted COVID-19. Then the last week of 9/2022, I could not see out of my left eye. I went to the Emergency room; I waited 36 hours. The ophthalmologist diagnosed me with bleeding in the back of my left eye and inflammation. The ophthalmologist explained to me that I had a stroke in my left eye, for no known reason. I went for a follow up. And the doctor said it was not a cause of my blood pressure and not caused by multiple sclerosis. The doctor thinks that it was due to COVID-19. They think COVID-19 caused a clot in the back of my eye. The doctor said it was not reversible. On 10/31/2022 I have an appointment with ophthalmologist to have an injection in my eye to help with the swelling in my eye.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: 9/3/2022 -COVID-19 home test- positive 10/14/2022 - Eye exam- bleeding in the back of my eye and inflammation
Aktuelle Erkrankungen: N/A
Vorgeschichte: Multiple sclerosis
Andere Medikamente: Lipitor; Cymbalta; Buspirone; Abalago
Allergien: None
Vorherige Impfungen: -

VAERS 2489860

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: MI
Alter: 92,0
Geschlecht: M
Eingang: 26.10.2022
Impfdatum: 27.04.2022
Beginn: 15.10.2022
Tage bis Beginn: 171,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal COVID-19 COVID-19 pneumonia Cardiac failure acute Cardiac failure congestive Chest X-ray abnormal Condition aggravated Cough Dyspnoea Goitre Hypoxia Mediastinal disorder Polyuria SARS-CoV-2 test positive Tracheal deviation

Symptomtext

COVID + 10/15/22 - Vaccination status - moderna x4 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/15/2022 Discharge Date: Oct 17, 2022 Active Hospital Problems Diagnosis Date Noted POA ? COVID-19 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 92-year-old man with past medical history significant for diastolic HF, CAD s/p CABG, atrial flutter s/p ablation, HTN, HLD and BPH who presented to the ED with cough and shortness of breath. Was saturating 76% o on room air in the emergency department and placed on 2 L which subsequently improved to 90%. COVID-19 PCR was positive. CXR showing mediastinal widening likely due to goiter, no airspace consolidation or effusions. Admitted with acute respiratory insufficiency with hypoxia, treatment for COVID-19 pneumonia. CT angiogram thorax demonstrated no pulmonary embolism, without any pulmonary consolidation or pleural effusions, worsening thyromegaly with left lower retrosternal extension, tracheal deviation, , known due to mass effect from above (tracheal diameter 1 cm previously 1.3 cm in 2019). Possible tracheal bronchomalacia. Findings were shared with ENT who recommended outpatient follow-up only. Patient was started on Decadron, remdesivir for COVID 19 PCR and continue with IV diuresis. Patient's hypoxia quickly resolved and he was no longer supplemental oxygen. IV Lasix was transitioned back to his home dose furosemide at discharge. Patient was discharged on oral Decadron. Id patient was evaluated by SLP who showed no significant dysphagia and recommended no further SLP intervention. Patient was evaluated by PT and OT recommended home with assist. Patient was subsequent discharged home in medically stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Arthritis Intestinal disaccharidase deficiencies and disaccharide malabsorption Elevated PSA- PSA 5.1 5-4-11, 6.6 3-23-10, 4.8 3-25-09, 5.7 9-14-07, 4.3 2006, 5.0 2000, Biopsy 6-6-12 Neg, 1-8-08 neg, HG PIN 2000, MUSIC BPH w Urinary Obs/LUTS- on Terazosin Prostate nodule Trux Bx 6-6-12 - Negative. MUSIC History of MI (myocardial infarction) Coronary artery disease involving native coronary artery of native heart without angina pectoris MI 2001 Hypercholesterolemia Hypertension Chronic diastolic congestive heart failure Aneurysm of infrarenal abdominal aorta S/P CABG x 3 2002 Atrial flutter Chronic diastolic (congestive) heart failure S/P atrial flutter ablation 2019
Andere Medikamente: Acetaminophen 500 mg Oral Every 6 hours PRN amLODIPine Besylate 2.5 MG TAKE 1 TABLET TWICE A DAY Amoxicillin 500 MG take 4 capsules by mouth 1 hour prior to dental appointment Aspirin 81 mg Oral Nightly Atorvastatin Calcium 40 MG TAKE 1 TAB
Allergien: Ace Inhibitors Cough
Vorherige Impfungen: -

VAERS 2467321

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: MI
Alter: 70,0
Geschlecht: M
Eingang: 03.10.2022
Impfdatum: 17.05.2022
Beginn: 18.09.2022
Tage bis Beginn: 124,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Anticoagulant therapy Asthenia Blood loss anaemia COVID-19 Deep vein thrombosis Delirium Disorientation Encephalopathy Faeces discoloured Gastric ulcer Gastrointestinal tube insertion Haematoma Haemoglobin decreased Hyperkalaemia Hypophagia Klebsiella infection

Symptomtext

Discharge Provider: DO Primary Care Provider: NP Admission Date: 9/18/2022 Discharge Date: 10/03/2022 PRESENTING PROBLEM: Acute renal failure (ARF) (HCC) AKI (acute kidney injury) (HCC) HOSPITAL COURSE: Patient is a 70 year old male with hx of HTN, thoraco-abdominal aortic aneurysm sp TEVAR (Jan 2022), CKDIIIa, OSA, chronic gastritis, protein calorie malnutrition and deconditioning who presented with 1 week of generalized weakness and was admitted for urosepsis, AKI, and COVID-19. He was lethargic and slow to answer questions on admission and oriented only to location. He was found to have a UTI from Klebsiella as well as acute hypoxic respiratory failure likely from COVID. He was treated Decadron for 10 days for his COVID. Upper and lower extremity US's were obtained which showed extensive DVT within his right lower extremity from femoral vein through posterior tibial vein. He was then started on a heparin drip. His encephalopathy was suspected from delirium with components of his sepsis and COVID. MRI brain was ordered which ruled-out stroke. He continued to have encephaloapthy despite antibiotics and so thiamine was ordered to empirically treat for Wernicke's. Something was placed for severe protein calorie malnutrition with inability to meet nutrition goals through oral intake. While he was on heparin drip, he then had an acute drop in hemoglobin. Heparin was held. No blood transfusions were given. GI was consulted as he does have a history of peptic ulcer disease with EGD in July 2022 which showed multiple benign-appearing ulcers in the antrum. He also started having black bowel movements as well. He was started on IV PPI drip per GI and he was deemed high risk for anesthesia with endoscopy with a hemoglobin <7. Interventional radiology was consulted for placement of IVC filter as his acute DVT was untreated. They did not recommend an IVC filter to be placed with his hemoglobin continuing to be around 5. IR was also asked about possible embolization for his upper GI bleed, but CTA was needed prior. Unfortunately, he had poor renal function. He had AKI on CKDIIIa likely due to ATN from his urosepsis and poor oral intake. His renal function continued to be poor and he developed hyperkalemia that was responsive to treatment. Since 9/26 His dark, tarry bowel movements ceased and hemoglobin remained around 4-5. Bloodless management of severe anemia recommendations were given which included high doses of Vitamin D3, EPO, IV iron, Folate, and Vitamin B12 as well as 6L of oxygen through nasal cannula. As no intervention was able to be done for his DVT and his hemoglobin was stable with no signs of active bleeding his case was discussed with UofM who agreed to transfer. Of note, on 9/30 patient did develop a new painless mass on the right inner thigh. An US was done and show an avascular lesion concerning for possible abscess or hematoma. Given lack of pain or purulent discharge hematoma was considered and this could be affecting patients hemoglobin. Patient's family was regularly updated with goals of care conference and Palliative Care consult was offered. Patient's wife who is DPOA declined Palliative Care consult at that time. -- On 10/1, patient had acute blood loss anemia from left calf hematoma. Hb 4s. Unable to receive blood and transferred emergently to U of M.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension Chronic gastritis with bleeding Blood transfusion declined Chronic ulcer of lower extremity (HCC) Urinary retention Chronic hypoxemic respiratory failure (HCC) Chronic hypercapnic respiratory failure (HCC) Morbid obesity (HCC) Obstructive sleep apnea Obesity hypoventilation syndrome (HCC) History of repair of Stanford type B dissecting aneurysm of thoracic aorta Chronic lymphangitis Physical deconditioning Lymphedema of both lower extremities Thoracoabdominal aortic dissection (HCC) Encysted hydrocele Chronic pain Localized edema Anemia Scrotal edema Left leg weakness
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet cholecalciferol (VITAMIN D3) 1.25 MG (50000 UT) cyanocobalamin (B-12) 1000 MCG/ML injection folic acid 1 mg in dextrose 5 % 100 mL insulin lispro (HUMALOG KWIKPEN) 100 UNIT/ML SOPN pen insulin lispro (H
Allergien: Benadryl [Diphenhydramine]Other Neomycin-bacitracin-polymyxinItching
Vorherige Impfungen: -

VAERS 2427648

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: MI
Alter: 79,0
Geschlecht: F
Eingang: 02.09.2022
Impfdatum: 08.08.2022
Beginn: 14.08.2022
Tage bis Beginn: 6,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 COVID-19 pneumonia Central venous catheterisation Cough Dyspnoea Positive airway pressure therapy Pyrexia Respiratory failure Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Patient with COVID booster on 08/08/2022 who was diagnosed with COVID via PCR on 08/14/22 and admitted to hospital with COVID complications. Provider d/c note: "79-year-old female patient with past medical history of morbid obesity, hypertension, diabetes mellitus, elevated cholesterol, was recently admitted the hospital from 08/04 through 8/8 for left calcaneal wound, osteomyelitis, on IV Unasyn at nursing home through September 18 th 79 YO female presenting to the ED with sob. Past medical history as listed below. Patient reports 1-2 days of shortness of breath, cough, congestion, fevers. She was recently admitted for left heel wound from 8/4-8/8. She is currently receiving Unasyn through a PICC line. She is living in a nursing facility. Overnight they noticed that she was satting 70-80% on her home CPAP with 2 L. they noticed a temperature of a 101? there. The EMS reported Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) treated for acute hypoxic respiratory insufficiency from COVID pneumonia, on Decadron and remdesivi"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: COVID detected PCR on 08/14/22
Aktuelle Erkrankungen: Infected wound and hospitalization 08/04/22 to 08/08/22.
Vorgeschichte: Essential hypertension Diabetes mellitus type 2 in obese Elevated cholesterol Morbid obesity with body mass index (BMI) of 50.0 to 59.9 in adult OSA (obstructive sleep apnea) Primary osteoarthritis involving multiple joints Depression Arthritis Former smoker First degree AV block Orthostatic hypotension Ulcer of right foot with fat layer exposed (*)
Andere Medikamente: Aspirin Lipitor D3 Prozac Neurontin Glucotrol Novolin Insulin Zestoretic Mobic Metformin Theragran Pataday Eye Drops Lovaza Fish Oil
Allergien: Tape/adhesives
Vorherige Impfungen: -

VAERS 2414753

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: MN
Alter: 56,0
Geschlecht: F
Eingang: 18.08.2022
Impfdatum: 05.05.2022
Beginn: 20.07.2022
Tage bis Beginn: 76,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure Condition aggravated Cough Dyspnoea Oropharyngeal pain SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient tested positive for COVID-19 on 7/15. She was seen in the ED on 7/20 for worsening shortness of breath, cough, and sore throat. While in the ED, she was placed on 1L O2. Patient was admitted from 7/20 - 7/23 for acute hypoxic respiratory failure due to COVID-19 pneumonia and acute exacerbation of HFpEF, newly diagnosed. Patient has been vaccinated and boosted against COVID-19. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2396319

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: WV
Alter: 79,0
Geschlecht: M
Eingang: 29.07.2022
Impfdatum: 04.06.2022
Beginn: 15.07.2022
Tage bis Beginn: 41,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Alanine aminotransferase normal Anion gap Anticoagulant therapy Aspartate aminotransferase normal Asthenia Atrial fibrillation Bandaemia Basophil count normal Basophil percentage decreased Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride decreased Blood creatinine increased Blood culture Blood glucose increased

Symptomtext

ED note by Dr. 7/15/22: "Date: 7/15/2022 Primary care provider: MD Means of arrival: ambulance History obtained from: patient History limited by: none Chief Complaint: Shortness of Breath HISTORY OF PRESENT ILLNESS Patient, is a 79 y.o. male who presents to the Emergency Department complaining of shortness of breath. The patient states that he has had symptoms of diffuse body aches, congestion, coughing, and generalized weakness for the past several days after returning from a trip. The patient states that his symptoms have persisted since onset, and he notes that he recently tested positive for COVID-19 on 7/10/22. The patient states that last night around 22:00 he developed a sudden onset of shortness of breath. The patient states that his breathing has been increasingly labored since this time, and he states that he has been unable to catch his breath prior to arrival to the ED. The patient denies any alleviation of his symptoms prior to arrival to the ED with breathing treatments at home, so he called EMS for transport here to the ED. The patient has a history of sleep apnea, diabetes, hypertension, and atrial fibrillation among other conditions. The patient is on the blood thinner Eliquis among other medications at this time. The patient denies symptoms of nausea, vomiting, diarrhea, syncope, fever, headaches, chest pain, abdominal pain, and any urinary or bowel issues. " H&P note by Dr. on 7/15/22: "Date of Service: 7/15/2022 Patient, 79 y.o. male Encounter Start Date: 7/15/2022 Inpatient Admission Date: 7/15/2022 PCP: MD Information Obtained from: patient and history reviewed via medical record Chief Complaint: Shortness of breath HPI: Patient is a 79 y.o., male who presents with shortness of breath. The patient states that he has had symptoms of diffuse body aches, congestion, coughing, and generalized weakness for the past several days after returning from a trip. The patient states that his symptoms have persisted since onset, and he notes that he recently tested positive for COVID-19 on 7/10/22. Relates that his symptoms were not severe at that time and he was not hypoxic. He was not offered Paxlovid due to his medical history and states that he was not offered monoclonal antibodies at that time. Patient is quadruple vaxxed for COVID, last booster approximately 1 month ago. The patient states that last night around 22:00 he developed a sudden onset of shortness of breath. The patient states that his breathing has been increasingly labored since this time, and he states that he has been unable to catch his breath prior to arrival to the ED. The patient denies any alleviation of his symptoms prior to arrival to the ED with breathing treatments at home, so he called EMS for transport here to the ED. The patient has a history of sleep apnea, diabetes, hypertension, CHF, permanent pacer and atrial fibrillation among other conditions. The patient denies symptoms of nausea, vomiting, diarrhea, syncope, fever, headaches, chest pain, abdominal pain, and any urinary or bowel issues. on arrival to the ED the patient was in some moderate respiratory distress, with cough productive of yellowish tan sputum and was immediately requiring supplemental oxygen at 6-8 liters/minute. Of note patient does wear nocturnal BiPAP for sleep apnea. Chest x-ray reveals bibasilar patchy infiltrates. Laboratory evaluation revealed a white count of 10.6 with bandemia and left shift, D-dimer is elevated at 4,958, CRP of 344.7 and LDH of 251. Chemistries otherwise reveal hyperglycemia consistent with his diagnosis of diabetes and stable baseline renal function with creatinine at 2.56. Confirmatory swab is positive for COVID-19. He will be admitted with acute hypoxemic respiratory failure likely due to COVID-19 with concern for superimposed bacterial pneumonia. Assessment/Plan: Active Hospital Problems (*Primary Problem) Diagnosis ? *Acute hypoxemic respiratory failure due to COVID-19 ? Bilateral pneumonia ? OSA treated with BiPAP ? Type 2 diabetes mellitus, with long-term current use of insulin ? Stage 4 chronic kidney disease ? Paroxysmal A-fib ? Chronic systolic congestive heart failure Acute hypoxemic respiratory failure due to COVID-19 Bilateral pneumonia --elevation multiple inflammatory markers --diagnosed with COVID-19 initially on 07/10 --begin appropriate COVID supplementation --enhanced droplet isolation --begin ceftriaxone and azithromycin for bacterial coverage --inhaled bronchodilators --Pepcid b.i.d. --Solu-Medrol 40 mg b.i.d. --melatonin --serial inflammatory markers --pulse oximetry --telemetry monitoring --close monitoring for decompensation given multiple risk factors for poor outcomes in COVID OSA with BiPAP --patient states he has been compliant with his nocturnal BiPAP --will continue BiPAP per outpatient orders --may require extension of BiPAP to waking hours as well if respiratory status declines --follows with local pulmonology as outpatient DM 2 --continue long-acting insulin --SSI protocol --patient advised likely to develop worsening hyperglycemia with steroid therapy --goal glucose 120-180 CKD 4 --continue current medications --continue current diuretic therapy --consult Nephrology Chronic systolic congestive Heart failure Paroxysmal atrial fibrillation Permanent pacemaker --EKG reflects ventricular pacing --continue anticoagulation with apixaban --continue rate control agents --given bibasilar infiltrates and history of CHF will check BNP --consider echocardiogram"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: PHYSICAL EXAM Vitals: ED Triage Vitals BP (Non-Invasive) 07/15/22 0242 (!) 163/69 Heart Rate 07/15/22 0242 (!) 116 Respiratory Rate 07/15/22 0242 (!) 30 Temperature 07/15/22 0242 37.1 ?C (98.7 ?F) SpO2 07/15/22 0240 92 % Weight 07/15/22 0242 98 kg (216 lb) Height 07/15/22 0242 1.803 m (5' 11") Labs: Results for orders placed or performed during the hospital encounter of 07/15/22 COMPREHENSIVE METABOLIC PANEL, NON-FASTING Result Value Ref Range SODIUM 141 136 - 145 mmol/L POTASSIUM 3.9 3.5 - 5.1 mmol/L CHLORIDE 97 96 - 111 mmol/L CO2 TOTAL 27 23 - 31 mmol/L ANION GAP 17 (H) 4 - 13 mmol/L BUN 86 (H) 8 - 25 mg/dL CREATININE 2.56 (H) 0.75 - 1.35 mg/dL BUN/CREA RATIO 34 (H) 6 - 22 ESTIMATED GFR 25 (L) >=60 mL/min/BSA ALBUMIN 2.9 (L) 3.4 - 4.8 g/dL CALCIUM 9.1 8.8 - 10.2 mg/dL GLUCOSE 226 (H) 65 - 125 mg/dL ALKALINE PHOSPHATASE 97 45 - 115 U/L ALT (SGPT) 23 10 - 55 U/L AST (SGOT) 23 8 - 45 U/L BILIRUBIN TOTAL 1.0 0.3 - 1.3 mg/dL PROTEIN TOTAL 7.0 6.0 - 8.0 g/dL TROPONIN-I Result Value Ref Range TROPONIN I 39 (HH) 7 - 30 ng/L CBC WITH DIFF Result Value Ref Range WBC 10.6 3.7 - 11.0 x10?3/uL RBC 3.72 (L) 4.50 - 6.10 x10?6/uL HGB 12.4 (L) 13.4 - 17.5 g/dL HCT 37.8 (L) 38.9 - 52.0 % MCV 101.6 (H) 78.0 - 100.0 fL MCH 33.3 (H) 26.0 - 32.0 pg MCHC 32.8 31.0 - 35.5 g/dL RDW-CV 15.6 (H) 11.5 - 15.5 % PLATELETS 256 150 - 400 x10?3/uL MPV 9.8 8.7 - 12.5 fL BLUE TOP TUBE Result Value Ref Range RAINBOW/EXTRA TUBE AUTO RESULT Yes COVID-19, FLU A/B, RSV RAPID BY PCR Result Value Ref Range SARS-CoV-2 Detected (A) Not Detected INFLUENZA VIRUS TYPE A Not Detected Not Detected INFLUENZA VIRUS TYPE B Not Detected Not Detected RESPIRATORY SYNCTIAL VIRUS (RSV) Not Detected Not Detected MANUAL DIFF AND MORPHOLOGY-SYSMEX Result Value Ref Range NEUTROPHIL % 76 % LYMPHOCYTE % 8 % MONOCYTE % 11 % EOSINOPHIL % 0 % BASOPHIL % 0 % NEUTROPHIL BANDS % 5 % NEUTROPHIL # 8.59 (H) 1.50 - 7.70 x10?3/uL LYMPHOCYTE # 0.85 (L) 1.00 - 4.80 x10?3/uL MONOCYTE # 1.17 (H) 0.20 - 1.10 x10?3/uL EOSINOPHIL # <0.10 <=0.50 x10?3/uL BASOPHIL # <0.10 <=0.20 x10?3/uL TOXIC GRANULATION Present (A) None RBC MORPHOLOGY Normal RBC and PLT Morphology LDH Result Value Ref Range LDH 251 (H) 125 - 220 U/L C-REACTIVE PROTEIN(CRP),INFLAMMATION Result Value Ref Range CRP INFLAMMATION 344.7 (H) <8.0 mg/L D-DIMER Result Value Ref Range D-DIMER 4,958 (H) <=232 ng/mL DDU Labs reviewed and interpreted by me. Cultures: BLOOD CULTURE - BMC ONLY - results pending at time of disposition BLOOD CULTURE - BMC ONLY - results pending at time of disposition Radiology: XR AP MOBILE CHEST (If patient condition warrants) Final Result Increased bibasilar opacities concerning for an infectious process in the appropriate clinical setting. Radiologist location ID: Radiological imaging interpreted by radiologist and reviewed by me. EKG: 12 lead EKG interpreted by me shows accelerated junctional rhythm, rate of 80 bpm, normal axis, nonspecific S and T wave abnormalities. tested positive for COVID-19 on 7/15/22 PCP is Dr.
Aktuelle Erkrankungen: -
Vorgeschichte: PAST MEDICAL: Past Medical History: Diagnosis Date ? A-fib ? Atrial fibrillation 11/24/2015 ? DM (diabetes mellitus) ? High cholesterol ? HTN (hypertension) 9/28/2015 ? Pacemaker ? Pleural effusion ? Sleep apnea Past Surgical History: Procedure Laterality Date ? HX APPENDECTOMY ? HX BACK SURGERY 11/15/2021 ? HX CORONARY ARTERY BYPASS GRAFT ? HX KNEE SURGERY ? HX PACEMAKER INSERTION 03/25/2016 ? HX TONSILLECTOMY Family History Family Medical History: Problem Relation (Age of Onset) Stroke Father Social History Social History Tobacco Use ? Smoking status: Former Smoker Packs/day: 1.00 Years: 45.00 Pack years: 45.00 Quit date: 11/18/2003 Years since quitting: 18.6 ? Smokeless tobacco: Never Used Substance Use Topics ? Alcohol use: Yes Alcohol/week: 0.0 standard drinks
Andere Medikamente: Medications Prior to Admission Prescriptions albuterol sulfate (PROVENTIL OR VENTOLIN OR PROAIR) 90 mcg/actuation Inhalation HFA Aerosol Inhaler Take 1-2 Puffs by inhalation Every 4 hours as needed (cough) Indications: bronchitis a
Allergien: Allergies Allergen Reactions ? Nkda [No Known Drug Allergies]
Vorherige Impfungen: -

VAERS 2388872

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: WA
Alter: 76,0
Geschlecht: M
Eingang: 25.07.2022
Impfdatum: 23.05.2022
Beginn: 19.07.2022
Tage bis Beginn: 57,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Inappropriate schedule of product administration SARS-CoV-2 test positive

Symptomtext

Patient received Moderna COVID vaccine on 2/16/21 (lot # 024M20A), 3/20/21 (lot # 001B21A), 11/2/21 (lot # 939904), and 5/23/22 (lot # 057M21A). On 7/19/22, patient admitted to our inpatient facility (med/surg unit) with acute hypoxemic respiratory failure due to COVID-19 pneumonia/infection. Patient was discharged home on 7/22/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: COVID status positive 7/19/22.
Aktuelle Erkrankungen: -
Vorgeschichte: history of COPD, OSA/OHS on CPAP, hypertension, hyperlipidemia, hypothyroidism, BPH
Andere Medikamente: acetaminophen, acetylcysteine, Advair inh, baby aspirin, atorvastatin, azithromycin, cetirizine, finasteride, gabapentin, hydrochlorothiazide, losartan, MVI, omeprazole, Proair HFA inh, sennosides/docusate, simethicone, Synthroid, tamsulosi
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2338995

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: OH
Alter: 84,0
Geschlecht: M
Eingang: 28.06.2022
Impfdatum: 03.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac failure Condition aggravated Death Intensive care

Symptomtext

Patient was en route to the ER but visited the pharmacy before getting admitted for symptomatic heart failure. Patient was then transferred to the ICU for exacerbated heart failure and passed two weeks later in his sleep.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Congestive heart failure
Vorgeschichte: Congestive heart failure
Andere Medikamente: don't know
Allergien: don't know
Vorherige Impfungen: -

VAERS 2320239

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 15.06.2022
Impfdatum: 25.04.2022
Beginn: 10.05.2022
Tage bis Beginn: 15,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Dyspnoea Respiratory failure

Symptomtext

Narrative: Per notes, patient was admitted to a local hospital on 5/3/22 with shortness of breath/respiratory failure and was offered intubation; however he did not want any further intervention and was made DNR/DNI. No other records from facility are available. There were 15 days from time of second booster to date of death. No autopsy report available.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2292628

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: MI
Alter: 92,0
Geschlecht: M
Eingang: 24.05.2022
Impfdatum: 26.04.2022
Beginn: 07.05.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Pre-existing disease

Symptomtext

death due to preexisting condition within 2 weeks of vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: cancer
Vorgeschichte: cancer
Andere Medikamente: multiple
Allergien: none
Vorherige Impfungen: -

VAERS 2290623

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: OH
Alter: 81,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 10.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Activated partial thromboplastin time Anticoagulant therapy Blood gases Catheter directed thrombolysis Chest X-ray Computerised tomogram head Computerised tomogram thorax Computerised tomogram thorax abnormal Differential white blood cell count Dizziness Dyspnoea Electrocardiogram Fibrin D dimer increased Full blood count International normalised ratio Laboratory test Prothrombin time Pulmonary embolism

Symptomtext

From 5/21/2022 Admission H&P: The patient is an 81-year-old female who presents to the ER with dizziness and sudden onset of shortness of breath that lasted for approximately 1/2-hour today. She recently flew approximately 1 month ago. She denies any chest pain, cough or hemoptysis. There has been no leg swelling or pain. She has not noticed any heart palpitations. During the ER evaluation a D-dimer was significantly elevated at 17,680. CT of the chest does confirm multiple numerous large acute bilateral pulmonary emboli. There is increased RV/LV ratio concerning for right heart strain. She will be admitted to the hospital for IV anticoagulation and EKOS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: CXR 5/21/22, 5/22/22, 5/23/22; CT Pulmonary Angiogram 5/21/22; CT Brain 5/21/22; ECG 5/21/22; Lower Extremity Venous Duplex 5/22/2022; CBC w/Diff 5/21/22, 5/22/2022, 5/23/2022; Blood Gas 5/21/2022, PT/PTT/INR 5/21/22, 5/22/22, 5/23/22; Chemistry 5/21/22, 5/22/22, 5/23/22: D-Dimer 5/21/2022
Aktuelle Erkrankungen: None known
Vorgeschichte: Impaired fasting glucose, hypertension, sinus tachycardia, pure hypercholesterolemia, vitamin D deficiency, GERD, iron deficiency, hair loss
Andere Medikamente: Vitamin D3 4000 units daily Zetia 10 mg daily Mobic 15 mg daily Omeprazole 10 mg capsule , two daily Altace 10 mg, two daily Maxzide -25 daily
Allergien: None known
Vorherige Impfungen: -

VAERS 2248211

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

kritisch

Staat: MN
Alter: 78,0
Geschlecht: M
Eingang: 22.04.2022
Impfdatum: 21.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

Massive stroke early this morning

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2632455

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 16.05.2023
Impfdatum: 04.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 22,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Aortic arteriosclerosis Cardiac failure congestive Cardiogenic shock Hyperparathyroidism secondary

Symptomtext

R57.0 CARDIOGENIC SHOCK 11/11/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED SECONDARY HYPERPARATHYROIDISM, RENAL ORIGIN R57.0 CARDIOGENIC SHOCK 11/11/2022 ATHEROSCLEROSIS OF AORTA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiogenic shock
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2582901

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: VT
Alter: 68,0
Geschlecht: F
Eingang: 16.02.2023
Impfdatum: 15.05.2022
Beginn: 01.05.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Deep vein thrombosis Ultrasound Doppler abnormal

Symptomtext

I had multiple small blood clots in right leg, saw doctor and he didn't think I need to see vein specialist, first booster did create blood clots that were discovered through ultrasound, the May vaccine bigger blood clots were discovered originally size of pea next were marble size.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: DVT 03Jan2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; low thyroid
Andere Medikamente: NP thyroid; metoprolol succ; hydrochlorothiazide; losartan; potassium; baby aspirin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2577275

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 07.02.2023
Impfdatum: 06.07.2022
Beginn: 30.12.2022
Tage bis Beginn: 177,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asymptomatic COVID-19 Blood lactic acid increased Condition aggravated Electroencephalogram normal SARS-CoV-2 test positive Seizure Seizure like phenomena Tachycardia White blood cell count increased

Symptomtext

Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Proviced d/c note: "72 year old female with a history of seizure disorder, schizoaffective disorder, T2DM, hypertension, hyperlipidemia, and hypothyroidism who presented a local HCF on 12/30/22 following seizure-like activity. Upon arrival to the ED, she was noted to be tachycardic with an elevated WBC and lactate. She did test positive for COVID, but had no clinical signs or symptoms of a systemic infection. It was presumed that her presentation was secondary to a breakthrough seizure. She was administered a Keppra loading dose and continued on her home Trileptal. An EEG was order, which failed to demonstrate and evidence of status. Neurology was consulted - recommending patient continue her current anti-epileptic regimen. They suspected that seizure was secondary to acute COVID infection. Patient was discharged in stable condition back to a facility. Seizure precautions were discussed including no driving, stating out of any depth of water/at heights/around heavy machinery or any other situation in which would be dangerous of a seizure what to occur."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 2,0
Labordaten: Covid PCR detected on 12/30/22
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Hypertension goal BP (blood pressure) < 130/80 Digestive Gastroesophageal reflux disease Endocrine Type 2 diabetes mellitus (*) Diabetic dermopathy (HCC) Primary hyperparathyroidism (HCC) Adrenal adenoma Uncontrolled type 2 diabetes mellitus with hyperglycemia (HCC) SIADH (syndrome of inappropriate ADH production) (HCC) Integumentary Acne rosacea Xerosis of skin Candidiasis of skin Psychological Anxiety disorder Schizoaffective disorder, depressive type (HCC) Urinary Absence of bladder continence UTI (urinary tract infection) Other Class 2 obesity due to excess calories without serious comorbidity with body mass index (BMI) of 36.0 to 36.9 in adult Mixed urge and stress incontinence History of 2019 novel coronavirus disease (COVID-19) Impaired mobility Impaired memory Fecal incontinence Dyslipidemia Arthritis, hip Sleep disorder due to a general medical condition, mixed type Non compliance w medication regimen Hyponatremia Tinea corporis Chest pain History of idiopathic seizure uncertain etiology Hypomagnesemia Weakness COVID-19 At risk for malnutrition Benzodiazepine dependence (HCC) Generalized muscle weakness Leukocytosis Elevated liver enzymes Seizure with history of prior seizure-like activity Transaminitis Troponin level elevated
Andere Medikamente: acetaminophen (TYLENOL) 500 mg tablet Take 1 tablet by mouth every 6 (six) hours as needed for Pain. amLODIPine (NORVASC) 5 mg tablet Take 1 tablet by mouth nightly. ammonium lactate (LAC-HYDRIN) 12 % lotion Apply topically as needed for
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2475452

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 12.03.2021
Beginn: 07.10.2022
Tage bis Beginn: 574,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Diabetic ketoacidosis Exposure to SARS-CoV-2 Intensive care SARS-CoV-2 test positive

Symptomtext

Pt arrived to the ICU from the Hospital post arrest and in DKA. Pt was also found to be COVID positive, and brother that she lives with is also COVID positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2344938

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: AZ
Alter: 65,0
Geschlecht: M
Eingang: 30.06.2022
Impfdatum: 29.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: ja

Aphasia Asthenia Gait inability Guillain-Barre syndrome Hypoaesthesia Immunoglobulin therapy Paraesthesia Tongue disorder

Symptomtext

Pt had received pfizer for all prior doses, then got moderna for last 4th booster dose. A few days later he started to develop paraesthesias/numbness in the hands/fingers. He gradually developed ascending weakness over the next month, ultimately affecting his tongue and speech. He was ultimately unable to speak or walk. he was ultimately hospitlized for his symptoms and diagnosed with Guillain Barre syndrome and was treated with IVIG, and his symptoms significantly improved, he was able to be discharged and returned to ambulation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 5,0
Labordaten: I don't yet have his discharge summary from his hospitalization.
Aktuelle Erkrankungen: Recent CABG, left ventricular thrombectomy, pericardiectomy, HFrEF, CAD, bioprosthetic mitral valve replacement all within 1-2 months prior. Was on home infusion pressors and midodrine for a while
Vorgeschichte: HFrEF, CAD
Andere Medikamente: midodrine, entresto, potassium chloride, furosemide, warfarin, aspirin, famotidine, atorvastatin, magnesium oxide, metolazone
Allergien: none
Vorherige Impfungen: -

VAERS 2312076

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

schwer

Staat: CO
Alter: 45,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 07.06.2022
Beginn: 07.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anaphylactic reaction Heart rate increased Pruritus Skin reaction

Symptomtext

Mild anaphylaxis, red pruritus on upper torso and neck, rapid heart rate, epi pen administered, major s/s resolved within 30 minutes, all symptoms resolved within 1 hour.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Allergies
Andere Medikamente: Unknown
Allergien: Mushrooms
Vorherige Impfungen: Moderna vaccine 5/1/21 & 5/29/21

VAERS 2310260

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: CO
Alter: 61,0
Geschlecht: F
Eingang: 06.06.2022
Impfdatum: 03.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Atrioventricular block second degree Blood test Cardiac disorder Cardiac imaging procedure abnormal Cough Dyspnoea Feeling abnormal Immunisation reaction Immunoglobulin therapy Laboratory test abnormal Malaise Myocarditis Nausea Pyrexia SARS-CoV-2 test negative Salpingectomy

Symptomtext

After receiving the vaccine I felt nauseas and I had a fever on May 5, 2022. I had a fever of 100.5 degrees and a cough. I felt a little better on Friday, May 6th, but I still felt a little sick just not as nauseas. The fever went away and then I flew. Then on May 18th I had a voluntary outpatient surgery to remove my fallopian tubes. It was preventive to prevent ovarian cancer. I do not have cancer. On May 19th my lingering cough got worse. Post surgery I started feeling bad. I developed a much worse cough and I started to feel very poorly and out of breath. When I called the surgery doctor she said to get a Covid test. I took the at home Covid test and it was negative. I went out on Tuesday and got a rapid and PCR Covid test did. They were both negative. In that time I was feeling very poorly until I called my internist. That doctor suggested I get a chest x-ray. My heart rate was 42 BPM when I checked it. I called my doctor and they told me to go to the ER which I did. In the ER they discovered that I have second degree AV block with 2 to 1 conduction. That's an electrical system heart problem that requires a pace maker to regulate my heartbeat for the rest of my life. I was admitted into the hospital and they decided to order a cardiac MRI. When the results came back from the MRI it showed I have myocarditis. That was causing me to have the AV block. They have run every infectious disease that could cause myocarditis, but everything so far that has come back negative with an exception of a few coming back with outstanding results. I have been working with a good infectious disease doctor who is well known. That doctor believes that the vaccine caused me to have myocarditis. I have had 2 infusions of IVIG for 2 days in a row. Today they are going to start me on steroids to reduce the inflammation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 8,0
Labordaten: Cardiac MRI- showed myocarditis; Multiple Infectious Disease Tests; Immunocompromising Disease Tests; Bloodwork. Infectious Disease Doctor.
Aktuelle Erkrankungen: Starting on 4/26/2022 I had a small cold, stuffy nose, and runny nose that lasted for 3 days.
Vorgeschichte: Osteoporosis; Right Bundle Branch Blockage (Benign)
Andere Medikamente: Vitamin B (possibly)
Allergien: NEOSPORIN (Topical)
Vorherige Impfungen: 2nd dose Covid Vaccine (2/17/2021)- I was sick for 3 days. I just got in bed and did nothing for 3 days. 3rd dose Covid Vaccine

VAERS 2283095

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: NY
Alter: 24,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 09.05.2022
Beginn: 09.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Chest discomfort Chest pain Dizziness Dysphagia Dyspnoea Eye swelling Fatigue Flushing Hyperhidrosis Lethargy Mouth swelling Nausea Pruritus Swelling face Swollen tongue Tachycardia Throat tightness

Symptomtext

Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe, Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Tachycardia-Severe, Additional Details: within 2 minutes of receiving the moderna covid 19 vaccine patient notified pharmacist she felt like her throat was closing, she said it felt like a brick was on her neck. she was also experiencing the symptoms checked above. following initial assessment pharmacist administered one dose (0.3mg) or epinephrine and called 911. pharmacist monitored patient symptoms and blood pressure and pulse until paramedics arrived. Patient was taken to local emergency department by ambulance.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2280866

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: IA
Alter: 67,0
Geschlecht: M
Eingang: 17.05.2022
Impfdatum: 22.04.2022
Beginn: 08.05.2022
Tage bis Beginn: 16,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test COVID-19 Chest X-ray Cough Dyspnoea Electrocardiogram Fatigue Loss of consciousness Nasopharyngitis SARS-CoV-2 test positive Throat irritation Urine analysis

Symptomtext

Approximately 2 weeks after my 4th dose I contracted COVID and had the following symptoms: Cough, Itchy/scratchy throat, Fatigue, Cold-like symptoms, Difficulty breathing. I also passed out and was brought to the Emergency Room and while I was there - they ran some tests (including COVID) and it came back positive. They prescribed me with Mucinex and Albuterol Inhaler and was also advised to do a little bit of movement exercises. As of today 05/17/2022 my symptoms have improved and I started feeling better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: COVID Test, Blood Test, Chest X-Ray, EKG, Urinalysis
Aktuelle Erkrankungen: Cold
Vorgeschichte: AFEB GERD, Sleep Apnea
Andere Medikamente: Metoprolol, Xarelto, Amlodipine, Losartan, Omeprazole, Famotidine, Prozac, Vitamin C, Vitamin D, Probiotic
Allergien: None
Vorherige Impfungen: -

VAERS 2273562

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: MA
Alter: 72,0
Geschlecht: F
Eingang: 12.05.2022
Impfdatum: 28.04.2022
Beginn: 06.05.2022
Tage bis Beginn: 8,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Oedema Pain in extremity Ultrasound Doppler abnormal Venous thrombosis limb

Symptomtext

5/06 Onset with edema, calf pain rt lower leg . 5/07 INR 2.0, 5/09 medical exam w/ ultrasound (result of 5 cm clot in peroneal vein), INR that day 2.7. Warfarin/ INR has been in good control for years after DVT/ PE event in 2005. Decision was to stop Warfarin and begin Apixaban and a hematology consult. Symptom are gradually resolving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Venous thrombosis limb
Hospital-Tage: -
Labordaten: as stated above
Aktuelle Erkrankungen: none
Vorgeschichte: hypertension, osteoarthritis, antithrombin deficiency
Andere Medikamente: losartan 50mg daily, warfarin, multivitamin, Tylenol prn, Zyrtec daily
Allergien: none
Vorherige Impfungen: -

VAERS 2271890

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

schwer

Staat: CO
Alter: 24,0
Geschlecht: M
Eingang: 11.05.2022
Impfdatum: 11.05.2022
Beginn: 11.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Fall Loss of consciousness

Symptomtext

After receiving his booster dose, patient lost conciousness and fell out of his chair. He remained unconcious for about 10 sec. He regained alterness but was still very "woozy" feeling.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2268834

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: MI
Alter: 72,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 24.02.2021
Beginn: 14.04.2021
Tage bis Beginn: 49,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Aspiration pleural cavity Chest discomfort Chills Dyspnoea Hyperhidrosis Pleural effusion Pneumonia Pulmonary oedema Vomiting

Symptomtext

Hospitalized with shortness of breath. See note. Patient is a 73 year old male with a history of coronary artery disease, COPD, kidney cancer, hypothyroidism, type II diabetes mellitus, a CABG, a nephrectomy with ESRD on HD, and a prostate resection who presents to the ED with a chief complaint of shortness of breath that began about 2 days ago. Patient states he was admitted to facility from 4/14/22-4/18/22 for pneumonia and pleural effusions. During this stay he had a thoracentesis performed. He states that since being discharged he has continued to experience chills, diaphoresis, and vomiting. Patient states that 2 days ago, he had the onset of shortness of breath and ?chest discomfort?, which he feels is similar to the last time he had ?fluid on his lungs?. Due to concerns for his symptoms, patient made the decision to return to the ED for evaluation today. Patient's wife additionally notes that he was supposed to receive dialysis yesterday, although he missed this appointment due to his symptoms. He rescheduled this appointment for today, although he wanted to be evaluated in the ED prior to this. He denies use of anticoagulants or fever. The patient is a former smoker and has no further complaints at this time. Patient is a 73 year old male with a history of coronary artery disease, COPD, kidney cancer, hypothyroidism, type II diabetes mellitus, a CABG, a nephrectomy with ESRD on HD, and a prostate resection who presents to the ED with a chief complaint of shortness of breath that began about 2 days ago. Patient states he was admitted to facility from 4/14/22-4/18/22 for pneumonia and pleural effusions. During this stay he had a thoracentesis performed. He states that since being discharged he has continued to experience chills, diaphoresis, and vomiting. Patient states that 2 days ago, he had the onset of shortness of breath and ?chest discomfort?, which he feels is similar to the last time he had ?fluid on his lungs?. Due to concerns for his symptoms, patient made the decision to return to the ED for evaluation today. Patient's wife additionally notes that he was supposed to receive dialysis yesterday, although he missed this appointment due to his symptoms. He rescheduled this appointment for today, although he wanted to be evaluated in the ED prior to this. He denies use of anticoagulants or fever. The patient is a former smoker and has no further complaints at this time. Patient discharged on 5/4/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CAD (coronary artery disease) Cancer COPD (chronic obstructive pulmonary disease) Diabetes ESBL (extended spectrum beta-lactamase) producing bacteria infection (~03/07/20) High cholesterol History of kidney cancer History of renal dialysis Hypothyroid PTSD (post-traumatic stress disorder) Type 2 diabetes mellitus
Andere Medikamente: Levothyroxine Aspirin Atorvastatin Amlodopine Bupropion HCL Loratadine Nitroglycerin
Allergien: Niacin, Pravastatin, Simvastatin
Vorherige Impfungen: -

VAERS 2267657

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21A

schwer

Staat: TX
Alter: 84,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 09.05.2022
Beginn: 09.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Loss of consciousness Syncope

Symptomtext

Patient received vaccine, went to sit down. After around 5-10 minutes became unconsious and suspected fainting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266984

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: TX
Alter: 76,0
Geschlecht: M
Eingang: 07.05.2022
Impfdatum: 04.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Atrial fibrillation Blood test Cardiac monitoring Cardiac stress test Heart rate increased Heart rate irregular Intensive care

Symptomtext

Patient presented to the ER with rapid and irregular heartrate. Patient was admitted to the ICU for continued evaluation and observation. He was diagnosed with new onset A-fib with RVR. Patient is being discharged with normal sinus rhythm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 2,0
Labordaten: Cardiac Stress Test, cardiac blood panels, constant cardiac monitoring, new medications with discharge.
Aktuelle Erkrankungen: None
Vorgeschichte: Hyperlipidemia, Hypertension, Benin prostatic Hyperplasia
Andere Medikamente: None
Allergien: Tetracycline
Vorherige Impfungen: -

VAERS 2264703

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: TX
Alter: 33,0
Geschlecht: F
Eingang: 05.05.2022
Impfdatum: 01.05.2022
Beginn: 02.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Flushing Hyperhidrosis Pyrexia Syncope Unresponsive to stimuli

Symptomtext

Systemic: Fainting / Unresponsive-Mild, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2261942

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

schwer

Staat: CA
Alter: 79,0
Geschlecht: F
Eingang: 03.05.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Chest discomfort Chest pain Confusional state Dizziness Dyspnoea Fatigue Hyperventilation Hypotension Lethargy Loss of consciousness Seizure Speech disorder Syncope Tremor Unresponsive to stimuli

Symptomtext

Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Hyperventilation-Medium, Systemic: Hypotension-Severe, Systemic: Shakiness-Severe, Systemic: Weakness-Severe, Additional Details: Patient came into pharmacy with 3 family members to receive their booster vaccine- previously had received two pfizer vaccines- walked around store before walking out to car- per family member (daughter?) patient began shaking/convulsing, unable to speak clearly, and "passed out" unresponsively. Emergency called/ems arrived prior to notification of pharmacist/pharmacy.. patient taken to hospital/emergency department

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2260071

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

schwer

Staat: NH
Alter: 25,0
Geschlecht: U
Eingang: 02.05.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope Unresponsive to stimuli

Symptomtext

Systemic: Fainting / Unresponsive-Medium, Additional Details: pt fainted within the 15 minute window post vaccination while still in pharmacy where vaccine was administered

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2248083

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: MA
Alter: 60,0
Geschlecht: M
Eingang: 22.04.2022
Impfdatum: 19.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure abnormal Dizziness Flushing Hyperhidrosis Presyncope

Symptomtext

Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: Patient almost fainted after vaccine administration (2 minutes). Called NP to him and NP had patient lie down for about 15 minutes. Symptoms resolved after fluids, lifting legs above head and giving patient an ice pack. BP measured at 5 minute increments until back to normal. Patient waited an additional 15 minutes post incident to ensure that he felt back to normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2246349

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

schwer

Staat: GA
Alter: 49,0
Geschlecht: M
Eingang: 21.04.2022
Impfdatum: 21.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Syncope

Symptomtext

The patient had syncope. He fell on the floor from a sitting position.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: asthma, he also stated he was immunocompromised
Vorgeschichte: asthma
Andere Medikamente: n/a
Allergien: none
Vorherige Impfungen: -

VAERS 2246204

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

schwer

Staat: MA
Alter: 27,0
Geschlecht: M
Eingang: 21.04.2022
Impfdatum: 21.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Seizure Syncope

Symptomtext

Patient received the first dose of Moderna vaccine today 4/21/22. After vaccine was administered and patient was moved to post-vaccination waiting area, he fainted, collapsed and began having a seizure. Code white was called, 911 called, seizure lasted about 15-20 seconds and patient came to. Cold compress was applied to back of patients neck, water and orange juice were given to patient. Patient stated having vasovagal reaction to a blood draw many years ago, but never with the vaccines that he has received in the past. Patient stated that he has had a seizure before, but not on any medication to treat seizures. All was discussed prior to vaccine administration and patient left with EMT's shortly after they arrived.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2639220

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: TX
Alter: 59,0
Geschlecht: F
Eingang: 31.05.2023
Impfdatum: 26.05.2022
Beginn: 18.01.2023
Tage bis Beginn: 237,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain Cough Ear infection Influenza like illness Influenza virus test negative Laboratory test normal Pain Respiratory tract congestion SARS-CoV-2 test negative Sinusitis Wheezing

Symptomtext

18JAN2023 I could not stop coughing and I was feeling achy and flu like symptoms, I had no temperature or fever. I had head congestion, chest pains when I would cough, coughing became worse especially when laying down. I went to the local clinic and was tested for COVID-19 an influenza both were negative. I was wheezing so the nurse prescribed cough medicine and to follow up with my PCP, with the stormy weather it was February 2023 before I saw my PCP. I was still coughing, wheezing and I was diagnosed with sinus and ear infections once I saw my PCP. I was tested for COVID-19 and bronchitis both were negative. This lasted for three or four weeks total.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Influenza and COVID-19 test negative.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: NORVASC
Allergien: Environmental; dairy
Vorherige Impfungen: -

VAERS 2628438

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 08.05.2023
Impfdatum: 17.06.2022
Beginn: 07.07.2022
Tage bis Beginn: 20,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Epilepsy Hypotension Idiopathic generalised epilepsy Reversible ischaemic neurological deficit

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE EPILEPSY, GENERALIZED IDIOPATHIC CLONIC EPILEPSY EPILEPSY, UNSPECIFIED REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME HYPOTENSION 7/8/2022 & 8/20/2022 -- HOSP- HOSPITAL

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627387

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MI
Alter: 84,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 12.05.2022
Beginn: 02.04.2023
Tage bis Beginn: 325,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Blood electrolytes COVID-19 Cardiac failure acute Cardiac failure congestive Chest discomfort Condition aggravated Cough Diuretic therapy Dyspnoea Dyspnoea exertional Electrolyte substitution therapy Gait disturbance Hypoxia Insomnia Joint swelling Left ventricular failure Oedema peripheral

Symptomtext

Discharge Physician: MD, MPH Primary Care Physician: MD Date of Admission: 4/2/2023 Discharge Date: 4/3/2023 Room Number: PRESENTING PROBLEM: Shortness of breath [R06.02] Pleural effusion [J90] Chest pressure [R07.89] Hypoxia [R09.02] Acute decompensated heart failure [I50.9] Acute on chronic diastolic (congestive) heart failure [I50.33] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 85 y.o. very pleasant female who presents to ER today with worsening dyspnea over last few days, Chest pressure - pleuritic, new nonproductive cough, new onset orthopnea, last 2 nights couldn't sleep, barely can walk 6 feet with severe dyspnea. Edema in LE are improving. Denies fever, chills, n/v, diarrhea, myalgias. Reports improvement in LLE knee pain and swelling. Patient's PCP referred her to the emergency room for further evaluation. In the ED she was +COVID19 and did not require supplemental oxygen. She was noted to be hypoxic with exertion only. She was started on IV diuresis and continued on IV antibiotics. Patient had good urine output and improvement of symptoms. Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Spinal stenosis of lumbar region with neurogenic claudication Essential hypertension Osteopenia of lumbar spine Hypothyroidism due to acquired atrophy of thyroid Mixed hyperlipidemia Major depressive disorder, recurrent, in remission, unspecified History of ductal carcinoma in situ (DCIS) of breast Primary osteoarthritis involving multiple joints Paroxysmal atrial fibrillation Primary osteoarthritis of left knee S/P revision of total knee, left Infection of prosthetic knee joint Multiple subsegmental pulmonary emboli without acute cor pulmonale Duodenal ulcer Acute blood loss anemia Primary insomnia Chronic diastolic heart failure Normocytic anemia MSSA (methicillin susceptible Staphylococcus aureus) infection left knee
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet apixaban (ELIQUIS) 5 MG tablet cephalexin (KEFLEX) 500 MG capsule furosemide (LASIX) 20 MG tablet levothyroxine (SYNTHROID) 100 MCG tablet metoprolol tartrate (LOPRESSOR) 25 MG tablet pantoprazole (PROT
Allergien: None
Vorherige Impfungen: -

VAERS 2626040

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MI
Alter: 57,0
Geschlecht: M
Eingang: 03.05.2023
Impfdatum: 29.04.2022
Beginn: 02.05.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Condition aggravated Cough Fatigue Productive cough Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

On 4/29/2022, I got my second Moderna COVID-19 booster and a flu shot. On 5/2/2022, I took a home antigen test and got a positive result. On 5/3/2022, I woke up and felt like I was getting chest congestion. I had a productive cough and coughed up some phlegm. I called my PA, and he prescribed me PAXLOVID, which I began taking that day. I had just the congestion, cough, and a bit of a chill for the rest of the day. On the morning of 5/4/2022, I woke with a productive cough. By that evening, the cough was pretty much gone, though. I had fatigue for a few days. I then finished my isolation and then returned to my normal life afterwards. I have been dealing with fatigue for the past couple of years, but it became even more pronounced in September 2022. I don't blame the vaccine or the COVID-19. I have osteoarthritis, psoriatic arthritis, and arteriosclerosis, so I think it may tie in with those conditions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 02MAY2022 home antigen test, positive result
Aktuelle Erkrankungen: None
Vorgeschichte: COPD; Osteoarthritis; Psoriatic Arthritis; Arteriosclerosis
Andere Medikamente: ONE-A-DAY multivitamin; B complex; DULCOLAX; vitamin D3 (Rx) (2000 IU); baclofen; atorvastatin; amitriptyline; nabumetone; albuterol inhaler; hydrocodone
Allergien: Penicillin; DEMEROL
Vorherige Impfungen: -

VAERS 2624699

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MS
Alter: 55,0
Geschlecht: F
Eingang: 02.05.2023
Impfdatum: 29.04.2022
Beginn: 13.02.2023
Tage bis Beginn: 290,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chest pain Cough Dizziness Dyspnoea Epistaxis Gait inability Headache Malaise Pyrexia SARS-CoV-2 test positive Taste disorder

Symptomtext

On February 13 I was not feeling well, I had a fever 101F, a bad headache, coughing, I could not breath, I was dizzy, I could not walk, my taste was not right, my nose was bleeding off and on. I went to the local Urgent Care they tested me for COVID-19, the test came back negative. The next day I was feeling even worse, I went back to the Urgent Care, they tested me again for COVID-19 this time the test came back positive. I was prescribed Paxlovid, Azithromycin, Dexamethasone that I was able to start that day. I was also advised to stop taking my Lipitor, baby aspirin while using the Paxlovid, I needed to use my Albuterol Inhaler daily. Three weeks after I started feeling better I my chest started hurting, I could breathe very well, my headaches are excruciating and will not go away. The doctors say it could be lingering COVID-19 side effects but I do have an MRI scheduled on May 10 so they can check to make sure nothing is causing the headaches.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 13FEB2023 PCR Rapid COVID-19 test - negative; 13FEB2023 PCR Rapid COVID-19 test - positive
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes; Hyperlipidemia; Migraines; Hypertension; Bulging Disc
Andere Medikamente: Baby Aspirin; Metformin; Lipitor; Losartan Potassium; Hydrochlorothiazide; Sucralfate; Nifedipine ER; Atenolol; Albuterol Inhaler as needed; Norco as needed; Flonase; Pantoprazole; Tizanidine; Linzess; Topamax; Nurtec as needed
Allergien: Sulfa Drugs; Amoxicillin
Vorherige Impfungen: -

VAERS 2624644

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MA
Alter: 77,0
Geschlecht: F
Eingang: 02.05.2023
Impfdatum: 25.04.2022
Beginn: 27.03.2023
Tage bis Beginn: 336,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood test abnormal Headache Hypertension Tri-iodothyronine increased

Symptomtext

My head was aching pretty bad. I took my blood pressure, and it read 200/110; I called my doctor and had to wait for an appointment. I took a second read which was still high but not as damaging as the initial one. When I finally had my doctor's appointment, we discussed what could of caused the elevated blood pressure. They took blood for testing; my T3 levels were higher than expected. I was instructed to stop taking my thyroid medication until my follow-up appointment. I stopped taking it for 5 days, and my blood pressure stabilized to normal. With Hashimoto's, I'm not suppose to go long periods without taking my medication. During the follow-up, they cut the dosage of my thyroid medication in half to keep it from elevating my blood pressure. Since then, my blood pressure has returned to what it used to be with seldom spikes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: MAR2023 -- Bloodwork
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypothyroidism (Hashimoto's Disease)
Andere Medikamente: Armour Thyroid; Omega-3; Vitamin D3; Multivitamin; Biotin
Allergien: Penicillin; Sulfa Drugs; Lactose Intolerant; Strawberries
Vorherige Impfungen: -

VAERS 2624228

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: TX
Alter: 72,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 29.04.2022
Beginn: 15.03.2023
Tage bis Beginn: 320,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Chest X-ray abnormal Chills Dizziness Oxygen saturation decreased Pneumonia SARS-CoV-2 test positive

Symptomtext

This started with chills. I started to get a little lightheaded and my oxygen level was low. I went to see the doctor who asked for chest x rays that revealed pneumonia. Tested positive on a PCR COVID-19 test. The next day I felt much better with my energy returned. Symptoms pretty much cleared up within a week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: 15Mar2023 PCR COVID-19 test, positive. 15Mar2023 Chest X-ray, revealed Pneumonia.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: Dairy
Vorherige Impfungen: -

VAERS 2622337

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: SC
Alter: 81,0
Geschlecht: M
Eingang: 27.04.2023
Impfdatum: 24.04.2022
Beginn: 23.12.2022
Tage bis Beginn: 243,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abnormal loss of weight Asthenia COVID-19 Condition aggravated Cough Dysstasia Fatigue Feeding disorder Malaise Mobility decreased Nasopharyngitis Pain SARS-CoV-2 test positive

Symptomtext

Around the morning of 12/23/2022, I had a cough and cold like symptoms. It got continuously worse, and I had a lot of fatigue. I wound up sick in bed, which is unusual for me. The coughing was incredibly painful. It went on for about a week or a little bit longer. At one point, I tried to get out of bed, and I was so weak, that I couldn't stand up. After I had been through all of this, my body was really sore from all of the coughing. After all of that, I wound up going to the doctor. He said that it was COVID-19. He prescribed me some antibiotics. It took a week to 10 days for the cough to go away. The fatigue took a week or two to go away. I lost around 25 or 26 pounds because I wasn't eating. Eventually, I got my energy back and was able to eat again slowly. It was a few weeks before I could eat again. I did drink a lot of fluids during that time. The antibiotics seemed to knock out the cough and cold like symptoms. It was all over a course of 10 days to 2 weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 02JAN2023 - COVID-19 Test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: Metformin; Hydrochlorothiazide; Lisinopril; Pramipexole; Multivitamin; Niacin; Potassium; Fiber
Allergien: None
Vorherige Impfungen: -

VAERS 2622198

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: AZ
Alter: 68,0
Geschlecht: F
Eingang: 27.04.2023
Impfdatum: 25.04.2022
Beginn: 27.03.2023
Tage bis Beginn: 336,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthropathy Chills Palpitations Peripheral coldness Temperature intolerance

Symptomtext

I experienced colon tolerance with chills, cold feet and hands, racing heart and I am experiencing joint issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Omeprazole; Aciclovir; Amlodipine; Atorvastatin; Estradiol
Allergien: N/A
Vorherige Impfungen: -

VAERS 2615387

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 14.04.2023
Impfdatum: 29.04.2022
Beginn: 27.03.2023
Tage bis Beginn: 332,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anaemia Aspartate aminotransferase increased Asthenia Atelectasis Bladder catheterisation Blood gases COVID-19 Cardiac monitoring Chest X-ray abnormal Dyspnoea Electrocardiogram normal Haemoglobin decreased Laboratory test normal Liver function test normal Platelet count decreased Pyrexia SARS-CoV-2 test positive Thrombocytopenia

Symptomtext

Patient is a 81 y.o. male patient of MD with history of Late stage dementia, CAD, HLD presented to a local Hospital with fever, weakness, SOB, covid positive test . Covid Virus infection Weakness P/w fever, SOB, weakness, tested + for covid on 3/27/23 Initial VS 99.5-69-18-117/64 93-95% on room air CXR trace atelectasis otherwise negative LA normal AST mildly elevated to 56, other hepatic panel normal Troponin 27 UA negative for infection VBG 7.37/49 IV fluids given Foley placed Monitor for Hypoxia PT/SS/OT Placement secured and transportation set up for this afternoon Late stage Dementia with Behavior Disturbance Follows with neurology Continue Aricept, Namenda and trazadone Delirium precautions CAD s/p CABG x 3 Cardiomyopathy HLD HTN Unable to assess for CP Troponin normal EKG no ischemia Resume Coreg, Asa, Lisinopril Allergies to all statins, do not carry crestor Cardiac monitoring Anemia Thrombocytopenia Hgb 11.4, Plt 115 Both have chronicity but plts lower likely reactive

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578977

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: TX
Alter: 59,0
Geschlecht: F
Eingang: 09.02.2023
Impfdatum: 27.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aphasia Chest pain Cough Decreased appetite Dyspnoea Epstein-Barr virus infection Fatigue Feeling abnormal Food intolerance Full blood count Hypotension Immediate post-injection reaction Infection Limb discomfort Magnetic resonance imaging Malaise Mast cell activation syndrome Muscular weakness

Symptomtext

Immediate pain in arm, feverish & general malaise for two days, Third day: muscle pain in both arms & legs, heaviness in legs, peripheral neuropathy in both arms and legs, extreme tightness, stiffness & pain in forearms; pain that feels like a "vibration" in arms & legs; neck pain, loss of appetite - (lost 20 pounds to date); constant tinnitus, muscle weakness. 3-4 weeks post vax: tachycardia, low blood pressure, inability to regulate body temperature, sensitivity to hot and cold, extreme fatigue, post-exercise malaise "brain fog", chest pain, vertigo, Breakthrough EBV virus 6 weeks post vax, myalgia, sore throat, weezing, difficulty catching breath & talking, coughing. 4 months post vax: hives, food intolerances. Diagnosed with mast cell activation syndrome.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: MRI X 2 CBC, Tryptase
Aktuelle Erkrankungen: hypothyroid
Vorgeschichte: hypothyroidism
Andere Medikamente: Levothyroxine 88mcg, estrodial, progesterone, .25 xanax prn
Allergien: Mountain Cedar
Vorherige Impfungen: COVID19 Moderna initial dose 1 & 2 Jan 2020

VAERS 2559667

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: TX
Alter: 72,0
Geschlecht: M
Eingang: 13.01.2023
Impfdatum: 24.08.2021
Beginn: 15.09.2021
Tage bis Beginn: 22,0
Dosis: 1
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Cognitive disorder Computerised tomogram abnormal Exercise tolerance decreased Gait disturbance Incontinence Lumbar puncture abnormal Magnetic resonance imaging abnormal Memory impairment Mobility decreased Neuropathy peripheral Normal pressure hydrocephalus Sepsis Urinary tract infection

Symptomtext

Following the first booster in Aug, 2021, Patient began experiencing mobility issues and memory issues which worsened in the weeks following the first booster. After the second booster, his mobility issues worsened greatly to the point that he was unable to walk without assistance and had trouble with his cognitive skills and incontinence. Over the following months, the symptoms continued to worsen and he developed neuropathy in his lower extremities. Prior to taking the vaccines, he was an active, vibrant person with a sharp mind. He ran 30 miles a week before the vaccines and was an active hiker and golfer. He climbed mt. Kilimanjaro a few years earlier. He is no longer capable of walking, much less running. Minor symptoms began in the weeks following the original two vaccines in Feb. of 2021 but got much worse after the boosters.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: 8,0
Labordaten: MRI, CT Scan and lumbar puncture resulted in a diagnosis of Normal Pressure Hydrocephaly. This was discovered after he was hospitalized with a severe UTI and sepsis in Sept. 2022.
Aktuelle Erkrankungen: Type II diabetes, Chronic kidney disease Stage 3
Vorgeschichte: Diabetes Type II, CKD Stage 3
Andere Medikamente: Actos, metformin, simivstatin, daily vitimin
Allergien: Penicilllin
Vorherige Impfungen: -

VAERS 2529913

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 13.12.2022
Impfdatum: 03.03.2021
Beginn: 20.11.2022
Tage bis Beginn: 627,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Mental status changes Pneumonia SARS-CoV-2 test positive

Symptomtext

Patient with history of 3 COVID vaccines who admitted with altered mental status and pneumonia. COVID test initially "not detected" upon admission on 11/20/22. Retesting on 11/29/22 resulted detected. Issues resolved and patient d/c back to facility.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: 17,0
Labordaten: COVID Detected PCR on 11/29/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Essential hypertension PAF (paroxysmal atrial fibrillation) Chronic systolic (congestive) heart failure Hyperlipidemia Digestive Dysphagia Psychological Anxiety and depression Vascular dementia Respiratory History of adenicarcinoma of rigtht lung Allergic rhinitis Other BPH (benign prostatic hyperplasia) History of stroke Anxiety state Constipation ED (erectile dysfunction) Insomnia Prediabetes Spinal stenosis of lumbar region without neurogenic claudication Mediastinal adenopathy Hip pain, left Alcohol use Sepsis due to Enterobacter species QT prolongation COVID-19 virus infection
Andere Medikamente: -
Allergien: Codeine PhosphateHallucination Effexor [Venlafaxine]Diarrhea GabapentinUnknown Lipitor [Atorvastatin] NortriptylineOther (See Comments) Simvastatin Wellbutrin [Bupropion Hcl]
Vorherige Impfungen: -

VAERS 2529758

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MO
Alter: -
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 02.12.2022
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood pressure abnormal Migraine

Symptomtext

Migraine headaches and uncontrolled blood pressure readings in the 150/90 range beginning The day after bivalent booster

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2528889

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MI
Alter: 76,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 26.04.2022
Beginn: 07.10.2022
Tage bis Beginn: 164,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cough Dyspnoea Productive cough SARS-CoV-2 test positive

Symptomtext

Patient complained of worsening shortness of breath, cough, and sputum production for 5 days. Presented to the hospital on 10/7/22 and tested positive for COVID. She was discharged home on 10/13/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2507179

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: FL
Alter: 69,0
Geschlecht: F
Eingang: 14.11.2022
Impfdatum: 03.05.2022
Beginn: 12.09.2022
Tage bis Beginn: 132,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Dyspnoea Fatigue Malaise Myalgia Nausea Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I did not have a reaction to the vaccine. I started feeling symptoms on 09/12/2022 of a fever, chills, fatigue, muscle aches, congestion, runny nose, shortness of breath and nausea. On 09/13/22, I tested positive for COVID-19 with home test. I contacted my doctor and since I take certain medication, I was unable to get the prescription for PAXLOVID. I took over the counter medication for my symptoms. I isolated for ten days, and the symptoms subsided on day seven.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 13SEPT2022 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Atrial Fibrillation; Neuropathy
Andere Medikamente: N/A
Allergien: Bacitracin
Vorherige Impfungen: -

VAERS 2499728

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MI
Alter: 69,0
Geschlecht: F
Eingang: 04.11.2022
Impfdatum: 04.05.2022
Beginn: 11.06.2022
Tage bis Beginn: 38,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anaemia Catheterisation cardiac Chest X-ray Computerised tomogram abdomen Computerised tomogram pelvis Computerised tomogram thorax Condition aggravated Dyspnoea Echocardiogram Electroencephalogram abnormal Endocarditis Fatigue Inflammatory marker increased Mitral valve incompetence Surgery

Symptomtext

I developed shortness of breath and fatigue on June 11, 2022. I had an EEG on the following Friday that showed that my Mitral Valve Regurgitation had worsened and was now severe. My symptoms caused me to be scheduled for surgery on August 23, 2022. While I was waiting for surgery, I had worsened symptoms that now included anemia and elevated inflammatory factors. During my surgery they determined I had endocarditis. I had a month of antibiotic to treat it. As of today, I have no symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 6,0
Labordaten: TEE; abnormal, June2022; Cardiac Catechization, July2022; CT Scan, chest abdomen, June2022, pelvis; Chest X-Ray, June2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Moderate Mitral Valve Regurgitation
Andere Medikamente: Losartan; rosuvastatin; multivitamin; vitamin D; calcium citrate; omega 3; biotin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2483173

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: CO
Alter: 58,0
Geschlecht: M
Eingang: 19.10.2022
Impfdatum: 18.04.2022
Beginn: 13.09.2022
Tage bis Beginn: 148,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aphasia Asthenia COVID-19 Cough Dyspnoea Feeling abnormal Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Throat irritation

Symptomtext

On 9/13/2022, I had a tickle in my throat. On 9/14/2022, I had full blown sore throat, fever, was never higher than 101.5, some congestion, but no coughing. The coughing came later. The sore throat was one of the worse sore throats that I can remember having and it lasted a good 6 days or so. On 9/14/2022, I took a COVID-19 home test- negative. I flew on 9/15/2022. I was wearing a mask the whole time. That evening I took another COVID-19 test and it was positive. I stayed in the hotel and quarantined for 5 days. I bought cough drops and cough medication for my symptoms. I sent the doctor an message, and they said to quarantine for 5 days and treat symptoms with cough drops and cough medication. Wednesday, 9/21/2022, I flew home. The symptoms kept lingering on and on 10/3/2022, I chatted with my doctor through the app and she prescribed Benzonatate capsule for cough and an inhaler with Albuterol on 10/3/2022. My cough is getting better, but I have had it for 5 weeks. I don't have a lot of energy, I don't have my full breath, and I have brain fog. I have a difficult time trying to remember words and names. I never lost my taste and smell.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 9/14/2022 - COVID-19 home test - negative 9/15/2022- COVID-19 home test- positive 9/21/2022 - COVID-19 home test- positive 10/8/2022 - COVID-19 home test - negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Vertigo attack 19 years ago.
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: Johnson and Johnson-4/8/2021, about 10 days after the vaccine, on 4/19/2021 through 9/13/2021, I was having vertigo attacks ever

VAERS 2476213

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: FL
Alter: 69,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 04.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Allergy test Angioedema Dermatitis contact Hypersensitivity Lymphadenopathy Allergy to chemicals Allergy to metals Condition aggravated Mammogram abnormal Mouth swelling Periorbital swelling Peripheral swelling Rash erythematous Skin exfoliation Skin lesion Skin test positive Swelling Swelling face

Symptomtext

Left lymph nodes are enlarged on left side (same arm she received vaccines); Allergic to Balsam of Peru, Cobalt, Formaldehyde, Gold, Quanterium-15/ Worse reaction was to balsam of Peru; Diagnosed with contact dermatitis; Diagnosed with Angioedema/ Neck and face are red, swollen, rashes, face and neck are the worse, legs and body are swelling and swollen; This spontaneous case was reported by a patient and describes the occurrence of ANGIOEDEMA (Diagnosed with Angioedema/ Neck and face are red, swollen, rashes, face and neck are the worse, legs and body are swelling and swollen) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure high, High cholesterol, Diabetes and Hypothyroidism (Low thyroid). Concomitant products included LISINOPRIL and HYDROCHLOROTHIAZIDE for Blood pressure high, METFORMIN for Diabetes, ATORVASTATIN for High cholesterol, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism. On 04-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 07-Sep-2022, the patient experienced ANGIOEDEMA (Diagnosed with Angioedema/ Neck and face are red, swollen, rashes, face and neck are the worse, legs and body are swelling and swollen) (seriousness criterion medically significant). On 19-Sep-2022, the patient experienced DERMATITIS CONTACT (Diagnosed with contact dermatitis). On 06-Oct-2022, the patient experienced HYPERSENSITIVITY (Allergic to Balsam of Peru, Cobalt, Formaldehyde, Gold, Quanterium-15/ Worse reaction was to balsam of Peru). On an unknown date, the patient experienced LYMPHADENOPATHY (Left lymph nodes are enlarged on left side (same arm she received vaccines)). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, ANGIOEDEMA (Diagnosed with Angioedema/ Neck and face are red, swollen, rashes, face and neck are the worse, legs and body are swelling and swollen), DERMATITIS CONTACT (Diagnosed with contact dermatitis), LYMPHADENOPATHY (Left lymph nodes are enlarged on left side (same arm she received vaccines)) and HYPERSENSITIVITY (Allergic to Balsam of Peru, Cobalt, Formaldehyde, Gold, Quanterium-15/ Worse reaction was to balsam of Peru) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Oct-2022, Allergy test: Was told that had worse reaction was to balsam of Peru. Allergic to Balsam of Peru, Cobalt, Formaldehyde, Gold, Quanterium-15. Patient received dose 1 on 12-Jan-2021 (0.5ml, batch no.: 026L20A), dose 2 on 09-Feb-2021 (0.5ml, batch no.: 032L20A), booster 1 on 22-Oct-2021 (0.25ml, batch no.: 017E21A) and booster 2 on 24-Apr-2022 (0.25ml, batch no.: 057M21A) from Moderna.Patient's HCP thinks it was related to the vaccines, because patient had never had those before. Patient wanted to know if there were any ingredients in the vaccine mentioning what was patient allergic to, or cross sensitivity related to Balsam of Peru or other things that patient was allergic to. Patient asked how long Angioedema last. The patient left lymph nodes were enlarged on left side (same arm where vaccine was received) and scheduled for a biopsy next day on 13-Oct-2022. Patient's symptoms had subsided after 8 days of prednisone. However it came back. Adverse event caused patient to seek medical care (office visit, Urgent care, ER, hospitalized). Patient had never experienced a similar event in the past. Company comment: This spontaneous case concerns a 69 year old female patient with no relevant medical history reported who experienced Serious ( medically significant ), unexpected event of Angioedema ( Diagnosed with Angioedema/ Neck and face are red, swollen, rashes, face and neck are the worse, legs and body are swelling and swollen) . This was accompanied by other non-serious unexpected event of dermatitis contact and non-serious expected events of lymphadenopathy (nodes are enlarged on left side (same arm she received vaccines) and hypersensitivity (Allergic to Balsam of Peru, Cobalt, Formaldehyde, Gold, Quanterium-15/ Worse reaction was to balsam of Peru). . The event angioedema occurred 3 days post vaccination with the mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) , while the event dermatitis contact occurred 15 days post vaccination , event hypersensitivity occurred one month , 2 days after the vaccination and the event lymphadenopathy occurred on an unknown date post vaccination with the bivalent vaccine. The initial four doses of Covid 19 vaccine of this patient were all mRNA-1273 vaccine. It was reported that her .neck, and face were red, swollen, rashes, face and neck are the worse, legs and body are swelling and swollen .She was diagnosed with Angioedema . Her left Lymph nodes are enlarged on left side(same arm she received vaccines) and she was scheduled for a biopsy . She was also diagnosed with Contact Dermatitis . An Allergy testing was done and was told that her worse reaction was to balsam of Peru. It was also reported that the patient's HCP thinks it was related to the vaccine . The events caused patient to seek medical care but not all details were provided. Some symptoms have subsided after 8 days of Prednisone however it was reported that there were recurrences.The use of Balsam of Peru may be considered as a confounder for the event hypersensitivity . The benefit -risk relationship of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) is not affected by this report.; Sender's Comments: This spontaneous case concerns a 69 year old female patient with no relevant medical history reported who experienced Serious ( medically significant ), unexpected event of Angioedema ( Diagnosed with Angioedema/ Neck and face are red, swollen, rashes, face and neck are the worse, legs and body are swelling and swollen) . This was accompanied by other non-serious unexpected event of dermatitis contact and non-serious expected events of lymphadenopathy (nodes are enlarged on left side (same arm she received vaccines) and hypersensitivity (Allergic to Balsam of Peru, Cobalt, Formaldehyde, Gold, Quanterium-15/ Worse reaction was to balsam of Peru). . The event angioedema occurred 3 days post vaccination with the mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) , while the event dermatitis contact occurred 15 days post vaccination , event hypersensitivity occurred one month , 2 days after the vaccination and the event lymphadenopathy occurred on an unknown date post vaccination with the bivalent vaccine. The initial four doses of Covid 19 vaccine of this patient were all mRNA-1273 vaccine. It was reported that her .neck, and face were red, swollen, rashes, face and neck are the worse, legs and body are swelling and swollen .She was diagnosed with Angioedema . Her left Lymph nodes are enlarged on left side(same arm she received vaccines) and she was scheduled for a biopsy . She was also diagnosed with Contact Dermatitis . An Allergy testing was done and was told that her worse reaction was to balsam of Peru. It was also reported that the patient's HCP thinks it was related to the vaccine . The events caused patient to seek medical care but not all details were provided. Some symptoms have subsided after 8 days of Prednisone however it was reported that there were recurrences.The use of Balsam of Peru may be considered as a confounder for the event hypersensitivity . The benefit -risk relationship of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Test Date: 20221006; Test Name: Allergy testing; Result Unstructured Data: Was told that had worse reaction was to balsam of Peru. Allergic to Balsam of Peru, Cobalt, Formaldehyde, Gold, Quanterium-15
Aktuelle Erkrankungen: Blood pressure high; Diabetes; High cholesterol; Hypothyroidism (Low thyroid)
Vorgeschichte: -
Andere Medikamente: LISINOPRIL; HYDROCHLOROTHIAZIDE; ATORVASTATIN; METFORMIN; SYNTHROID
Allergien: -
Vorherige Impfungen: -

VAERS 2476658

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: IL
Alter: 73,0
Geschlecht: M
Eingang: 12.10.2022
Impfdatum: 08.07.2022
Beginn: 30.08.2022
Tage bis Beginn: 53,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Injury Nervous system disorder Reflex test normal

Symptomtext

Saw Dr and was given a brief Neurological Reflex test with Normal results; Dr thinks my nerve problems could have exacerbated the injury I had in 2009.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Neurological Reflex test - Normal.
Aktuelle Erkrankungen: n/a
Vorgeschichte: Neuralgic Amyotrophy; Carotid Artery Disease; Depression
Andere Medikamente: Baclofen; Ibuprofen; Aspirin; Statin
Allergien: Lyrica, Atorvastatin
Vorherige Impfungen: 2009 N1H1 vaccine; caused intense pain in my shoulders.

VAERS 2471028

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: NJ
Alter: 57,0
Geschlecht: M
Eingang: 06.10.2022
Impfdatum: 19.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Allergy test Cardiac flutter Chest pain Dyspnoea Flushing Hypertension Laboratory test Pulmonary function test

Symptomtext

Following Dose #4 on 5/19/2022, I developed chest pains within 36 hours of receiving this vaccine. There was significant fluttering and flushness. My blood pressure went from normal range to a high of 146/100 with a pulse rate of 120 BPM at 11:20pm. The following morning, May 21 at 8:39am, my blood pressure fell to 134/87 with a pulse rate of 91 BPM. The following morning, May 22 at 7:41am, my blood pressure returned to normal at 115/78 with a pulse rate of 88. I was made aware of this potential following a different episode following Dose #3 on 9/25/2021. For several weeks, I was experiencing shortness of breath. I went through a battery of tests to eliminate all possible risks, including pulmonary test, allergy evaluations and other exams. At the time, my cardiologist did raise the possibility of myocarditis related to the vaccine. Though, at the time he indicated that this was typically prevalent in younger vaccine recipients. However, following the episode with Dose #4, my cardiologist advised against taking further doses of the vaccine until there are more data to demonstrate the risks associated with the vaccine and myocarditis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Other than blood pressure monitoring, there were no specific tests administered.
Aktuelle Erkrankungen: None
Vorgeschichte: Pre-diabetes, elevated cholestorol and blood pressure
Andere Medikamente: Metformin 100mg Rosuvastatin 5mg Losartan 25mg Allopurinol 200mg Amlodipine 5mg Vitamins B, C, D3 and E Baby aspirin 162mg
Allergien: Eggplant
Vorherige Impfungen: Moderna COVID Vaccine Booster - Dose #3, 9/25/2021 Age 56

VAERS 2446321

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: OH
Alter: 83,0
Geschlecht: M
Eingang: 15.09.2022
Impfdatum: 04.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dyspnoea Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

Tested COVID positive, symptoms include sore throat, cough, and shortness of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 1,0
Labordaten: Swab collected on 5/10/2022 detected SARS-CoV-2 Antigen on 5/10/2022.
Aktuelle Erkrankungen: -
Vorgeschichte: Type 2 diabetes mellitus, cardiovascular disease, hypertension, and chronic renal disease.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2434614

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: CA
Alter: 47,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 25.04.2022
Beginn: 14.05.2022
Tage bis Beginn: 19,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Heart rate increased Hypertension Laboratory test normal SARS-CoV-2 test positive Tachycardia

Symptomtext

I started experiencing tachycardia/ hypertension. When my blood pressure goes down my heart beat goes up. I took my blood pressure and send my doctor the result through email. He immediately called me after my email. I spoke with my doctor through tele health, within 10 days after my talk with doctor. I went to see him. He took blood pressure which was showing the same results I had. The blood test was showing cortisone level was low. He prescribed me Floranex and a Holter monitor for 2 weeks. He also performed cortisol level test which was normal. After 3-4 weeks everything was normal again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: COVID-19 Home Test- Positive
Aktuelle Erkrankungen: Migraine
Vorgeschichte: Migraine; Osteoarthritis
Andere Medikamente: Enoxaparin; Vitamin B2; Hydrocodone; Tylenol;
Allergien: Epinephrine
Vorherige Impfungen: -

VAERS 2431176

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MI
Alter: 57,0
Geschlecht: F
Eingang: 07.09.2022
Impfdatum: 10.06.2022
Beginn: 24.08.2022
Tage bis Beginn: 75,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 COVID-19 pneumonia Chest X-ray normal Chills Cough Dyspnoea Headache Hypoxia Laboratory test normal Pyrexia SARS-CoV-2 test positive Treatment noncompliance

Symptomtext

PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 virus infection [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: 58-year-old lady with medical history of bipolar disorder, chronic obstructive pulmonary disease, cervical cancer, cognitive impairment presenting with dyspnea, fever, dry cough, headaches and chills for 1 day. In ER patient was found to be COVID positive. Upon ambulation she had hypoxia to 87%. Patient's rest of the labs unremarkable. Chest x-ray without any infiltrates. No concerns for superimposed bacterial infection. She was started on 6 mg dexamethasone and kept overnight for observation. In the morning patient was able to walk without getting short of breath or hypoxic. Patient had no complaints including no dyspnea are chest pain or cough or nausea or vomiting. Patient was advised to take dexamethasone for total of 10 days. She was also advised to be compliant with her home inhalers (which she has not been using lately). Patient was discharged in stable condition to home with family. ER return precautions also given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis of hip S/P total hip arthroplasty Degeneration of intervertebral disc Encounter for screening colonoscopy Arnold-Chiari malformation (HCC) Bipolar disorder (HCC) Chronic back pain Chronic sinusitis Gastroesophageal reflux disease Migraine Pneumonia due to COVID-19 virus Chronic obstructive pulmonary disease (HCC)
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler EPIPEN 2-PAK 0.3 MG/0.3ML SOAJ fluticasone-umeclidin-vilant (TRELEGY ELLIPTA) 100-62.5-25 MCG/INH inhaler gabapentin (NEURONTIN) 300 MG capsule levothyrox
Allergien: Bee Venom
Vorherige Impfungen: -

VAERS 2427614

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: NJ
Alter: 58,0
Geschlecht: F
Eingang: 02.09.2022
Impfdatum: 23.05.2022
Beginn: 01.06.2022
Tage bis Beginn: 9,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Asthma Chronic spontaneous urticaria Condition aggravated Lip swelling Pruritus Rash macular Swelling Swelling face Urticaria

Symptomtext

I developed hives within a week of the second Moderna booster shot on May 23, 2022, accompanied by stomach pain, which I believe to be internal hives because it only happens during daily hives flareups. I saw an allergist who diagnosed me with chronic spontaneous urticaria and told me to take three Allegra 180 allergy pills. That kept hives away for 2 days and then they returned. Allegra has since come out with a hives formula, which seems to help insofar as the itch, but the hives bumps, clusters and splotches remain. Each daily hives flare is different and not precipitated by anything I can put my finger on. Serious flares also cause swelling in my lips and the inside of my cheeks, and cause a medium asthma flareup requiring the use of my inhaler. Prior to these hives, I hadn't needed my inhaler or had any asthma related symptoms in over 20 years. I am also now very sensitive to ibuprofen, which is my go-to pain medicine. When I take it, it causes certain parts of my throat to become inflamed and sore and makes my voice very hoarse for hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: No tests have been performed. The allergist said an allergy tests would not assist in determining the cause of the hives and said they are idiopathic.
Aktuelle Erkrankungen: None
Vorgeschichte: Spina Bifida from birth Type II diabetes Cholesterol (now normal) BP is now normal without drugs
Andere Medikamente: Synthroid 200mcg, Lexapro 5mg, Losartan Potassium and Diltiazem for BP, Rosuvastatin and Fenofibric Acid, Vascepa (triglycerides and cholesterol), Metformin (2G 2xday), Glipizide (5 mg), Trulicity 0.75 mg, 1xweek, Vitamin C, Vitamin D3, Co
Allergien: Allergic to penicillin and IV contrast dye
Vorherige Impfungen: -

VAERS 2420166

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: CA
Alter: 61,0
Geschlecht: F
Eingang: 25.08.2022
Impfdatum: 19.05.2022
Beginn: 25.07.2022
Tage bis Beginn: 67,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Disturbance in attention Dizziness Dyspnoea Exposure to SARS-CoV-2 Fatigue Feeling abnormal Headache Impaired work ability Insomnia Mobility decreased Nausea Palpitations Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I received my second Moderna booster for COVID-19 on 5/19/2022. On 7/25/2022, I had a little bit of a headache. My daughter tested positive for COVID-19 that day. On 7/26/2022, I had a more significant headache and underwent a PCR test, which yielded a positive result. Because of my history of asthma, I was prescribed PAXLOVID. Not only did I have a headache that day, but I also had a bit of nausea and an overall bodily feeling of something not being right. On 7/27/2022 and 7/28/2022, I was able to work from home, but on 7/28/2022, I had to stop working early, because I began to feel worse. I had a headache, dizziness, crushing fatigue, and a fever. At one point, the fever was at 100.4. I had also never been as fatigued in my life as I was during my bout of COVID-19. Starting on the mid-morning of 7/28/2022, I stayed in bed. On the night of 7/26/2022 or 7/27/2022, I had difficulty sleeping, because my breathing was obstructed by a large quantity of mucus in my sinuses; the mucus then settled in the back of my throat, which was not pleasant. During the night, I had a couple of episodes in which I found it hard to breathe because of this. It felt like someone had put a plug in my throat, and I was just gasping for air. It was very alarming. After I started taking the PAXLOVID, it felt like it kicked in quickly, because the symptoms didn't worsen, and they seemed to stabilize. The fever went away, and the mucus blockage and drainage abated. After that, I dealt mainly with headache and fatigue. I stayed in bed and just occasionally got up to use the toilet. Whenever I went to the toilet, my heart would start racing. On 8/1/2022, I took a home COVID-19 test, which yielded a negative result. I took a home test again on 8/3/2022 and 8/6/2022, and the results were negative both times. On about 8/4/2022, my isolation ended, though I made it a point to wear a mask around my family. I was still extremely fatigued and didn't return to work until 8/8/2022. During my time with COVID-19, I had major brain fog. I couldn't even concentrate well enough to read a novel. At the time of this writing, I feel that my mental function is gradually returning to normal and I am beginning to function at my pre-COVID level at work.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 7/26/2022 PCR test positive result; 8/1/2022, 8/3/2022, and 8/6/2022 home COVID-19 tests negative results
Aktuelle Erkrankungen: None.
Vorgeschichte: Asthma.
Andere Medikamente: SINGULAIR; glucosamine; FIBERCON; TYLENOL; alpha lipoic acid; vitamin B12; multivitamin; 5 HTP; omega 3; turmeric extract; vitamin D3; tums with calcium; PREMARIN cream.
Allergien: Sulfa drugs; erythromycin; TALWIN; DARVOCET-N; COMPAZINE; SEREVENT; bananas; lemons; onions; blueberries; strawberries; walnuts; asparagus; cantaloupe; peaches; pears; clams; crabs; tuna; tomatoes; sweet potatoes; string beans; squash; potatoes; kidney beans; celery; oats; buckwheat; watermelons; pineapples; oysters; wheat; milk; chicken.
Vorherige Impfungen: About 10 years ago, I had a flu shot, and the bursa of the shoulder (I don't remember which one, but I think it was the left) wa

VAERS 2408620

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 11.08.2022
Impfdatum: 11.05.2022
Beginn: 21.07.2022
Tage bis Beginn: 71,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac disorder Condition aggravated Cough Disturbance in attention Dyspnoea Fatigue Feeling abnormal Headache Malaise Nausea Oropharyngeal pain SARS-CoV-2 test positive Throat irritation

Symptomtext

I had been very unfocused and could not concentrate at work. I then developed a scratchy throat I then took at COVID-19 Home test while I was at work and that was negative. I took a second one when I got home and it was positive. I was having fatigue, nausea, headache, sore throat, it was hard to breath, I was coughing and just really not doing well. I reached out to my doctor and they gave me Paxlovid to help with my symptoms. By the 26th I was doing better. I took another test and it was negative on the 28th. I was feeling poorly again and was positive again on the 30th. This time I was having the same symptoms but it was not as severe. Since having COVID my symptoms with my heart condition have flared up and when I went to the ER for that they did ask if I had had a COVID vaccine recently.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: COVID-19 Home Test
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Propranolol; Rosuvastatin; Armor Thyroid; Vitamin D; Multivitamin; Dim
Allergien: Codeine
Vorherige Impfungen: Shingrix- Shingles vaccine in 2018

VAERS 2407025

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

moderat

Staat: NY
Alter: 80,0
Geschlecht: M
Eingang: 10.08.2022
Impfdatum: 21.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Asthenia Injected limb mobility decreased Injection site pain Injection site swelling

Symptomtext

Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Joint Pain-Severe, Systemic: Weakness-Severe, Additional Details: pt came to pharmacy to pick up prescription and in passing mentioned that after his vaccine on 4/21/22 he could not raise his arm at all. Patient stated that his doctor told him it was the vaccine that caused this. Patient stated that he has been going to physical therapy and has regained some motion to left his left arm again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injected limb mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2399321

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: HI
Alter: 65,0
Geschlecht: F
Eingang: 02.08.2022
Impfdatum: 02.05.2022
Beginn: 22.07.2022
Tage bis Beginn: 81,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea Injection site erythema Injection site pruritus Injection site warmth

Symptomtext

After the second booster in May I noticed that my arm had a a 6 inch in diameter around the injection area that was red, warm and itchy. This lasted about a week. I took a picture of this on May 5th. I got a resting heart rate alert 3 times in a 24 hour period. My heart rate was around 130. This happened on May 22th and 23th. Then there was nothing else until Wednesday May 27th I had another alert for the same resting heart rate. To be clear, I was sitting, at rest each time. I also have seen on my smartwatch report that on two nights, maybe 3/4 days apart, I had between 10 and 30 breathing difficulty episode between 3 and 4 in the morning. It happened 3 or 4 nights later again and it stated I had between 30-50 breathing difficulty episodes between 3 and 5 in the morning. Again, on August 1st I took a nap for about an hour long and my app reported another episode of breathing difficulty. I have an upcoming cardiologist appointment August 24, 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Osteoporosis; Arthritis; Celiac' s Disease
Andere Medikamente: Montelukast; Probiotic; Cholestoff; Calcium; Ibuprofen; B12; Risedronate Sodium; Omeprazole
Allergien: Flagyll; Potato; Orange; Lettuce; Dust
Vorherige Impfungen: -

VAERS 2399278

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: HI
Alter: 64,0
Geschlecht: M
Eingang: 02.08.2022
Impfdatum: 29.04.2022
Beginn: 23.07.2022
Tage bis Beginn: 85,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest discomfort Cough Dyspnoea Fatigue Pain Productive cough SARS-CoV-2 test positive Sinusitis Upper-airway cough syndrome

Symptomtext

Basically I had a lot of fatigue, not so much body aches. They were there, but it was mild. The other part was difficulty breathing. Not labored per say but I couldn't take deep breaths of air. About a week or so before this, I went to the doctor and she diagnosed me with a sinus infection. I had post nasal drip and cough. It sounded good at the time. I did a 5 day regimen of CEFTIN (antibiotics) along with cough medication. A week and a half after this sinus infection I started feeling a new feeling of breathing issue, increase in cough and a lot deeper, phlegm, and heavy fatigue. My phlegm was milky. I used to get Bronchitis, and this was not like it at all. Just a pressure on my chest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: At home test- positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2399276

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: IA
Alter: 71,0
Geschlecht: F
Eingang: 02.08.2022
Impfdatum: 27.07.2022
Beginn: 27.07.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Dyspnoea Dyspnoea exertional Fatigue Flushing Gait disturbance Headache Hyperhidrosis Injection site erythema Injection site swelling Joint range of motion decreased Lethargy Nausea Pain

Symptomtext

Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Dizziness/Lightheadedness-Mild, Systemic: Exhaustion/Lethargy-Medium, Systemic: Flushed/Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Mild, Additional Details: Difficulty lifting arm the morning after immunization. Shortness of breath during walk in the park. Unable to do walk as usual.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2390983

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: FL
Alter: 69,0
Geschlecht: F
Eingang: 26.07.2022
Impfdatum: 21.04.2022
Beginn: 03.07.2022
Tage bis Beginn: 73,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ageusia Anosmia COVID-19 Cough Dyspnoea Head discomfort Nasopharyngitis Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I started getting symptoms of a sore throat and head congestion. I developed a cough then to a fever for 2 days. I felt like I had a really bad cold. I had a lot of shortness of breath. I took an at home COVID-19 test and then went to ER to get a test that were both positive and was prescribed Paxlovid. After Paxlovid, my symptoms went away shortly after. My symptoms lasted a total of 9 days. I still do have shortness of breath and I am getting treated by my cardiologist. I have also lost most of my taste and smell.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: COVID-19 test - positive
Aktuelle Erkrankungen: None
Vorgeschichte: Airborne allergies
Andere Medikamente: N/A
Allergien: Sulfa
Vorherige Impfungen: Moderna - aches, pains, headaches, and fever for 2 days

VAERS 2388215

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: WA
Alter: 63,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 25.01.2021
Beginn: 10.07.2022
Tage bis Beginn: 531,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dyspnoea Headache Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Positive Covid test 7/10/2022, fever, slight cough, headache, lasted for 3 days. Breakthrough Covid. Paxlovid 150 (X2) -100 mg PK (EUA) for 5 days. Negative Covid tests 7/16/2022 and 7/18/2022. Symptoms returned, positive Covid test 7/23/2022. Rebound Covid, increased cough, congestion, shortness of breath, with mild fever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Mild high blood pressure, obese, moderate high cholesterol
Andere Medikamente: Zinc, senior vitamins, hydrochlorothrazide 25 mg, simvastatin 40 mg
Allergien: None
Vorherige Impfungen: -

VAERS 2379455

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: NY
Alter: 72,0
Geschlecht: F
Eingang: 22.07.2022
Impfdatum: 21.02.2021
Beginn: 21.02.2021
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Asthenia Balance disorder Fatigue Gait disturbance Headache Hemiparesis Loss of personal independence in daily activities Mobility decreased Muscular weakness Visual impairment

Symptomtext

02/24/2021 = dose #1 within 30 minutes of receiving first dose I had a severe , throbbing headache that lasted 6 days with no relief from Tylenol (only treatment tried), extreme weakness resulting in being in bed x 4 days and needing assistance to get out of bed to use bathroom facilitiy, unable to function with daily ADL's, vision disturbance, extreme fatigue lasting 2 weeks, balance/walking issues that still exist today, weakness to right leg/foot. On 6 different occassions after the headaches landed me back in bed for roughly 36 hours. The headache was in less severity but lasted until approximately 1 month ago (06/2022). 03/25/2021 = dose #2 = same experience as after dose #1. 11/03/2021 = booster #1 or dose #3 = same as above, but bed time was 3 days. 05/20/2022 = fourthe dose or booster #2 = same as booster #1 above.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: MS; HTN
Andere Medikamente: Copaxone 40 mg; Cardia XT; HCTZ; Pravastatin; ASA; Omeprozole; Botin; Vit. D3; Calcium;
Allergien: Toprol; Bactrim; Macrobid
Vorherige Impfungen: -

VAERS 2373927

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: CA
Alter: 63,0
Geschlecht: M
Eingang: 19.07.2022
Impfdatum: 15.04.2022
Beginn: 08.07.2022
Tage bis Beginn: 84,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Dyspnoea Fatigue Headache Nasal congestion Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

On July 8, 2022 I had congestion in my left nostril, the nest day it moved to the right nostril, a headache that has not went away, fatigue, shortness of breath, sore throat. I used my home COVID-19 test that came back positive on July 9, 2022, I went to an urgent care on July 10, 2022 to have PCR COVID-19 test done, they called me July 12, 2022 with a positive result. I was prescribed FLONASE nasal spray. I still have congestion and a headache I am getting better and I can work.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Home COVID-19 test, PCR COVID-19 test.
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: No
Allergien: No
Vorherige Impfungen: -

VAERS 2344764

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: TX
Alter: 65,0
Geschlecht: F
Eingang: 30.06.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood pressure decreased Condition aggravated Malaise Mast cell activation syndrome Mental status changes Pain in extremity

Symptomtext

I generally did not feel well after my vaccination and my arm was sore for about a week. Mast Cell activation disorder has been flaring up more frequently since receiving the shot. I was receiving an IV infusion on 06/24/2022, where I then had a terrible mast cell reaction during my IV infusion. I was given steroids in my IV to counteract the reaction as quickly as possible. I was then just placed on observation and on Tuesday, I saw my primary care and they said I should have went to the ER. My blood pressure dropped very low and I was in an altered state of mind during the recovery period. I started to feel better on 06/29/2022 and am still recovering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: COVID - Common Variable Immunodeficiency Disorder; MCAD Mast Cell Activation Disorder; High Blood Pressure; Diabetes; Depression; Insomnia; Sleep Apnea with O2
Andere Medikamente: OXICAM; spironolactone; TRIBENZOR; vitamin D3; vitamin B12 injection; ALLEGRA; PEPCID; ZYRTEC; DEXILANT; CYMBALTA; vitamin C; allergy shot; CELEBREX; trazadone; glimepiride; metformin; TRULICITY
Allergien: Reaction odors; fumes; fragrances; smoke; paint; diesel fumes; hummus; strawberries; grass; pollen; cats
Vorherige Impfungen: Pneumonia shot

VAERS 2335889

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: PA
Alter: 62,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 15.05.2022
Beginn: 22.06.2022
Tage bis Beginn: 38,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Chest X-ray normal Computerised tomogram normal Cough Disorientation Dizziness Fatigue Hypotension Laboratory test abnormal Pyrexia Rhinorrhoea

Symptomtext

I was coughing and had fever, fatigue and runny nose. It was in the middle of the day and took 3 test that were positive. I went to the ER the next morning. I had to call an ambulance I was disoriented, light head and extremely week. At the ER received iv fluid for low blood pressure. I just finished a prescription of Paxlovid on 06/27/2022. I now still have fatigue and coughing still, but definitely improved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: CT Scan and Chest X-Ray - Normal - 06/26/2022
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Dexilant, Verapamil
Allergien: Sulfa Drugs
Vorherige Impfungen: on 9/10/2021 the 1st booster of Moderna, I passed out the next day. My PCP, thought I passed out because I had a full dose. I di

VAERS 2332382

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: WV
Alter: 60,0
Geschlecht: F
Eingang: 24.06.2022
Impfdatum: 09.06.2022
Beginn: 10.06.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Pain Tendonitis

Symptomtext

Patient reports that her tendonitis has returned. It woke her up the following morning in pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: asthma, allergies
Andere Medikamente: Breo, flonase, sudafed, singular, cetirizine, omeprazole, eye lubricant drops, Bromelain, tumeric, magnesium, prevagen, align,
Allergien: Latex, cashews
Vorherige Impfungen: -

VAERS 2327075

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MS
Alter: 66,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 04.11.2021
Beginn: 01.11.2021
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Burning sensation Dehydration Diarrhoea Dizziness Nausea Pain in extremity Peripheral swelling Ultrasound scan normal Vomiting

Symptomtext

Experienced vomiting, diarrhea, nausea, severe, abdominal cramps and dehydration as a result of other symptoms which increased dizziness and light headedness for 4 days. Right thigh became larger than left leg. Burning sensation in inner thigh. As of this date, still larger. When 2nd booster was administered on 6/16/2022, leg became swollen and very painful. Size did not decrease, vascular was done, no DVT. Leg is considerably larger.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: -
Labordaten: Vascular ultrasound was completed on 6/21 after 2nd booster and increased swelling, Second adverse reaction will be completed for 6/16 vaccination
Aktuelle Erkrankungen: Breast cancer - last chemotherapy date - 8/2021
Vorgeschichte: Rheumatoid arthritis, osteoarthritis, chronic pain disorder
Andere Medikamente: Norvasc - 5 mg daily Magnesium - 500 mg nightly D3 - nightly
Allergien: Eggs Codeine Opioids
Vorherige Impfungen: 60 years old, Smallpox vaccine, date-2015

VAERS 2327015

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: IN
Alter: 67,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 16.06.2022
Beginn: 18.06.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cold sweat Cough Erythema Extra dose administered Fatigue Headache Injection site swelling Injection site warmth Laryngitis Migraine Pain Pain in extremity Productive cough SARS-CoV-2 test positive Secretion discharge Sputum discoloured

Symptomtext

Day of vaccine and for 5 days sore arm with redness, heat and swelling at injection site. Day 2 post injection severe headaches/migraines started. Day 3 headaches continue, fatigue and bad cough (non productive) started in the evening. Day 4, headaches continue, fatigue is worse and the cough is worse, becoming a productive cough. Finally gave in and went to bed in early evening. Day 5, all symptoms much worse and now have cold sweats. Cough is producing a yellow mucus. Severe headaches. Today is Day 6 post injection. Severe headaches continue, cough is now producing a thick green mucus. Laryngitis from all the coughing. Still have body aches and fatigue. I did a home self test for Covid this morning. It was POSITIVE!! I thought the vaccine wasn't suppose to give a person Covid??? This one gave it to me!! I had no respiratory illness for months prior to receiving this booster. I have been taking OTC Tylenol for pain, my migraine medicine for the migraines and drinking water. After testing positive for Covid this morning, I called my doctor. They called in a Rx for me for Covid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: Rapid home Covid-19 test. Run 6/22/2022 in morning. Results = POSITIVE
Aktuelle Erkrankungen: No other illness.
Vorgeschichte: High blood pressure, high cholesterol, hypothyroidism
Andere Medikamente: trazodone, levothyroxine, estradiol, amlodipine, B12, Vit D, Magnesium, Krill oil, Calcium supplements, eye supplement and Iodine supplement.
Allergien: Sulfa, tegretol, lamictal, topamax, Biozyme ointment, morphine, codeine, anticholenergics, wellbutrin
Vorherige Impfungen: Moderna, 044A21A, 03/24/2021, age 65, first dose; sore arm fever, fatigue, bed ridden for 2 days Moderna 039B21A,04/21/2021, Age

VAERS 2326947

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 057M21A

moderat

Staat: MA
Alter: 52,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 07.05.2022
Beginn: 12.06.2022
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest discomfort Condition aggravated Feeling abnormal Head discomfort Headache Impaired work ability Migraine Productive cough Rhinorrhoea SARS-CoV-2 test positive Sinus disorder Throat irritation Vaccine breakthrough infection

Symptomtext

Breakthrough case of Covid, sx began on 06/12/2022. Tested positive 06/16/2022. I started by noticing sinus sx with runny nose on 06/12/2022. On 06/13/2022 thru 06/16/2022, I was supposed to be flying back from vacation that night, I started having chest scratchiness, headache and cough with sputum. On 06/16/2022, I still had the same sx and a runny nose started again. I spoke to my doctor and I received monoclonal antibodies on 06/17/2022. I actually had a migraine on the morning of the 17th. I was able to pull it together to get the antibodies on the 17th. Since having the antibodies, I have continued to rest, When I move around and try to do things I h =get pressure in my head and as we speak, I am getting the scratchiness in my throat. I have some cloudiness; I have been unable to work due to being unorganized. My doctor says I can start physical activity one I feel better. I feel like I can get out and do things, but when I do I start feeling issues in my chest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 06/13/2022 self-test - negative 06/14/2022 PCR ? negative 06/15/20222 self-test - negative 06/16/2022 Hospital PCR - positive
Aktuelle Erkrankungen: migraine or two
Vorgeschichte: fatty liver, migraines, sleep apnea, acid reflux, high cholesterol, hemorrhoid's, unburst 3mm embolism in my brain, overweight
Andere Medikamente: aimovig, pravastatin sodium, propranolol ER, nortriptyline HCL, ubrelvy, Viton topical cream, Luzu topical cream, Colace, Vitamin D3, Magnesium citrate / malate, Magnesium glycinate, Magnesium thermite, silymarin, Ultra 360Men's multi 50+,
Allergien: rabies vaccine, MSG sensitivity
Vorherige Impfungen: rabies vaccine - rash, swelling, anaphylactic reaction, about 8 years ago

VAERS 2314202

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: NH
Alter: 63,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 30.04.2022
Beginn: 02.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Headache Influenza like illness Lower respiratory tract congestion Mobility decreased Pain in extremity Sleep disorder

Symptomtext

I got up with a headache, chest was extremely congested, took some medication and went back to sleep. Both of my arms hurt from the shots but that was to be expected. When I woke up later my head was still hurting and my chest was still congested but the CORICIDIN D had helped break up some of the congestion. I went back to sleep to see if my head would stop hurting. It felt like I had the flu. I woke up on the second day after the vaccines I got up in the morning still had the headache and congestion but I could actually move around and do things around my home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: No
Vorgeschichte: Chest Congest from Smoking
Andere Medikamente: Lisinopril; Metoprolol Tartrate; Clonidine
Allergien: No
Vorherige Impfungen: -

VAERS 2311644

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: UT
Alter: 36,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 25.04.2022
Beginn: 25.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Back pain Cluster headache Condition aggravated Heart rate increased Hyperhidrosis Injection site pain Injection site swelling Migraine Pyrexia

Symptomtext

Starting right after receiving the vaccine, I had pain and swelling at the injection site. Then, I started getting a fast heart rate and they said that was okay. I stayed at the clinic for 30 min after receiving it to be monitored. I went back to work and a few hours later I developed back pain. I have arthritis so i didn't think to much about it at first. However, it got so much worse that it felt like I was in labor (10/10 pain) and I was instructed to go see the doctor. So I went back to the clinic (Dr.) and he gave me Naproxen 250mg to take and I was instructed to take 2 tablets 2x daily. I went home and laid in bed. I got full body sweats and I felt like I had a fever. I have never sweat so bad before. Then, the next day, I was okay after taking the naproxen. Just recently, 06/03/2022 I stayed home because I had a really bad migraine. I took the naproxen, benadryl and the motion sickness medicine and I stayed in bed all day. Since then, I have been having intermittent cluster headaches which I had following the 2nd COVID vaccine (Pfizer). Since I had the Pfizer COVID19 vaccines, I have developed migraines and they have gotten worse with each shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: SARS positive on 04/02
Vorgeschichte: Asthma
Andere Medikamente: Tylenol 325 mg 2x day, Ibuprofen 800mg 1x day, benadryl 25 mg 1xday, Naproxen and Birth Control
Allergien: Penicillin, amoxicillin, crandomicin, pseudoephedrine, sulfa
Vorherige Impfungen: Migraines following dose 1 and 2 of the COVID vaccine (both were Pfizer)

VAERS 2310292

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: OH
Alter: 74,0
Geschlecht: F
Eingang: 06.06.2022
Impfdatum: 31.05.2022
Beginn: 01.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Headache Hypophagia Mobility decreased Nausea Retching

Symptomtext

On 5/31/2022, client presented to clinic for 2nd Moderna booster. Reported no issues or concerns. Had two-dose Moderna primary series and 1st Moderna booster previously. Administered Moderna booster 50mcg/0.25mL into left deltoid IM at 1330. No reaction within 15 minutes of administration. On 6/6/2022, client called in to report reaction to 2nd booster dose. Client admitted had a history of a feverish reaction of 100 degrees Fahrenheit after 2nd primary dose (reports average normal body temperature 97.5). Described no reactions after 1st primary dose or 1st booster dose. Received 2nd Moderna booster at 1330 5/31/2022 as per recommendation from Dr. due to history of double pneumonia that required surgical draining. At 0300 on 6/1/2022, client reported waking to 100 degree fever, severe nausea/dry heaves, and severe headache that "when I closed my eyes I saw white, not black." Unable to tolerate anything by mouth. Unable to take any medications due to unable to tolerate anything by mouth. Client stated was unable to get out of bed for two days due to headache; did not seek further medical attention. Fever broke after three days. Dry heaves subsided after four days. Discussed Covid-19 side effects and typical durations. Encouraged client to speak with Dr. about reaction and to seek advice in event a future Covid-19 booster would be recommended.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None reported
Vorgeschichte: History of double pneumonia with bilateral surgical drainage procedure
Andere Medikamente: None reported
Allergien: None reported
Vorherige Impfungen: Client stated had 100 degree fever after 2nd Moderna primary dose of similar magnitude to this event. Client received 2nd Modern

VAERS 2305098

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: TX
Alter: 71,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 29.04.2022
Beginn: 01.04.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Condition aggravated Vertigo

Symptomtext

I have been experiencing vertigo prior to the first booster and it worsened after the second booster.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Blood work
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes; Hypertension
Andere Medikamente: Metformin 500mg 2 Tab x Daily; Montelukast 10mg QAN; Atorvastatin 20mg Bedtime; Pantoprazole 40mg; Amlodipine 5mg; Magnesium 400mg; FOSAMAX 70 mg Weekly; Duloxetine 40mg Daily; Gabapentin 100mg PRN; Fluticasone Spray; TYLENOL 500mg 1-2 Dail
Allergien: Kiwi; Latanoprost
Vorherige Impfungen: -

VAERS 2301467

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

moderat

Staat: OR
Alter: 47,0
Geschlecht: F
Eingang: 28.05.2022
Impfdatum: 25.04.2022
Beginn: 25.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Joint injury Paraesthesia

Symptomtext

Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298591

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: MS
Alter: 52,0
Geschlecht: F
Eingang: 27.05.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Hypertension Palpitations Tachycardia

Symptomtext

ONSET OF REACTION WAS "LATE NIGHT" ON THE DAY OF VACCINATION - STAFF BEGAN HAVING HEART PALPITATIONS AND TACHYCARDIA. MD NOTIFIED OF SYMPTOMS AND ADVISED STAFF TO GO TO THE ER. STAFF WENT TO THE ER. DISCOVERED TO HAVE VERY HIGH BLOOD PRESSURE. WAS GIVEN 2 BAGS OF IV FLUIDS AND 3 DOSES OF "BLOOD PRESSURE MEDICATION" BEFORE BLOOD PRESSURE WAS CONSIDERED STABLE, PULSE REMAINED TACHYCARDIC. AFTER ABOUT 6 HOURS, SHE WAS DISCHARGED WITH INSTRUCTIONS TO F/U WITH PRIMARY MD, IF CONDITION PERSISTED. STAFF REPORTED FEELING MUCH BETTER UPON DISCHARGE AND NOT REPORTED ANY FURTHER EPISODES OR REACTIONS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: UNKNOWN
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: POSSIBLE (NOT VERIFIED) OXYCODONE
Vorherige Impfungen: -

VAERS 2292437

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

moderat

Staat: NV
Alter: 47,0
Geschlecht: F
Eingang: 24.05.2022
Impfdatum: 15.05.2022
Beginn: 15.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Burning sensation Chills Dehydration Dysgeusia Injection site erythema Pain

Symptomtext

Site: Redness at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: metalic taste, dehydration, burning sensation-Severe, Additional Details: Severely dehydrated to point where doctor prescribed IV drip for patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2286778

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: OH
Alter: 24,0
Geschlecht: F
Eingang: 20.05.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea Hypoaesthesia

Symptomtext

Systemic: patient reported difficulty breathing and numbing of legs and arm. Severity unknown.s-Medium, Additional Details: Patient called and reported having difficulty breathing and legs and hands feeling numb. Severity Unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2321740

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: -
Alter: 70,0
Geschlecht: M
Eingang: 19.05.2022
Impfdatum: 28.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Ageusia Anosmia Chills Cough Diarrhoea Dizziness Dyspnoea Headache Hyperhidrosis Influenza A virus test negative Influenza B virus test Injection site swelling Myalgia Nausea Oropharyngeal pain Pyrexia Respiratory syncytial virus test SARS-CoV-2 test negative

Symptomtext

Headache, Myalgia, Fever, CoughWheeze, Diarrhea, NauseaVomiting, right arm swelling from injection site to wrist, chills, sweats, dizziness, sore throat, loss of taste/smell, SOB Narrative: Tested for COVID, RSV, Flu B, Flu A on 5/9/22 and all were negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2283067

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: PA
Alter: 58,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 10.05.2022
Beginn: 11.05.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Condition aggravated Diverticulitis

Symptomtext

Started experiencing Diverticulitis symptoms the morning following the 4th shot. I started antibiotics on 5/18 & have improved considerably since then but not 100% yet. I also had Diverticulitis symptoms following the 1st shot but did not believe it was vaccine related at the time. After the 1st shot it was the first time that I need to be treatment for Diverticulitis. The situation resolved itself after taking antibiotics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Blood work was done a few days ago
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure, high cholesterol, skin cancer, seasonal allergies, diverticulitis
Andere Medikamente: Lovastatin, Lisinopril, Calcium, Fexofenadine Hydrochloride
Allergien: None
Vorherige Impfungen: Covid Vaccine; Moderna, 03/03/21

VAERS 2278163

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: VA
Alter: 29,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 11.05.2022
Beginn: 11.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Diarrhoea Electrocardiogram abnormal Erythema Feeling abnormal Flushing Heart rate increased Influenza like illness Metabolic function test Mobility decreased Oxygen saturation Pain Palpitations Platelet count decreased SARS-CoV-2 test negative Throat tightness Vertigo Vomiting

Symptomtext

About five hours after I got my second booster I feeling a little off with flu like symptoms. By 2AM I was flushed and turning red, I was achy and feeling the spins and had heart palpitations. I woke up Friday and could not even sit up and ended up staying in a Benadryl coma. I was vomiting and having diarrhea. I even took a Covid and that came back negative. I started feeling this impending doom. I became flush and my heart rate sky rocketed into the 140's I was on hold trying to talk to my doctor and then my throat starting closing and I had to use my EpiPen and called 911.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: Covid Test, EKG, Metabolic test, Heart rate and pulse-ox was monitored. Blood pressure was tracked. Low platelets but that may be due to my ITP.
Aktuelle Erkrankungen: None
Vorgeschichte: Ehlers Danlos Syndrome; ITP; Mass cell activation disease; Asthma; Disk degenerative disease; ADHD
Andere Medikamente: Wellbutrin XL; Celebrex; Allegra; gabapentin; methylphenidate ER; Pepcid; tapentadol ER; Xolair
Allergien: Percocet; Pentynyl; ideated contract medium; Vicodin; gluten
Vorherige Impfungen: -

VAERS 2273238

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

moderat

Staat: MA
Alter: 65,0
Geschlecht: F
Eingang: 12.05.2022
Impfdatum: 08.05.2022
Beginn: 08.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Discomfort Dyspnoea Pain

Symptomtext

Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Chest Tightness / Heaviness / Pain-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2328510

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: -
Alter: 35,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 25.04.2022
Beginn: 21.04.2022
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Constipation Flushing Headache Menstrual disorder Palpitations Rash Tachycardia Tongue disorder

Symptomtext

Headache, SkinRash, Constipation, Palpitations, Tachycardia, Flushing throughout, abnormal menstruations, pink patches on tongue, Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2268943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: TX
Alter: 32,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 07.05.2022
Beginn: 08.05.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inflammation Injection site erythema Injection site inflammation Injection site pain Injection site swelling Lymph node pain Lymphadenopathy Paraesthesia Pruritus

Symptomtext

Steady increases of injection site pain, inflammation, and redness. Left bicep is swollen up to twice normal size and affecting nerve, with tingling pain from tip of fingers to teeth on left side. Lymph node under left armpit is also very swollen, painful. Mild body itching with widespread inflammation. Progressive since time of injection despite use of NSAIDs and Benadryl

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Seasonal allergies
Vorgeschichte: Hypothyroidism, chronic myofascial pain syndrome, sinus tachycardia
Andere Medikamente: Euthyrox 25mcg, Benadryl
Allergien: Latex, gluten
Vorherige Impfungen: -

VAERS 2267242

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: IL
Alter: 56,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 04.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Paraesthesia Pruritus Rash

Symptomtext

Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266558

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: WA
Alter: 68,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 04.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal distension Chest discomfort Chest pain Dyspnoea Induration Injection site pain Mobility decreased Pain

Symptomtext

On day patient received the vaccine patient reports only mild side effects similar to side effects with previous doses of vaccine, primarily light soreness in injection side. Starting the next day, patient reports starting to feel intense chest pain which radiated to the back. Patient describes it like a band squeezing around her torso. Patient reports an intensity "15 / 10" to the point where she could not sit up or get up from a prone position. Additionally, patient reports "hardness" and swelling of abdomen and trouble breathing. She says symptoms were mostly resolved by 05/06/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No known
Vorgeschichte: No known
Andere Medikamente: No known
Allergien: No known
Vorherige Impfungen: -

VAERS 2266028

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: GA
Alter: 63,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 04.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Dizziness Fibromyalgia Headache Hyperaesthesia Pain SARS-CoV-2 test negative Toothache

Symptomtext

On the evening of the 4th, my body was in pain. It started on my left side and continued to the left side. I had a pain in my head that was so severe, even my teeth were hurting. It hurt for anything to touch me. I saw my doctor and she explained there was some adverse effects from the vaccine. It seemed it triggered my Fibromyalgia like it has never been treated. She gave me 60gram of Toradol and Meloxicam. The Toradol knocked me out completely, from 05/05/2022, I have been sleeping. I awoke today 5/6/2022 with a headache and achiness in my body. I have had a negative COVID-19 test twice. Basically my doctor called today and I told her that I was doing a bit better. I don't want anyone else to go through the pain I went through, I was in such severe pain I was asking God to take me. I also had dizziness if I stood up to long.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Fibromyalgia Depression Anxiety
Andere Medikamente: Flexural Vitamin D Rosuvastatin Etodolac Omeprazole Cymbalta Tramadol Adderall
Allergien: None
Vorherige Impfungen: -

VAERS 2263482

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: NJ
Alter: 59,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 29.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Arthralgia Asthenia Blood test normal Chills Computerised tomogram normal Condition aggravated Electrocardiogram normal Feeling abnormal Feeling cold Head discomfort Headache Limb discomfort Magnetic resonance imaging head normal Magnetic resonance imaging normal Mobility decreased Muscular weakness Musculoskeletal disorder

Symptomtext

The day of the vaccine, I had a headache with muscle and joint pain all over my body. That night I had chills with my skin hot. I felt like that triggered my RA and made a flare up. On 05/01/2022 around 2:30AM, I woke up and then I experienced pain in my stomach. I went downstairs to get Gaviscon medication and milk. I bent down to get the quart of milk and I could not lift the milk. I could not move my right arm and it felt like my head was being pushed down. It was a weird feeling. I could not control my arm and spilled my medication. My arm was extremely weak and heavy. This completely stopped when I got halfway up the stairs. I wanted to call 911 because I thought I was having a stroke. I sat on my bed and then got extremely cold. I drove myself to the ER. I had a CT Scan and EKG. I was admitted and had a brain and Carotid artery MRI as well as blood work. Nothing was indicated. The neurologist at hospital diagnosed it as a TIA. I went to a cardiologist 5/2/2022 and I will have a TTE next week. I am still very week. I was prescribed Prednisone that may resolve the weakness due to the RA flare up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 1,0
Labordaten: CT Scan, EKG, Brain MRI, Carotid artery MRI, Bloodwork, scheduled TTE
Aktuelle Erkrankungen: None
Vorgeschichte: RA HTN Thyroid issues
Andere Medikamente: I was off of my RA medications for a week before and will off 2 weeks after which is Levothyroxine, Valsartan, Hydrochlorothiazide. Folic Acid, Vitamin B12, Vitamin D.
Allergien: Penicillin Sulfa Percocet Mushrooms
Vorherige Impfungen: -

VAERS 2263433

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

moderat

Staat: MA
Alter: 74,0
Geschlecht: M
Eingang: 04.05.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Joint injury Limb injury Pain Paraesthesia

Symptomtext

Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2262129

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: CA
Alter: 30,0
Geschlecht: F
Eingang: 03.05.2022
Impfdatum: 29.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood test Chest X-ray Chest pain Dyspnoea Electrocardiogram Pyrexia Vaccine positive rechallenge

Symptomtext

I had a fever spike of 104 followed by a down tick in temperature to 90 and also severe chest pains that cause difficulty breathing. I also experienced these symptoms after my second dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKG, chest x-ray and bloodwork.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2260445

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: CA
Alter: 39,0
Geschlecht: F
Eingang: 02.05.2022
Impfdatum: 29.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chills Feeling abnormal Headache Hyperhidrosis Injection site erythema Injection site mass Injection site pain Injection site swelling Injection site warmth Lethargy Muscular weakness Myalgia Nausea Pain Pyrexia Tremor Vomiting

Symptomtext

Half an hour after shot I started feeling nauseous, there was a golf ball size lump at injection site, my arm had a shooting radiating pain like fire down to my wirst and injection arm feels weak with throbbing pain. Fever set in a few hours later with unconrollable shivering and shaking. The injection site progressively over a few days got more red, swollen and extremely hot to touch. My entire left upper arm by day three is swollen, painful, hot to touch, still weak and red. Within 18 hours I was vomiting and shaking unable to keep any fulids down. Physically I have been on and off with a fever, cold chills and shivering then sweating. Muscle pains, lethargic, foggy headed and have had an on going headache.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: none yet, I have called my Doctors office and left messages. I have an apt May 3rd (tomorrow) for other reasons.
Aktuelle Erkrankungen: none
Vorgeschichte: DDD, GERD, Arthritis
Andere Medikamente: omeprazole 20 mg, claritin, birth control, multi vitamins
Allergien: Vicodin
Vorherige Impfungen: Hep B vaccine in high school approximately 1999

VAERS 2248385

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

moderat

Staat: CA
Alter: 61,0
Geschlecht: F
Eingang: 22.04.2022
Impfdatum: 19.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angina pectoris Chest X-ray normal Chest discomfort Dizziness Fatigue Headache Hyperhidrosis Hypertension Hypoaesthesia Laboratory test normal

Symptomtext

Shortly after the injection part of my arm down to my pinky finger became mildly numb and it still is 3 days later. The following morning I awakened to sweats yet it resolved quickly. I am a psychologist and began telehealth session with a client and during that appt my heart fell heavy and like it was being squeezed causing mild to mod pain. I attempted to relax. The pain would come and go but I knew something was wrong. My blood pressure is typically very steady and consistently normal. I stopped my appt and took my blood pressure and it was 142 over 92. This is high for me. I stayed calm took an 81 mg baby asperin and called a COVID hotline nurse through the hospital to go to the ER so I did. They triaged me quickly. Thankfully my labs, portable chest x-ray came back normal and I was released 8 hours ish later. The dr. mentioned that when we have injury in the past a vaccine may inflame an old condition. I remain tired and dizzy, with a minor headache. The ER visit was 04/20/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: Refer to 18
Aktuelle Erkrankungen: None. I do have osteoarthritis, otherwise, healthy
Vorgeschichte: Approx 10 to 15 years ago had 1 incident of pleurisy, and pericarditis.
Andere Medikamente: Bio identical hormones, daily vitamins.
Allergien: Ampicilin Chocolate mild Basic allergies in the spring.
Vorherige Impfungen: Moderna

VAERS 2637675

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: NY
Alter: 50,0
Geschlecht: F
Eingang: 29.05.2023
Impfdatum: 03.05.2022
Beginn: 01.06.2022
Tage bis Beginn: 29,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dry skin Injection site pruritus Pruritus Psoriasis Rash Skin exfoliation

Symptomtext

Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: itchy scalp flaky rough skin on elbow legs and stomach after the two vaccines were administered together-Medium, Additional Details: Pt reported after recieving shingles and covid vaccine together a month later in june and july she experience itchly flaky scalp on elbows, legs, and stomach and was diagnosied with psoriasis per dermatologists

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2598499

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NC
Alter: 69,0
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 29.04.2022
Beginn: 19.02.2023
Tage bis Beginn: 296,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Heart rate increased Magnetic resonance imaging normal Malaise

Symptomtext

On 02/19/2023, at 11:00AM, I wasn't feeling well. I left church and was going to go home, but instead went to the Emergency Room because my heart was beating so fast. They gave me some medication to slow my heart down. They took an MRI to make sure I didn't have any blockage. I am better now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 19FEB2023 - MRI - Normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Multi Vitamins; Vitamin B 12; Vitamin B 6; Vitamin D 3; Sinopril; Hydrochlorothiazide
Allergien: Citric Acid
Vorherige Impfungen: -

VAERS 2579587

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 56,0
Geschlecht: F
Eingang: 10.02.2023
Impfdatum: 19.05.2022
Beginn: 01.06.2022
Tage bis Beginn: 13,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Lymph node pain Neck pain Pain

Symptomtext

About two weeks after receiving the second booster of Moderna, I started to experience pain up the left side of my head, that I've never experienced before. I was unable to lie on that side. The pain moved to the left side of my neck and progressed to my lymph nodes. I could feel the pain and pressure. The headache and pains up to my temple lasted through the summer. The pain in my lymph nodes became dormant. Once I received the Moderna Bivalent booster, the pain in my lymph nodes, neck and upper torso had increased and become constant. I have not sought care from my physician yet, but I am working with a licensed massage therapist. After my sessions, I feel better for about 3-5 days, but the pain returns. If my daily activities become interrupted, I will seek care from my PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymph node pain
Hospital-Tage: -
Labordaten: Blood work
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin; Biotin; B-Complex; Bone Strength; Co-Q-10; Magnesium Oxide.
Allergien: None
Vorherige Impfungen: -

VAERS 2566704

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 53,0
Geschlecht: F
Eingang: 24.01.2023
Impfdatum: 09.05.2022
Beginn: 24.12.2022
Tage bis Beginn: 229,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Nausea Pyrexia SARS-CoV-2 test positive Vomiting

Symptomtext

12/24/22 presents to ED for "fever, N/V". PMHx of "Addisons, Met Breast CA"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nausea
Hospital-Tage: -
Labordaten: 12/24/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2561132

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 60,0
Geschlecht: F
Eingang: 16.01.2023
Impfdatum: 08.05.2022
Beginn: 01.09.2022
Tage bis Beginn: 116,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ear discomfort Ear pain Pain in jaw Swelling face

Symptomtext

In September 2022 I noticed I was having pain in right ear. I went to the doctor and received some medication to help the symptoms. However, the problem persisted. One day in mid-December, I woke up and I was in severe pain in my jaw and my ear. I visited with a doctor again and received pain relievers and was told to take SUDAFED. The pain in my ear is a constant ache and my ear feels full. My right lower jaw swelled a little bit near my ear with constant pain like a toothache. The pain will resolve itself and return and as of today I have a slight pain in my ear.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Partial onset seizures; low thyroid level
Andere Medikamente: KEPPRA; SYNTHROID; vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2555797

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 10.01.2023
Impfdatum: 07.04.2021
Beginn: 25.11.2022
Tage bis Beginn: 597,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Mental status changes Pyrexia SARS-CoV-2 test positive

Symptomtext

11/25/22 presents to ED for "altered mental status and fever". PMHx of "Alzheimer's dementia, kidney transplant on mycophenolate"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 11/25/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2551561

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 21.01.2021
Beginn: 15.11.2022
Tage bis Beginn: 663,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal pain COVID-19 Nausea SARS-CoV-2 test positive Vomiting

Symptomtext

11/15/22 presents to ED for "abdominal pain, nausea, vomiting". PMHx of "CAD, hypothyroidism, dementia, and CKD"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain
Hospital-Tage: -
Labordaten: 11/15/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2551366

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 50,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 19.05.2022
Beginn: 15.07.2022
Tage bis Beginn: 57,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Osteoarthritis Pain in extremity X-ray

Symptomtext

mid-July 2022 - Onset of right hand pain 8/24/2022 Appt with Dr - diagnosis osteoarthritis right thumb CMC metacarpal 10/26/2022 Follow-up appt with Dr - will need to manage condition

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: XRays 8/24/2022
Aktuelle Erkrankungen: None
Vorgeschichte: allergic asthma, chronic environmental allergies, Fuchs Dystrophy
Andere Medikamente: Claritin, Benadryl, Muro 128, Alaway, Ibuprofen, Sudafed (Dietary Supplements): glucosamine sulfate
Allergien: Food & Medications, Food: soy, peanuts, tree nuts, legumes, orange, tomato, seeds (sesame, sunflower, poppy), banana, kiwi, avocado Meds: metronidizole, latex
Vorherige Impfungen: Covid Moderna booster (Oct 2021): Posterior Vitreous Detachment, osteoarthritis left thumb CMC

VAERS 2538023

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: PA
Alter: 33,0
Geschlecht: F
Eingang: 20.12.2022
Impfdatum: 16.06.2022
Beginn: 14.11.2022
Tage bis Beginn: 151,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ear pain Neck pain Neuralgia Oral pain Pain in jaw Pruritus Rash Skin burning sensation

Symptomtext

It started with a burning sensation on my scalp. I had a coworker and my mom looked at my scalp and saw nothing. My mom did see small bumps on my neck. I had nerve pain down my head to my neck, around my ear to my jaw, and my mouth. The doctors gave me medication. I am sleeping with an ice pack which helps with the itching. I am still having nerve pain and itchiness. I also had a rash on my scalp.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Gianza; Multivitamin; Calcium; Fiber; Claritin; Probiotic; Biotin; Sudafed; Ibuprofen
Allergien: Mangos; Latex
Vorherige Impfungen: -

VAERS 2520943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 39,0
Geschlecht: F
Eingang: 01.12.2022
Impfdatum: 03.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site pain Joint range of motion decreased

Symptomtext

Pain in Right shoulder since injection with decreased ROM, laying on side, and lifting arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: Migraines Asthma GERD Insomnia Blindness
Andere Medikamente: -
Allergien: Sulfa antibiotics
Vorherige Impfungen: -

VAERS 2517838

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 82,0
Geschlecht: M
Eingang: 28.11.2022
Impfdatum: 24.05.2022
Beginn: 28.11.2022
Tage bis Beginn: 188,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Pyrexia

Symptomtext

FEVER, CHILLS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2508402

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 66,0
Geschlecht: F
Eingang: 15.11.2022
Impfdatum: 09.05.2022
Beginn: 09.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Myalgia

Symptomtext

The next day after receiving the vaccine, I started having joint and muscle pain in my arms and legs. They lasted about three or four weeks. I took ibuprofen to help with the pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Arthritis; Psoriasis
Andere Medikamente: ZOLOFT; omeprazole
Allergien: ROCEPHIN
Vorherige Impfungen: -

VAERS 2495135

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21-A

mild

Staat: NH
Alter: 74,0
Geschlecht: M
Eingang: 01.11.2022
Impfdatum: 01.05.2022
Beginn: 14.09.2022
Tage bis Beginn: 136,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I had my vaccination on 05/01/2022. On 09/14/2022 I started to experience cough congestion body aches and low grade fever. I took a COVID-19 test at home on 09/15/2022 and it was Positive. I took Paxlovid for 5 days. I tested COVID-19 Negative on 09/25/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: COVID-19 Positive 09/15/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; High Cholesterol; Type II Diabetes
Andere Medikamente: Multivitamin; Vitamin D; Vitamin C; Glucosamine; Valsartan; Metoprolol; Atorvastatin; Amlodipine Besylate; Metformin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2495044

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: -
Alter: -
Geschlecht: U
Eingang: 01.11.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Malaise Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Sick with COVID. Symptoms started with fatigue on 8/29/2022, progressed to sore throat and cough on the evening of 8/30/2022 (negative antigen test), and then fever and malaise on 8/31/2022 (followed by positive antigen test).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home COVID rapid test on 8/30/2022 and 8/31/2022.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2495023

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NY
Alter: 68,0
Geschlecht: F
Eingang: 01.11.2022
Impfdatum: 27.04.2022
Beginn: 17.09.2022
Tage bis Beginn: 143,0
Dosis: 4
Route/Site: SYR / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Antibody test positive Asthenia Blood test COVID-19 Headache Oropharyngeal pain SARS-CoV-2 test positive Sinusitis

Symptomtext

Had headache; sore throat; and weak. Took a home COVID-19 test; called doctor and was prescribed PAXLOVID; still felt weak and congested a week later decided to go to urgent care and was told that it was sinus infection; went to primary care doctor and was given a blood test, showed antibodies were high.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Home COVID-19 positive; home COVID-19 test negative; blood test, antibodies were high.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Acid Reflux; Diverticulitis
Andere Medikamente: Gabapentin; atorvastatin; pantoprazole; multivitamin; fish oil; vitamin D; biotin; probiotics; glucosamine.
Allergien: Penicillin; apricot's; apples; pears.
Vorherige Impfungen: -

VAERS 2493577

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: TX
Alter: 61,0
Geschlecht: F
Eingang: 30.10.2022
Impfdatum: 21.04.2022
Beginn: 01.10.2022
Tage bis Beginn: 163,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Influenza like illness Oropharyngeal pain Pain SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

Symptoms started October 1. Sore throat, headache, body ache, flu like symptoms. Symptoms lasted 5 days. Tested positive for Covid October 4 2022. Tested negative October 17.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: At home Covid tests daily stating October 4.
Aktuelle Erkrankungen: None
Vorgeschichte: Epilepsy
Andere Medikamente: Lamotrigine
Allergien: sulfa
Vorherige Impfungen: -

VAERS 2491251

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NC
Alter: 69,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: 24.04.2022
Beginn: 14.08.2022
Tage bis Beginn: 112,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cough Headache Nasal congestion Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

8/14 symptoms started mild sore throat progressed to nasal congestion and headache that evening. 8/15 tested positive with an At Home COVID-19 test. Positive. Went to urgent care, saw a PA who prescribed remdesivir. 8/15 I had a fever was on and off, spiked at 100, lasting about 3 days. Started Remdesivir on 8/16. Used Robitussin to treat cough. Tested Negative on an AT Home COVID-19 test 8/21. 8/23 symptoms, nasal stuffiness, returned, and 8/24 tested positive on an At Home COVID-19 test. Tested Negative on an AT Home COVID-19 test 8/28. Cough lasted until 9/8.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 8/15 tested positive with an At Home COVID-19 test. Positive. 8/24 tested positive on an At Home COVID-19 test. Tested Negative on an AT Home COVID-19 test 8/21. Tested Negative on an AT Home COVID-19 test 8/28
Aktuelle Erkrankungen: No
Vorgeschichte: Cough Variant Asthma; Beta Thalassemia Minor; Seasonal allergies; Hashimoto's
Andere Medikamente: Levothyroxine; Trazadone; Valacyclovir; Vitamin D; Calcium; Magnesium; Melatonin; Zyrtec
Allergien: Penicillin; Ceftin
Vorherige Impfungen: -

VAERS 2488618

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 55,0
Geschlecht: M
Eingang: 25.10.2022
Impfdatum: 24.04.2022
Beginn: 29.08.2022
Tage bis Beginn: 127,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Myalgia Pyrexia SARS-CoV-2 test positive Sneezing

Symptomtext

I tested positive for Covid 19 on August 29,2022 I experienced Fatigue, Fever of 102.0, muscle aches, sneezing, cough. I was taking Tylenol and was prescribed Paxlovid for my symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Sinus; Asthma
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2488495

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: SC
Alter: 69,0
Geschlecht: F
Eingang: 25.10.2022
Impfdatum: 26.04.2022
Beginn: 07.10.2022
Tage bis Beginn: 164,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Malaise Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I started getting symptoms but did not test positive to COVID-19. Both my daughter and husband tested positive. I took PAXLOVID for 5 days and was feeling better then on the 19th I spiked a fever then tested and I was positive. I still have sniffles and congestion today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 negative 10/07; positive on 10/19; negative 10/25
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Rosuvastatin; meloxicam; gabapentin; BENEDYRL; B complex; biotin; phylum; fish oil; coQ10
Allergien: No
Vorherige Impfungen: -

VAERS 2484005

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: TN
Alter: 56,0
Geschlecht: F
Eingang: 20.10.2022
Impfdatum: 20.04.2022
Beginn: 28.08.2022
Tage bis Beginn: 130,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Injection site pain Malaise Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I had a mildly sore arm at the injection site for a day. I started feeling symptoms on 08/28/2022 with a terrible headache. On 08/29/2022 the headache was worse with a fever and body aches. I tested with a home test for COVID-19, and it was positive on 08/29/2022. I had a telehealth visit with my insurance company and talked with a provider. I was concerned that it would be moving into my chest. I was advised to load up on vitamin C and vitamin D and oranges. A couple of days later I was feeling better. I tested negative within six days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 29AUG2022 COVID-19 test positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Multivitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2483478

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: WA
Alter: 64,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 19.04.2022
Beginn: 25.07.2022
Tage bis Beginn: 97,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia COVID-19 Cough Headache Nasopharyngitis Nausea Pyrexia SARS-CoV-2 test positive

Symptomtext

I had a headache, felt like a cold, low grade fever of 101 for a week, lost sense of taste, nausea, and dry cough. I went to a clinic to test and I was positive for COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19, Positive,07/28/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypothyroidism; Barrett's Esophagus
Andere Medikamente: Omeprazole; Levothyroxine
Allergien: Tetracycline
Vorherige Impfungen: -

VAERS 2481768

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: TX
Alter: 51,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 16.04.2022
Beginn: 11.10.2022
Tage bis Beginn: 178,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Feeling cold Malaise Nasal congestion No adverse event SARS-CoV-2 test positive Sneezing

Symptomtext

I did not have an adverse reaction to the vaccine. I started to not feel well on 10/11/2022. It started with a stuffy head, and it felt like I was getting a general cold. I tested positive with a home test for COVID-19 on 10/13/2022. I contacted my doctor and was given a prescription for PAXLOVID. As of today, I am feeling better, but I still have a cough and sneezing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 13OCT2022 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2451271

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 19.05.2022
Beginn: 10.08.2022
Tage bis Beginn: 83,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aortic valve incompetence Cardiac murmur Echocardiogram abnormal Fatigue Mitral valve incompetence

Symptomtext

On August 10, 2022, I learned I had a heart murmur that I did not have before. I did not have any symptoms prior to this. I have been very tired since the first vaccine but didn't have a health issue to report until after dose 4 when I learned of the heart murmur.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Echocardiogram, 08/24/2022, mild aortic regurgitation, trace mitral regurgitation.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Herpes; Migraines; Arthritis
Andere Medikamente: Levothyroxine; atorvastatin; aspirin; vitamin B12; vitamin D3; sumatriptan; vitamin C; magnesium; MCT oil; multi collagen; AGELESS IMMUNITY
Allergien: Bees
Vorherige Impfungen: -

VAERS 2440685

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: WI
Alter: 86,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 03.05.2022
Beginn: 02.09.2022
Tage bis Beginn: 122,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Back pain COVID-19 Pain in extremity SARS-CoV-2 test positive

Symptomtext

Admitted to local hospital for back pain and thigh pain. Tested positive for COVID prior to transfer to alternate local Centre Hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 2429384

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: -
Alter: 60,0
Geschlecht: F
Eingang: 05.09.2022
Impfdatum: 23.06.2022
Beginn: 28.06.2022
Tage bis Beginn: 5,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Extra dose administered Injection site erythema Injection site swelling Injection site warmth

Symptomtext

Narrative: Pt had erythematous, warm, swollen softball size area at the injection site. She was instructed to take OTC Benadryl and use heat packs for relief. Pt was also instructed not to receive any more COVID vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2419443

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NC
Alter: 82,0
Geschlecht: F
Eingang: 24.08.2022
Impfdatum: 20.04.2022
Beginn: 27.04.2022
Tage bis Beginn: 7,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Computerised tomogram Fatigue Magnetic resonance imaging Myasthenia gravis

Symptomtext

Within one week of the shot, episodes of weakness and unusual tiredness when walking. Within two weeks, five emergency room visits, one hospitalization, MRIs, CTs and other exams. Diagnosis of Myasthenia Gravis, Dr/Hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: MRI, CT
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2416887

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: PA
Alter: 64,0
Geschlecht: F
Eingang: 21.08.2022
Impfdatum: 03.05.2022
Beginn: 21.06.2022
Tage bis Beginn: 49,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Malaise Nasal congestion SARS-CoV-2 test positive Throat irritation Vaccine breakthrough infection

Symptomtext

Breakthrough Covid. I started having very mild Covid symptoms on June 19th after air travel. Because a co-worker tested positive, I knew to keep testing and to isolate. On June 21st, I tested positive. I called my Dr immediately and was started on a course of Paxlovid. My symptoms never moved from the mild stage (scratchy throat, slight stuffy nose). No fever, no fatigue. I quarantined but worked from home. I then tested negative on June 26th. Because I had Paxlovid, i also tested every few days and never tested positive again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: the only testing was home tests.
Aktuelle Erkrankungen: no illnesses
Vorgeschichte: High blood pressure under control with meds, Catheters in my heart, had carotid endarterectomy, obesity
Andere Medikamente: atorvastatin - 40mg, carvedilol 12.5mg, valsartan-hydrochlorozide 25mg, aspirin 81mg, flonase, claritin, nifedipine 60mg
Allergien: seasonal allergies
Vorherige Impfungen: -

VAERS 2414715

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NJ
Alter: 69,0
Geschlecht: M
Eingang: 18.08.2022
Impfdatum: 18.05.2022
Beginn: 07.07.2022
Tage bis Beginn: 50,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Oropharyngeal pain Pyrexia Respiratory disorder SARS-CoV-2 test positive

Symptomtext

I received sore throat; fever; upper respiratory for about 4 days and I took Tylenol and I felt better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: I tested positive COVID 19 on 07/07/2022.
Aktuelle Erkrankungen: N/A
Vorgeschichte: High blood pressure
Andere Medikamente: Blood pressure medication
Allergien: N/A
Vorherige Impfungen: -

VAERS 2413527

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: KS
Alter: 60,0
Geschlecht: F
Eingang: 17.08.2022
Impfdatum: 23.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bacterial test negative Blood creatinine normal Blood test normal Blood urea normal Blood urine present Chromaturia Computerised tomogram kidney abnormal Culture urine negative Cystoscopy normal Haematuria Malaise Metabolic function test normal Microscopy Protein urine present Pyrexia pH urine normal Red blood cells urine positive Renal cyst

Symptomtext

The adverse event is hematuria, which started the day after I received the vaccine and continued for about 48 hours. Here is the timeline: 23-Apr-2022: I received the Moderna vaccine as my second booster for Covid-19 after three previous doses of Pfizer Covid-19 vaccine (17-Mar-2021, 06-Apr-2021, and 22-Oct-2021). As with the first three, I developed a fever and was feeling unwell by that evening. 24-Apr: The fever and malaise continued and I also noticed that my urine was dark brown by the afternoon. I drank a lot, but the color did not change. 25-Apr: My urine was no longer dark brown but had a red tinge. I called my primary care provider and was seen in the office that afternoon. (Continued below) 25-Apr (cont): My primary care provider confirmed blood in urine (test in office) and recommended a CT scan and kidney function test 26-Apr: CT scan showed a cyst on my left kidney, and blood tests showed normal kidney function. Because of history of breast cancer, primary care office recommended seeing a urologist. 27-Apr: Blood in urine no longer visible to my eye 10-Jun: Office visit to urology specialist. Urinalysis showed no blood in urine. Recommended cytoscopy and retrograde pyelograms. 21-Jun: Pre-procedure blood tests (chemistry) were normal 24-Jun: Cytoscopy and retrograde pyelograms showed normal findings 11-Aug: Follow-up visit showed no blood in urine (test in office). Since no cause was found for post-vaccine hematuria, I completed this VAERS form.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 25-Apr: Urinalysis w microscopy Abnormal: Occult blood 3+; Protein Trace; RBC 3-10 HPF 25-Apr: Urine BAC culture Normal; and Urinalysis automated w micro Abnormal: Protein Trace; 25-Apr (cont): Blood +++; pH 6; Color red pink. 26-Apr: Comprehensive metabolic panel normal; includes BUN 16 mg/dL; Creatinine 0.82 mg/dL 26-Apr: CT report showed "2 cm left renal upper pole fluid density cyst density of 9 units. No urinary calculi or hydronephrosis or perinephric edema." 10-Jun: Microscopy results: WBC none; RBC none; Bacteria none; Epi cells none. 21-Jun: Blood chemistry normal; includes BUN 15 mg/dL; Creatinine 0.7 mg/dL 24-Jun: Procedure report: "Cytoscopy was performed showing a normal urethra. The bladder is inspected with 30 and 70 degree lenses and found to be normal. Bimanual examination is also normal. Retrograde pyelograms were performed bilaterally with 5-10 cc diluted Omnipaque showing normal course, caliber, and peristalsis of both ureters without filling defects. Renal pelvis and calyceal systems are normal without evidence or tumors or stones."
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis (hands, feet)
Andere Medikamente: Multivitamins, Vit D, Miralax, vaginal estrogen
Allergien: Possible amoxicillin
Vorherige Impfungen: -

VAERS 2411298

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NY
Alter: 66,0
Geschlecht: F
Eingang: 15.08.2022
Impfdatum: 10.05.2022
Beginn: 29.07.2022
Tage bis Beginn: 80,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Diarrhoea Habit cough Headache Pyrexia SARS-CoV-2 test positive

Symptomtext

I had a fever, headache, tickle cough without production and loose stools. I tested positive for COVID-19 on 07/29/2022. I began taking Paxlovid and felt better. I tested negative for COVID-19 by 08/01/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: Home test positive COVID-19 on 07/29/2022.
Aktuelle Erkrankungen: None
Vorgeschichte: First degree heart block; mitral valve collapse; enteritis
Andere Medikamente: Crestor, Vitamin D
Allergien: Latex
Vorherige Impfungen: -

VAERS 2411294

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 67,0
Geschlecht: F
Eingang: 15.08.2022
Impfdatum: 15.05.2022
Beginn: 03.08.2022
Tage bis Beginn: 80,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Fatigue Headache Myalgia Nasal congestion Pyrexia SARS-CoV-2 test positive

Symptomtext

Muscle aches, fever, headache, chills, fatigue, nasal congestion and cough. Symptoms developed and worsened over 3 days. Tested positive on day three (August 5). Had a virtual visit with PCP who prescribed Paxlovid. Started Paxlovid on day three of symptoms (August 5) and felt better within hours of first dose. Completed a five day course of Paxlovid treatment on August 9. Continue to feel tired, have occasional cough and nasal congestion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: At-home COVID-19 antigen test August 5, 2022.
Aktuelle Erkrankungen: None
Vorgeschichte: High cholesterol, hypothyroidism, GERD
Andere Medikamente: Atorvastatin 10mg, Levothyroxine 50mcg, Omeprazole 40mg, Loratadine 10mg
Allergien: NKDA, seasonal allergies
Vorherige Impfungen: -

VAERS 2405820

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: AZ
Alter: 60,0
Geschlecht: M
Eingang: 09.08.2022
Impfdatum: 09.05.2022
Beginn: 18.07.2022
Tage bis Beginn: 70,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Headache Laryngitis Pulmonary congestion Rhinorrhoea Secretion discharge Sinus congestion

Symptomtext

I contracted Covid-19 I had a cough and chest congestion, sinus congestion runny, nose mucus head ache fatigue and laryngitis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Bronchitis; Cough; allergies
Vorgeschichte: Hypothyroidism; Depression; Anxiety; high Cholesterol; High Blood Pressure
Andere Medikamente: Irbesartan; levothyroxine; duloxetine; atorvastatin; buspirone
Allergien: CLARITIN D; multivitamin; fish oil; vitamin D
Vorherige Impfungen: Shingles vaccine

VAERS 2394995

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 86,0
Geschlecht: F
Eingang: 08.08.2022
Impfdatum: 28.04.2022
Beginn: 01.08.2022
Tage bis Beginn: 95,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection Oropharyngeal pain

Symptomtext

covid vaccine breakthrough dose 1 Moderna 2/4/21 038K20A dose 2 Moderna 3/5/21 030A21A dose 3 Moderna 10/26/21 014F21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: covid+ 8/1/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2394995

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 86,0
Geschlecht: F
Eingang: 08.08.2022
Impfdatum: 28.04.2022
Beginn: 01.08.2022
Tage bis Beginn: 95,0
Dosis: 4
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection Oropharyngeal pain

Symptomtext

covid vaccine breakthrough dose 1 Moderna 2/4/21 038K20A dose 2 Moderna 3/5/21 030A21A dose 3 Moderna 10/26/21 014F21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: covid+ 8/1/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2404043

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21A

mild

Staat: NJ
Alter: 50,0
Geschlecht: F
Eingang: 06.08.2022
Impfdatum: 05.08.2022
Beginn: 05.08.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Injection site swelling Injection site warmth Pain Pain in extremity Pyrexia

Symptomtext

Left arm soreness, swelling, warmth around injection site. Headache, body aches. Fever the whole day and night of 8/6/22, inspite if me taking tylenol 500 mg x 2.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: I did not go to the doctor or hospital.
Aktuelle Erkrankungen: Asthma, diabetes, hypertension, hyperthyroidism
Vorgeschichte: Asthma, diabetes, hypertension, hyperthyroidism
Andere Medikamente: Metformin, tapazole, losartan
Allergien: Shellfish, Diovan, Bactrim, latex, iv dye, sulfa,nickel
Vorherige Impfungen: Moderna

VAERS 2402908

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 58,0
Geschlecht: F
Eingang: 05.08.2022
Impfdatum: 24.04.2022
Beginn: 14.06.2022
Tage bis Beginn: 51,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaemia Blood test abnormal Fatigue Full blood count abnormal Haemoglobin decreased Oxygen saturation increased Red blood cell abnormality SARS-CoV-2 test negative Vitamin B12 decreased Vitamin D decreased

Symptomtext

I went in for my yearly check up to have my blood checked on 06/14/2022. It came back showing I was severely anemic, very low on vitamin D3, low on B-12, very large red blood cells but low hemoglobin, my saturation is high. I went back on August 3, 2022 my blood showed I was still severely anemic, low on vitamin D3. I am very fatigued and do not have COVID-19, I test myself periodically using the home COVID-19 test. I will be getting a vitamin D2 50,000.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Complete blood panel
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Progesterone; ALLEGRA; estradiol patch
Allergien: No
Vorherige Impfungen: -

VAERS 2400501

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 69,0
Geschlecht: M
Eingang: 03.08.2022
Impfdatum: 01.05.2022
Beginn: 27.07.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Influenza Laboratory test Liver function test normal Nasopharyngitis Pain Renal function test normal Respiratory tract congestion Rhinorrhoea Vaccine breakthrough infection

Symptomtext

N OTE: On the date above, I recived the first in the series of vaccinations. I received the second on 01/MAR/2021, and Boosters on 17NOV 21 and on 01MAY22. The adverse event is a breakthrough case of COVID-19. Day Zero on 27JUL 22. On 30JUL22, I started a course of treatment with PAXLOVID. the first day or two of infection caused symptoms consistent with a bad cold or flu, aches, extreme fatigue, runny nose, and chest congestion. Those have been improving with each passing day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Labs, CHEM 6 prior to Rx of PAXLOVID - Renal and hepatic functions all OK.
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma, CAD, BPH, RBBB, GERD
Andere Medikamente: fluticasone- Umeclidinium vilanterol ?Trelegy? inhaler ? asthma control - daily montelukast ?Singular? 10 mg ? asthma control ?daily rampril ?Altace? ? 2.5mg - ACE inhibitor BP control ? daily metoprolol ?Toprol-XL? 25mg ? Beta Blocker BP
Allergien: NKA
Vorherige Impfungen: -

VAERS 2400457

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: TX
Alter: 73,0
Geschlecht: F
Eingang: 03.08.2022
Impfdatum: 23.05.2022
Beginn: 25.06.2022
Tage bis Beginn: 33,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Myalgia Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Covid infection with muscle aches, mild fever, sore throat, sporadic cough

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myalgia
Hospital-Tage: -
Labordaten: Abbot lab binax Covid repeated followed by Flow max Covid test all positive
Aktuelle Erkrankungen: Non
Vorgeschichte: High blood pressure, elevated LDL, atrial fibrillation
Andere Medikamente: Metropolis, amlodipine,,Eliquis, rosuvasatin, calcium, co-q10
Allergien: Photosensitive to doxycycline
Vorherige Impfungen: -

VAERS 2400441

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MO
Alter: 74,0
Geschlecht: F
Eingang: 03.08.2022
Impfdatum: 03.05.2022
Beginn: 18.07.2022
Tage bis Beginn: 76,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Nasopharyngitis Pyrexia SARS-CoV-2 test positive

Symptomtext

I felt like I was coming down with a cold. After getting home from vacation, during that trip my granddaughter had a cold so I did not think too much of it. After two days I was not feeling better so I took a COVID-19 Home Test and it was positive. I started having a fever and was just not doing better so I called my Doctor and I was put on Paxlovid. That resolved all symptoms other than being tired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Home Test
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Bisoprolol; Levothyroxine; Fish Oil; Daily Vitamin; Baby Aspirin
Allergien: Penicillin; Sulfa
Vorherige Impfungen: -

VAERS 2399243

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CO
Alter: 61,0
Geschlecht: F
Eingang: 02.08.2022
Impfdatum: 27.07.2022
Beginn: 29.07.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site erythema Injection site inflammation Injection site pruritus Injection site warmth

Symptomtext

Itchy, red, inflamed, hot to touch area developed over the injection site on 7/29/22 at 4am. It was approximately 2x2 inches. Benedryl for the skin was applied and decreased it's appearance. No other signs or symptoms developed. First 3 Moderna vaccines were "fine." Patient did state that she has many allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2399128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: FL
Alter: 71,0
Geschlecht: F
Eingang: 02.08.2022
Impfdatum: 30.04.2022
Beginn: 23.06.2022
Tage bis Beginn: 54,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Paranasal sinus hypersecretion Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had gone on vacation and had been on a long flight. My husband ended up in the hospital and I was there with him. A day or two later I had a runny nose, sinus drainage, congestion, and cough. I was tired but thought that may be because of the trip. My daughter had a COVID-19 Home Test and I took that I was positive. I took a baby Aspirin and about four days in I was doing better. The symptoms were really only like a mild cold.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Home Test
Aktuelle Erkrankungen: N/A
Vorgeschichte: Breast Cancer Survivor
Andere Medikamente: Latanoprost; Ezetimibe
Allergien: N/A
Vorherige Impfungen: -

VAERS 2398226

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NY
Alter: 76,0
Geschlecht: M
Eingang: 01.08.2022
Impfdatum: 27.04.2022
Beginn: 15.07.2022
Tage bis Beginn: 79,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Fatigue Influenza like illness Malaise Myalgia Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive Throat irritation

Symptomtext

Felt symptoms starting on Friday evening 15 July around 9PM. Tested positive for COVID on Saturday 16 July at 0900. Symptoms at that point were runny nose, scratchy throat (not sore), muscle aches as in flu, fatigue. No loss of appetite. Isolated until Sunday 17 July, when spouse tested positive as well. After that, we both isolated together. Called doc's office. Since I have no asthma, diabetes, or heart / lung problems, he said Paxlovid was not necessary -- my temperature was 97.5 and oxygen was 98 or 99%. He prescribed rest, acetaminophen as necessary, plenty of fluids. He said to contact him by Monday if symptoms worsened, or just let him know. I posted status updates in my portal on Monday. Symptoms started to abate by day 6, I think. However I still tested positive. I first tested negative on Saturday 30 July, followed by negative tests on 31 July and 1 August.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Positive antigen tests: 16, 20, 24, 27, 29 July Negative antigen tests 30 and 31 July and 1 August
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Tamsulosin Multi-vitamin Vitamin C Lutein Ginseng
Allergien: None
Vorherige Impfungen: -

VAERS 2398151

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 75,0
Geschlecht: F
Eingang: 01.08.2022
Impfdatum: 28.04.2022
Beginn: 15.07.2022
Tage bis Beginn: 78,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Cough Feeling hot Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

I had a runny nose, sneezing and I could tell I was warm & I had a bad cough. I had 2 nights of a bad cough & 2 mornings of a sore throat. I went to the urgent care and got prescription for Z-PAK and nasal spray. I tested positive for COVID19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes
Andere Medikamente: Atorvastatin; metformin; amlodipine; valsartan; NEXIUM; calcium; fish oil; CLARITIN; probiotic
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2398053

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: GA
Alter: 69,0
Geschlecht: M
Eingang: 01.08.2022
Impfdatum: 30.04.2022
Beginn: 13.06.2022
Tage bis Beginn: 44,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Insomnia Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

COVID-19 symptoms started 06/13/22; tested positive 06/15/22. Symptoms started Sunday night and I woke up next morning with sore throat and I had tossed and turned and when I had woken up the next morning I felt some degree of fatigue and sore throat as well as low grade fever. I called PCP on 06/15/22 and they prescribed PAXLOVID but I was on other medications that would interact with it so I didn't start that until the 16th. Symptoms were cleared up after 2 days of taking PAXLOVID. I'm still a little off but vastly improved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 positive 06/15/22
Aktuelle Erkrankungen: None
Vorgeschichte: Elevated cholesterol; osteoarthritis; gastroesophageal disease/Barrett's esophagus; benign colonic polyps; benign prostate hypertrophy; coronary atherosclerosis.
Andere Medikamente: Rosuvastatin; ZETIA; alfuzosin; tadalafil; vitamin B12; NEXIUM
Allergien: Cefazolin
Vorherige Impfungen: -

VAERS 2397988

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: TN
Alter: 66,0
Geschlecht: F
Eingang: 01.08.2022
Impfdatum: 25.04.2022
Beginn: 08.07.2022
Tage bis Beginn: 74,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Oropharyngeal pain Productive cough Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Starting 07/08/2022, I started having a headache, sore throat and congestion. Shortly after, I tested myself with an at-home COVID-19 test which was positive. These would be the only symptoms I would experience this entire case. I called my doctor right after testing positive and he prescribed me PAXLOVID. That evening, I started taking it, and over the next 5 days the symptoms would gradually improve. By 07/14/2022, I was feeling better and I could go outside with a mask on. I tested myself with an at-home COVID-19 test and it was negative. On 07/16/2022, my throat started getting sore again followed by a headache and congestion. I took another COVID-19 test that day and it was positive. I called my doctor to let them know I was positive again and decided not to take any medicine this time. The symptoms were pretty much identical to the first episode and I decided to just ride it out. By 07/25/2022, I tested negative for COVID-19, and again on 07/27/2022 I tested negative. My symptoms lingered a little longer this time with a slight headache and slight sore throat off and on. The only symptom I have to date is intermittent phlegm in the throat but otherwise I am feeling fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: At-home COVID-19 test (07/08/2022): positive; at-home COVID-19 test (07/14/2022): negative; at-home COVID-19 test (07/16/2022): positive; at-home COVID-19 test (07/25/2022): negative; at-home COVID-19 test (07/27/2022): negative
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroidism
Andere Medikamente: SYNTHROID; biotin; magnesium; multivitamin; calcium; vitamin D
Allergien: Amoxicillin
Vorherige Impfungen: -

VAERS 2397973

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NY
Alter: 68,0
Geschlecht: F
Eingang: 01.08.2022
Impfdatum: 30.04.2022
Beginn: 10.07.2022
Tage bis Beginn: 71,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Malaise Respiratory tract congestion SARS-CoV-2 test positive Upper-airway cough syndrome

Symptomtext

Approximately 2 months after tested positive for COVID-19. I had post nasal drip, cough, fatigued, congestion. I was prescribed a Paxlovid. Tested negative after course of Paxlovid but began not feeling well and tested positive again a few weeks later.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19
Aktuelle Erkrankungen: No
Vorgeschichte: High cholesterol, hypothyroidism; GERD
Andere Medikamente: Synthroid; omeprazole; Atorvastatin; Duloxetine; nasal spray
Allergien: CT contrast
Vorherige Impfungen: -

VAERS 2397957

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NJ
Alter: 74,0
Geschlecht: M
Eingang: 01.08.2022
Impfdatum: 29.04.2022
Beginn: 15.07.2022
Tage bis Beginn: 77,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Influenza Lacrimation increased Oropharyngeal pain Pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I had gone on a vacation and came home and started having a sore throat and thought I may have a mild flu as time went on. I had some congestion and achiness. I did go see my health provider and I was positive for COVID-19. They gave me Paxlovid to help. I did recover but then it came back and I was still positive. I was having watery eyes, a sore throat, I was tired, coughing, very fatigued and just had about three days that were pretty bad. Currently I wake up in the mornings with mild symptoms and then they get better throughout the day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Rapid Test
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Cholesterol;
Andere Medikamente: Levothyroxine; Simvastatin; Evetimibe; Baby Aspirin; Multivitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2397920

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NE
Alter: 69,0
Geschlecht: M
Eingang: 01.08.2022
Impfdatum: 27.04.2022
Beginn: 26.07.2022
Tage bis Beginn: 90,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Malaise Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sinus headache

Symptomtext

I started running a fever of 100.0, when I woke up and had a sore throat that lasted maybe a half hour. I also had some congestion with headache, more like a sinus headache and that was it and I basically took a home COVID-19 test and it was positive. Called the doctor next and picked up the anti viral that afternoon and started it that evening. I was sick for about 4 days. I was actually working in the yard on Saturday and I hadn't completed the antiviral.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 Test Home 7/26/22 Positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Coronary Artery Disease; Heart Disease; Cataracts; Vitreous Detachment; West Nile Virus; Asthma; Pericarditis; Cellulitis.
Andere Medikamente: Atenolol; Aspirin; Isosorbide; Lenexa ER; Atorvastatin; Vitamin D3; Niacin; Folic Acid; Potassium; Multivitamin 50+ Mens; Montelukast; Zyrtec; Flonase; Vision Formula 50+.
Allergien: Penicillin; Norvasc; Dust; Mold; Trees; Plants; Sweet Potato.
Vorherige Impfungen: -

VAERS 2396528

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 62,0
Geschlecht: M
Eingang: 29.07.2022
Impfdatum: 28.04.2022
Beginn: 22.06.2022
Tage bis Beginn: 55,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Chills Cough Diarrhoea Feeling abnormal Headache Impaired work ability Oropharyngeal pain Pain Productive cough Pyrexia Rhinorrhoea SARS-CoV-2 test positive Secretion discharge Sinusitis

Symptomtext

started feeling bad on Wednesday June 22. sore through, cough, runny nose, soreness, headaches. Ran a home health test Thursday morning and it was negative. Thursday picked up the remaining symptom, fever, chills and diarrhea. Went to urgent care on Friday and tested positive. I did not work Thursday or Friday. June 23 24. Started to feel better but by Tuesday of the next week (June 28) was feeling worse and coughing up a lot of mucus. Setup a zoom appointment and got prescribed antibiotic for the sinus infection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 6/23/22 VOCID-19 home test brand - negative 6/24/22 COVID-19 Molecular collected - positive
Aktuelle Erkrankungen: Sinus infection
Vorgeschichte: Non-Hodgkin's lymphoma - started chemo 5-15-17
Andere Medikamente: Fish Oil 1000 mg Aspirin 81 mg B6 100 mg Mens 50+ vitamin
Allergien: Morphine
Vorherige Impfungen: -

VAERS 2396504

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: VA
Alter: 56,0
Geschlecht: M
Eingang: 29.07.2022
Impfdatum: 27.04.2022
Beginn: 20.06.2022
Tage bis Beginn: 54,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest discomfort Cough Fatigue Illness SARS-CoV-2 test Upper respiratory tract congestion

Symptomtext

He contracted COVID-19 on 06/20/2022 with symptoms cough, fatigue, chest tightness, and chest congestion. He was prescribed Butalin inhaler, Amoxicillin, and Prednisone on 06/21/2022. He was ill for 10 days before symptoms began to abate. He is fully recovered with no lingering symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 rapid nasal swab home test on 06/20/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Allergies
Andere Medikamente: Allegra D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2396441

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: TX
Alter: 60,0
Geschlecht: F
Eingang: 29.07.2022
Impfdatum: 28.04.2022
Beginn: 24.07.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest discomfort Cough Fatigue Headache Nasal congestion Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Symptoms were sore throat, headache, congestion, coughing, low grade fever and fatigue on Sunday. Tested on Sunday afternoon at home twice and they were negative. Monday I went to work and symptoms got worse throughout the day. I tested again at work (medical care facility) and this test was positive. I picked up Paxlovid on Monday and taking since then. I began to feel better on Wednesday but today Friday (day 6) I am feeling more fatigued again. I still have a headache and nasal congestion. First thing in the morning my chest is heavy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home COVID-19 tests, negative; PCR, positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; Hypothyroidism; Fibromyalgia
Andere Medikamente: Vitamin D3; Coreg; Lasix; Lisinopril; Synthroid; Protonix; Gabapentin; Norco
Allergien: Penicillin; Latex
Vorherige Impfungen: -

VAERS 2395036

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: GA
Alter: 75,0
Geschlecht: F
Eingang: 28.07.2022
Impfdatum: 22.04.2022
Beginn: 18.07.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Cough Feeling abnormal Headache Malaise Pyrexia SARS-CoV-2 test positive Throat irritation

Symptomtext

I was having a headache with a scratchy throat along with a cough. I was generally just not feeling well. I ended up taking a COVID-19 Home Test which was negative. The next day I was still feeling poorly so I took another test and it was also negative. I still just felt horrible so I went to the doctor and they did a COVID-19 PCR Test and it was positive. I had gotten worse by this point and just was feeling so bad along with having developed a slight fever. My doctor gave me some cough syrup and some nose spray.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19 Home Test; COVID-19 PCR Test
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes; Cardiovascular Disease
Andere Medikamente: Amlodipine; Atorvastatin; Carvedilol; Hydrochlorothiazide; Losartan Potassium; Meloxicam; Omeprazole; Janumet
Allergien: Shellfish
Vorherige Impfungen: -

VAERS 2394884

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 62,0
Geschlecht: F
Eingang: 28.07.2022
Impfdatum: 21.04.2022
Beginn: 30.06.2022
Tage bis Beginn: 70,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Aphonia Asthenia COVID-19 Exposure to SARS-CoV-2 Fatigue Headache Oropharyngeal pain SARS-CoV-2 test positive Sneezing

Symptomtext

I woke up with a sore throat, headache and sneezing. My husband had already tested positive. I was losing my voice and was very tired so I tested on July 1st and was positive. I was sick for about 5 days with the sore throat and headache coming and going. I had virtual healthcare visit with my doctor and they recommended mixing TYLENOL and MOTRIN. I declined taking PAXLOVID as I was not compromised and my case was relatively mild. I tested negative on the 13th. The fatigue lasted for a while but I would say I am completely recovered from myself. For 2 weeks I felt not myself and I didn't have much energy. The other symptoms started to wain after the first week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Home test July 1st, 2022 positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Hydrochlorothiazide; daily multivitamin; vitamin B12
Allergien: Penicillin
Vorherige Impfungen: COVID 19 1st Dose Moderna, fatigue, sore arm.

VAERS 2393340

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: WA
Alter: 66,0
Geschlecht: F
Eingang: 27.07.2022
Impfdatum: 26.04.2022
Beginn: 13.07.2022
Tage bis Beginn: 78,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Fatigue Headache Nasal congestion Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I woke up with a slight headache, sore throat, nasal congestion, and cough. The next morning I had chills, and I had a fever of 101.3. I took a COVID-19 test that came back positive. I called my doctor that day and they gave me PAXLOVID. The next morning I felt tired but my symptoms had improved. My symptoms lasted about 5 days, and the next weekend I woke up and all my symptoms started again. I took at another COVID-19 test and it came back positive. I am still currently experiencing symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 test- positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Multivitamin; vitamin D; calcium
Allergien: Sulfite
Vorherige Impfungen: -

VAERS 2393225

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: VA
Alter: 57,0
Geschlecht: F
Eingang: 27.07.2022
Impfdatum: 26.04.2022
Beginn: 22.07.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Exposure to SARS-CoV-2 Fatigue Feeling abnormal Malaise Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I received my second Moderna booster for COVID-19 on 4/26/2022. On either the evening of 7/21/2022 or the morning of 7/22/2022, I developed a cough and some upper respiratory congestion. My husband had recently tested positive for COVID-19, so I just started masking and then took a home test on the evening of 7/23/2022. The result was positive. I just treated my symptoms with OTC medicines like Delsym, Mucinex, and Sudafed. I then called my PCP on 7/25/2022 to notify her. She prescribed me some benzonatate pills to treat my cough. Since I've been ill, I've dealt with significant fatigue, brain fog, cough, and congestion. I've been regularly checking my blood oxygen levels, and they have never dipped below 97%. At the time of this writing, my symptoms are improving. I'm now not as tired as I was from 7/24/2022-7/26/2022, plus my brain fog has diminished. However, I still have cough and congestion. Having said that, though, I would say that the OTC medicines and the benzonatate have worked well. I haven't had difficulty breathing, and I have been able to sleep well at night.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 7/23/2022--home COVID-19 test--positive result
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: Zyrtec; Paroxetine; Aleve.
Allergien: Probable Allergy to Penicillin (But Not Derivatives); Poison Ivy; Mild Seasonal Allergies.
Vorherige Impfungen: After I received both doses of the Shingrex vaccine in 2021, I experienced body aches, extreme chills, and fatigue for about 12

VAERS 2392945

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MS
Alter: 60,0
Geschlecht: M
Eingang: 27.07.2022
Impfdatum: 22.04.2022
Beginn: 15.07.2022
Tage bis Beginn: 84,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Oropharyngeal pain Pain Productive cough Pyrexia SARS-CoV-2 test positive Throat irritation

Symptomtext

Irritation throat, pain throat, body aches, fever, cough with salty clear sputum

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: SARS-COV-2 COVID-19 AMP PRB on 7/16/2022 positive
Aktuelle Erkrankungen: None
Vorgeschichte: HTN Hyperlipidemia
Andere Medikamente: Amlodipine Atorvastatin Vitamin D3
Allergien: Sulfa ARB
Vorherige Impfungen: -

VAERS 2391224

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MD
Alter: 53,0
Geschlecht: M
Eingang: 26.07.2022
Impfdatum: 25.04.2022
Beginn: 24.07.2022
Tage bis Beginn: 90,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Malaise Nasopharyngitis Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

On Thursday he felt like he was coming down with a cold, ad a cough, runny nose. He took a home COVID-19 test that came back negative. On Sunday he was still feeling unwell and I had an event that I was going to that would have a lot of people there so as a precaution I had him test. This time the home COVID-19 test came back positive. he called and had a telehealth visit. They prescribed him Paxlovid that he started taking on Monday July 25, 2022. He is sleeping a lot but we are quarantined away from each other.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Home COVID-19 test
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma
Andere Medikamente: Multivitamins; Zinc
Allergien: Latex; Avocado; Banana
Vorherige Impfungen: -

VAERS 2391113

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: TX
Alter: 55,0
Geschlecht: M
Eingang: 26.07.2022
Impfdatum: 23.04.2022
Beginn: 23.06.2022
Tage bis Beginn: 61,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Headache Oropharyngeal pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Developed a sore throat on 6/23 and took a test but it came up negative. Developed a fever later that evening with a headache and severe fatigue. I tested positive on 6/25. I reached out to my NP on 6/27 and received the PAXLOVID. I finished the medication on 6/30 but was still showing positive. My symptoms had mostly subsided other than slight fatigue and runny nose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Magnesium; vitamin A; vitamin B; krill oil
Allergien: None
Vorherige Impfungen: -

VAERS 2391105

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: GA
Alter: 68,0
Geschlecht: F
Eingang: 26.07.2022
Impfdatum: 22.04.2022
Beginn: 30.06.2022
Tage bis Beginn: 69,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Pain Pain in extremity Pyrexia SARS-CoV-2 test positive

Symptomtext

Arm hurt after vaccination, fever, fatigued, achy. Did a home test, then had a telehealth appt with PCP. Decided not to take Paxlovid. Tested positive for 13 days. Fully recovered now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD; Colitis, Acid Reflux
Andere Medikamente: Omeprazole; Rosastatin; Inhaler Spiriva Resptinat; Multivitamin; Probiotic; Tumeric; Claratin; Lop Emad
Allergien: N/A
Vorherige Impfungen: Shingles in 2021

VAERS 2391101

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NC
Alter: 66,0
Geschlecht: M
Eingang: 26.07.2022
Impfdatum: 22.04.2022
Beginn: 20.07.2022
Tage bis Beginn: 89,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I took a nap in the afternoon and woke up with a sore throat. I was out of town so I drove back. The sore throat worsened and I had a headache. I also had a runny nose so Friday morning I completed an at home COVID-19 Test and it was positive. I called my doctors office. I took ibuprofen and antihistamine. I was prescribed Paxlovid. I started the first dose on Friday night. I have continued taking the medication and I have improved. I did have to stop taking 2 of my normal medications while taking the Paxlovid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19 Home Test-July 22, 2022-Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; Type 2 Diabetes; Stage 3 Kidney Disease; Obstructive Sleep Apnea
Andere Medikamente: Losartan; Amlodipine; Hydrochlorothiazide; Rosuvastatin; Aspirin; Vitamin B12
Allergien: N/A
Vorherige Impfungen: -

VAERS 2388205

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OK
Alter: 71,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 22.04.2022
Beginn: 21.06.2022
Tage bis Beginn: 60,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Dizziness Headache Oropharyngeal pain Pain SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19 on 06/21/2022. I had a sore throat at first. Then, I had a headache, body aches, coughing that was very painful, and dizziness. I was prescribed Paxlovid and I started feeling better after taking that after about four days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: COVID-19 Test- 06/21/22- Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Vitamin D3; Fish Oil
Allergien: N/A
Vorherige Impfungen: -

VAERS 2376597

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: FL
Alter: 67,0
Geschlecht: F
Eingang: 21.07.2022
Impfdatum: 18.04.2022
Beginn: 28.06.2022
Tage bis Beginn: 71,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Ear pain Nasopharyngitis SARS-CoV-2 test positive

Symptomtext

I woke up Tuesday, the 28th, with cold symptoms and sore ears. I took over the counter cold medicine. The cold went away, but I was stuck with a really harsh cough that got progressively worse. I was going to go to urgent care, but I knew the first thing they would ask would be if I did a COVID-19 test. I was shocked to find out that I tested positive. I took a second COVID-19 test and it was positive, too. Urgent care didn't have any appointments until Monday. I had a telehealth visit with my doctor instead. He ordered PAXLOVID. I started it right away. I would like to say that it knocked it right out of me, but I still had the cough. The cough is much better. I have no other symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: 07/01/2022 at home COVID-19 test x2 - positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Partial Lung Removal
Andere Medikamente: Coenzyme Q10; vitamin C; turmeric curcumin; vitamin D2; amitriptyline; tolterodine tartrate; DULCOLAX
Allergien: Tea
Vorherige Impfungen: -

VAERS 2376576

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: TX
Alter: 56,0
Geschlecht: F
Eingang: 21.07.2022
Impfdatum: 20.04.2022
Beginn: 25.06.2022
Tage bis Beginn: 66,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Enlarged uvula Exposure to SARS-CoV-2 Fatigue Feeling abnormal Headache Night sweats Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Throat clearing

Symptomtext

The first symptoms were runny nose, congestion, cough, fatigue, light headaches, and night sweats. I didn't lose taste or smell or get a sore throat. The fatigue was the most extreme. I don't think I have had a fever. I just felt so run down that I tested for COVID-19 at home and it was positive. I called my doctor and he prescribed PAXLOVID. It helped with the major symptoms though I did experience metal mouth with it. I still have a swollen uvula and I need to clear my throat and cough a lot. My parents and husband also tested positive. I tested negative 14 days after first testing positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: At-home COVID-19 test 06/25/2022 (positive); At-home COVID-19 test 07/09/2022 (negative).
Aktuelle Erkrankungen: N/A
Vorgeschichte: Rheumatoid Arthritis; Hashimoto's Disease; Diabetes Type 2; Fibromyalgia; Migraines
Andere Medikamente: Levothyroxine; VASCEPA; VIIBRYD; topiramate; simvastatin; lisinopril; JENTADUETO; omeprazole; HUMALOG; LEVEMIR; magnesium; ibuprofen
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2373780

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: AZ
Alter: 64,0
Geschlecht: F
Eingang: 19.07.2022
Impfdatum: 18.04.2022
Beginn: 10.07.2022
Tage bis Beginn: 83,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Ear pain Fatigue Headache Mucosal hypertrophy Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

The onset of symptoms was on July 10 with tiredness and slight headache. By day 2, I had a raging sore throat, thick mucus, headache, and some chills. I did not know what the temperature was. It didn?t feel like a normal cold, so I took a COVID-19 test and it came back positive. The sore throat was bad and lasted around 5 to 6 days. The congestion I still have right now. There are some headaches even on day 10. No GI symptoms, no loss of taste or smell. No shortness of breath or anything. I did have some ear pain with the sore throat. I self-medicated over the counter with Dayquil. I took Nyquil at night. I also alternated with ibuprofen for the pain of the sore throat. I stayed hydrated, rested, and quarantined. Today is day 10 and I?m on half doses of the medications. No more ibuprofen and no sore throat or ear pain. I am getting better. The only thing really is congestion now. In the process of recovering, not fully there, but getting better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: At Home COVID-19 07/12/2022 - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2368994

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: PA
Alter: 61,0
Geschlecht: F
Eingang: 14.07.2022
Impfdatum: 16.06.2022
Beginn: 16.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Eye pain Hypoaesthesia Hypoaesthesia eye Pain in extremity Pain in jaw Periorbital pain

Symptomtext

Sharp pain behind and above right eye, pain in jaw on right hand side, pain in arm and shoulder on right hand side. Lasted for approximately 5 minutes. Numbness in same areas, including right side of face, afterwards. Not constant, but sporadic

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A Contacted PCP and was advised to wait a few days to see if it got better. It did after approximately 8-10 days, but will occasionally flare up.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2344874

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 70,0
Geschlecht: M
Eingang: 30.06.2022
Impfdatum: 18.05.2022
Beginn: 23.06.2022
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Aphasia COVID-19 Cough Headache Paranasal sinus discomfort Rhinorrhoea SARS-CoV-2 test positive Sinus congestion Sneezing

Symptomtext

I had a runny nose, a little bit of a cough, sneezing, low grade headache, my sinuses were congested and I had sinus pressure. I took a home COVID-19 test and it came back positive so I called my PCP who I was unable to talk to at that time. So I called telehealth COVID-19, after we discussed my symptoms they called in a prescription of Paxlovid I just took my last dose today, I am feeling better just a little tired with a bit of a runny nose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Home COVID-19 test
Aktuelle Erkrankungen: No
Vorgeschichte: Hypertension, Type II Diabetes, Heart Condition
Andere Medikamente: N/A
Allergien: Keflex
Vorherige Impfungen: -

VAERS 2341494

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NE
Alter: 54,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 29.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Ear pain Fatigue Headache Laboratory test Neck pain Pain Pain in extremity

Symptomtext

I had reactions after first and third shot. Started ext. having severe headaches. fatigue, left side of body aching, arm, shoulder pain. After first shot neck area 2 blood vessels sensitive pain full through ears had long recovery. After third shot left side hurting so bad under breast doctor gave me first time symbalta medicine. It helped

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: sent my medical history includes lab results
Aktuelle Erkrankungen: -
Vorgeschichte: High Cholesterol; Menopause Symptoms; Hot Flashes; Chronic Bronchitis; Left side weakness
Andere Medikamente: No meds
Allergien: None
Vorherige Impfungen: -

VAERS 2335859

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 40,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 16.06.2022
Beginn: 16.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anxiety Pruritus Swelling Throat irritation

Symptomtext

The patient started experiencing an itchy throat and ears at 1045am. We then gave her one dose of 25mg benadryl. After 5 minutes the patient started reporting more itchiness and she felt like she had some swelling happening so we gave her one more dose of 25mg benadryl. The patient starting feeling better and was talking to a coworker to ease her anxiety about it. At 1130am the patient said she was feeling back to normal and asked if she could leave, which we did allow her to leave after hearing her symptoms had gone away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2332374

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 71,0
Geschlecht: F
Eingang: 24.06.2022
Impfdatum: 11.05.2022
Beginn: 22.06.2022
Tage bis Beginn: 42,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cough Fatigue Feeling abnormal Headache Oropharyngeal pain Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Viral infection

Symptomtext

I did travel out of the country prior and I was battling a viral infection on my way home. I woke up this Wednesday feeling awful with a lot of congestion, sore throat, terrible headache, and coughing as well. I had both fevers and achiness all over my body, and so I contacted my PCP and I did request for the monoclonal antibody infusion on the 23rd. After the infusion I have seen significant improvement in symptoms. I am still having headaches and a cough that is improving, I do still have some congestion. I still have some fatigue and body aches.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 test: positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Lisinopril; eye vitamin; calcium
Allergien: MACROBID
Vorherige Impfungen: -

VAERS 2327084

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 057M21A

mild

Staat: VA
Alter: 58,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 21.06.2022
Beginn: 21.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Headache

Symptomtext

c/o dizziness and severe headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: htn, hx of papillary thyroid ca, pre dm, hemorrhoid
Andere Medikamente: Hydrocortisone prn hydrochlorothiazide Levothroxine vitamin d colchine retin a
Allergien: none
Vorherige Impfungen: -

VAERS 2320437

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: SC
Alter: 66,0
Geschlecht: F
Eingang: 15.06.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Eye disorder Eye irritation Immediate post-injection reaction Intraocular pressure test abnormal Malaise Ocular discomfort Ocular hyperaemia Viral infection

Symptomtext

Starting immediately after receiving the vaccine, I was sick for 3 days. I became aware of the eye issue 3 days later and it felt very irritated. It became more irritated and red, and on 06/01/2022 and 06/09/2022 I saw the eye doctor. They told me I had a recurrent viral infection (which I had originally had in my 20s). I had lesions and graying on the surface of my eye. After a few days of run around due to the cost of the prescriptions, I finally got substitutes and samples for the medications and started them. Since starting them, it has gotten better and they have noticed my eye pressure in both eyes is elevated (unsure if related to this or not). I saw them on Monday 06/13/22 and they said its about 75% better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Fluorescein dye tests and eye pressure tests.
Aktuelle Erkrankungen: None
Vorgeschichte: MH malignant hyperthermia; Sporadic high blood pressure; Hypothyroidism
Andere Medikamente: Levothyroxine; omeprazole; multivitamin
Allergien: Gas anesthetics; old class original Novocaine
Vorherige Impfungen: -

VAERS 2319111

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: FL
Alter: 86,0
Geschlecht: M
Eingang: 14.06.2022
Impfdatum: 17.05.2022
Beginn: 04.06.2022
Tage bis Beginn: 18,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

Symptoms started 06/05/2022. I tested positive on 06/04/2022. Doctor prescribed Paxlovid to take for 5 days. Symptoms disappeared within 48 hours of starting Paxlovid. I still have low energy to this day but otherwise feel normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Covid test (06/04/2022): Positive, Covid test (06/10/2022): Negative
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis
Andere Medikamente: Lipitor and miscellaneous vitamins
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2317278

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MD
Alter: 62,0
Geschlecht: F
Eingang: 13.06.2022
Impfdatum: 01.05.2022
Beginn: 11.06.2022
Tage bis Beginn: 41,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Eye swelling Nasal congestion Oropharyngeal pain SARS-CoV-2 test

Symptomtext

Approximately 1 month after my 4th dose vaccination I contracted Covid-19 and had the following symptoms: stuffy nose, sore throat, nasal congestion, swollen eyes. I had a tele visit with a doctor and was prescribed with BENADRYL at night to help keep my nose open. MUCINEX, vitamin C, zinc and to use cough drops to preserve my voice and also to take TYLENOL and ibuprofen. So far, it's only been 12 hours since I started the medications so I can't say for sure if it's improved my symptoms or not.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: COVID-19 test
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Cholesterol; Overweight
Andere Medikamente: Lipitor; vitamin D; aspirin
Allergien: Bee stings
Vorherige Impfungen: -

VAERS 2317199

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: PA
Alter: 59,0
Geschlecht: F
Eingang: 13.06.2022
Impfdatum: 06.06.2022
Beginn: 30.05.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Cough Diarrhoea Ear pain Fatigue Headache Hypersomnia Oral pain Pulmonary congestion Pyrexia

Symptomtext

I had a morning cough develop and headache as well as fatigue on the morning of May 30th. This morning cough lasted for a few weeks. I had to take naps during the day which is very unusual for me. The first indication was my left ear was hurting as well as the inside of my mouth. I received my vaccine, 4th dose, and developed diarrhea and chills. A few days later, I developed an even worse cough. I had low-grade fever of which I did not check. This lasted for a couple of days. I also had congestion in my chest. Today is the first day I feel better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Cold /allergies
Vorgeschichte: Hyperoliid Osteopenia Pre-cancer Spinal Stenosis of neck and lumbar spine
Andere Medikamente: Zyrtec Celebrex Fish oil Glucosamine Turmeric Magnesium Cinnamon B12 Extra strength Tylenol for headaches
Allergien: Allergic to anthrax vaccine and PPD.
Vorherige Impfungen: -

VAERS 2314066

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 62,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 06.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Injection site erythema Injection site pain Injection site swelling Injection site warmth

Symptomtext

Patient called on 6/8 to report symptoms in left upper arm of soreness, redness, swelling, warm to touch. Patient said redness had began to spread downward from the injection site. Patient called her PCP on 6/8 and was directed to take benadryl and call PCP back if got worse. When I spoke to patient, I told her that putting ice on the area might help. She said she would do that and call me back on 6/9 if got worse. I spoke with patient on 6/9 at 1025am. She said that the swelling had gone down and that she was going to take more benadryl today and follow up with her PCP if symptoms got worse.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2311247

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: LA
Alter: 74,0
Geschlecht: F
Eingang: 07.06.2022
Impfdatum: 28.04.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site movement impairment Vaccination site pain Vaccination site swelling

Symptomtext

Unable to move right arm; a lot of swelling at injection site; A lot of pain; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to move right arm), VACCINATION SITE SWELLING (a lot of swelling at injection site) and VACCINATION SITE PAIN (A lot of pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included AMLODIPINE, BUSPIRONE HYDROCHLORIDE (BUSPAR), SITAGLIPTIN PHOSPHATE (JANUVIA), LOVASTATIN, LOSARTAN and HYDROCHLOROTHIAZIDE (HCTZ) for an unknown indication. On 28-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to move right arm), VACCINATION SITE SWELLING (a lot of swelling at injection site) and VACCINATION SITE PAIN (A lot of pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Unable to move right arm), VACCINATION SITE SWELLING (a lot of swelling at injection site) and VACCINATION SITE PAIN (A lot of pain) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient had been alternating heat and ice, and also taking Tylenol and Zyrtec for treatment. Caller says none of those have helped.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: No medical history was provided by the reporter.
Andere Medikamente: AMLODIPINE; BUSPAR; JANUVIA; LOVASTATIN; LOSARTAN; HCTZ
Allergien: -
Vorherige Impfungen: -

VAERS 2310572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: TX
Alter: 56,0
Geschlecht: F
Eingang: 06.06.2022
Impfdatum: 30.04.2022
Beginn: 01.06.2022
Tage bis Beginn: 32,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Cough Fatigue Headache Oropharyngeal pain Pain Respiratory tract congestion

Symptomtext

It started with a sore throat-felt like needles. That evening, it progressed into body aches. The next couple of days I developed fatigue, headache, coughing, congestion. This lasted for a few days. I could feel I was getting stronger and having more energy. Today, I have a lingering cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: N/a
Vorgeschichte: N/a
Andere Medikamente: Lisinopril HCL 10 Wellbutrin XL Singulair Advair Diskus (inhaler) Ambien Zyrtec Colon Health Steroid Injection received March 31st, 2022 (Depo-Medrol)
Allergien: N/a
Vorherige Impfungen: -

VAERS 2310144

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: IN
Alter: 66,0
Geschlecht: F
Eingang: 06.06.2022
Impfdatum: 29.04.2022
Beginn: 28.05.2022
Tage bis Beginn: 29,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Malaise Nasal congestion SARS-CoV-2 test positive Throat irritation

Symptomtext

I did not have an adverse reaction to the vaccine but I contracted Covid 19 and tested positive on June 1, 2022. I began having symptoms on May 28 with a scratchy throat. About five days afterwards, I just wasn't feeling well. I had nasal congestion, fatigue and frequent dry cough. I took Tylenol or Aleve but it really didn't help. I had a Telehealth visit with my doctor and she prescribed an anti viral medication. By June 4th, I was feeling better but still have fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home test Covid 19 positive on June 1.
Aktuelle Erkrankungen: N/A
Vorgeschichte: high blood pressure
Andere Medikamente: Participant is taking several medications and a couple of over-the-counter meds. Declined to list.
Allergien: minocycline, ace inhibitors
Vorherige Impfungen: -

VAERS 2308467

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: DE
Alter: 63,0
Geschlecht: F
Eingang: 03.06.2022
Impfdatum: 29.04.2022
Beginn: 26.05.2022
Tage bis Beginn: 27,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Fatigue Feeling cold Headache Oropharyngeal pain SARS-CoV-2 test positive Sinusitis

Symptomtext

Woke up tired with feelings of a sinus infection, sore throat, headaches and cold chills. Took a rapid covid test and it was positive

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Rapid Covid test 05/28/2022 result was positive
Aktuelle Erkrankungen: No.
Vorgeschichte: Sarcoidosis Diabetes
Andere Medikamente: Januvia Jardiance Cymbalta Vitamin D Vitamin C Cranberry Elderberry Nexium Singular Levocetirizine Crestor Inhalers; Breo Symborcit Ipratropium bromide
Allergien: Bactrim
Vorherige Impfungen: -

VAERS 2307035

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CO
Alter: 72,0
Geschlecht: M
Eingang: 02.06.2022
Impfdatum: 27.04.2022
Beginn: 29.05.2022
Tage bis Beginn: 32,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I developed a cough and sore throat, on May 29, 2022 I took home COVID-19 Test that was positive. I called the doctors office spoke to doctor who prescribed Paxlovid that I am currently taking. After a couple days on the Paxlovid I no longer have a sore throat and have much less coughing than before.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Home COVID-19 test.
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Finasteride; simvastatin; terazosin
Allergien: Penicillin; erythromycin
Vorherige Impfungen: -

VAERS 2306962

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 51,0
Geschlecht: M
Eingang: 02.06.2022
Impfdatum: 04.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 22,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthma COVID-19 Cough Malaise Nasal congestion Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID breakthrough case. I received my 2nd booster shot on 05/04/2022 and my COVID symptoms started on 05/26/2022 it was in the morning cough, asthma, stuffy nose, later that day I had low grade fever. 05/28/2022 high grade fever. I also did a COVID home test that day which was positive. I did a tele heath with doctor who prescribed me with PAXLOVID for 5 days. I finished my whole course. I am recovering but I still have cough and congestions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID home test.
Aktuelle Erkrankungen: Seasonal allergies
Vorgeschichte: Asthma; high blood pressure; insomnia; eczema
Andere Medikamente: Regular meds diltiazem 240mg 1 per day; amitriptyline 10 milligrams 3 per day; Flovent 100mcg; albuterol
Allergien: Oysters; cats; dog
Vorherige Impfungen: -

VAERS 2305312

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: WA
Alter: 69,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 19.04.2022
Beginn: 25.05.2022
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Pulmonary congestion SARS-CoV-2 test positive Upper-airway cough syndrome

Symptomtext

I started having a dry cough then a lot of post nasal drip. It went right to my lungs with congestion. I was also super tired thursday may 26th i self tested positive with covid. the previous day it was negative I called the doctor and got paxlovid and started that night and it completely reversed the symptoms so in two days i had a lot less symptoms. I tested negative on may 30th and 31st.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: covid test 5/26 - positive covid test 5/25- negative covid tests 5/30, 5/31 - negative
Aktuelle Erkrankungen: no
Vorgeschichte: osteoporosis, low thyroid
Andere Medikamente: Multivitamin, magnesium, calcium, omega 3, vitamin k, iodine, iron, vitamin a, d3 5000iu
Allergien: bell pepper
Vorherige Impfungen: -

VAERS 2305115

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NJ
Alter: 43,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 07.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Eyelid pain Hordeolum Pain Rash Skin discolouration Staphylococcal infection Swelling of eyelid

Symptomtext

DEVELOPED STAPH INFECTION AROUND NOSE/ON FACE ON 5/10/22. RASH HAD NOT GONE AWAY BY 5/15/22 SO RX CREAM RX BY DOCTOR. ON 5/23/22. ON 5/29/22, DEVELOPED PAINFUL EYELID-SWELLING, PURPLE SKIN, PAINFUL TO OPEN EYE-DX WITH STYE AND SWOLLEN EYELID-RX KEFLEX PRESCRIBED-I HAVE NEVER HAD THIS ISSUE WITH MY EYE EVER IN MY LIFE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Eyelid pain
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: HYPOTHYROIDISM
Andere Medikamente: SYNTHROID CYTOMEL
Allergien: REGLAN PERCOCET CIPRO LATEX ADHESIVE TAPE
Vorherige Impfungen: -

VAERS 2303654

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 66,0
Geschlecht: F
Eingang: 31.05.2022
Impfdatum: 20.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Muscle spasms Myalgia Pyrexia

Symptomtext

Fever, muscle spasm, severe muscle ache fatigue lasting three days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: -
Vorgeschichte: Multiple sclerosis; Sleep apnea.
Andere Medikamente: Baclofen; 4 Aminopyridin; Tylenol; Cranberry supplement; Turmeric.
Allergien: None.
Vorherige Impfungen: -

VAERS 2303448

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: RI
Alter: 62,0
Geschlecht: M
Eingang: 31.05.2022
Impfdatum: 22.04.2022
Beginn: 24.05.2022
Tage bis Beginn: 32,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Headache Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

I woke up with a sore throat on Tuesday and I took a COVID-19 test and it was negative but was experiencing congestion, runny nose, and sore throat and draggy just a little tired. On Thursday I had the same symptoms plus a headache, and again I took a COVID-19 test and was negative. On Friday I still had the same symptoms but wasn't tired and tested again and I was positive. That is when I called my doctor and she prescribed Paxlovid for 5 days and I took my first dose that day and immediately went to quarantine and Sunday night I had a great deal of coughing from 1AM to 6AM while I was in bed and that went away after that one bad time. As of right now a week later I am mostly symptom free, I have a desire to cough but cough every once in awhile and have 1 dose left of the medication and have test negative today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Mild Sleep Apnea; Psoriasis; Osteoarthritis; Diverticulosis
Andere Medikamente: Acitretin; fish oil; glucosamine; vitamin C; coQ10; aspirin 81 mg every 2 days; biotin
Allergien: Pollen
Vorherige Impfungen: Shingles Vaccine, 2021 Age 61, felt achy, tired, fever.

VAERS 2303319

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 91,0
Geschlecht: F
Eingang: 31.05.2022
Impfdatum: 12.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Asthenia C-reactive protein increased Pyrexia Urinary tract infection

Symptomtext

Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 5/14/2022 Discharge Date: 5/29/2022 PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] Acute pain of right knee [M25.561] HOSPITAL COURSE: The patient is a 91 y.o. female with a past medical history of hypertension, hypothyroidism, DVT on Eliquis, cancer breast, insomnia who presents today with generalized weakness. Patient was noted to have a fever and elevated CRP. She had recently received her 4th COVID booster shot approximately 2 days ago. Her symptoms were considered likely secondary to sequelae from this vaccine. She was seen by Neurology who recommended treatment with Neurontin. Patient was started on low-dose at 100 mg TID, titrated to 200 mg TID which she tolerated well. She was noted to have a urinary tract infection concurrently. She was started on Keflex and finished a 5 day treatment course. She was started on supportive management. Patient was monitor for resolution of her symptoms. PT / OT worked with her who recommended SAR which was arranged by care management. As the patient was clinically stable, and had been cleared from COVID isolation she was discharged to skilled nursing facility on 05/29/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Breast cancer, left, multi-focal, ER+ Displaced intertrochanteric fracture of right femur, initial encounter for closed fracture (HCC) Peri-prosthetic fracture of shaft of femur DVT, lower extremity, distal, acute, bilateral (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet bisacodyl (DULCOLAX) 5 MG enteric coated tablet cholecalciferol (VITAMIN D3) 50 MCG (2000 UT) tablet ELIQUIS 5 MG tablet gabapentin (NEURONTIN) 100 MG capsule glycerin-hypromellose-PEG 400 (ARTIFIC
Allergien: None
Vorherige Impfungen: -

VAERS 2302103

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MN
Alter: 66,0
Geschlecht: F
Eingang: 30.05.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Injection site erythema Injection site pain Injection site pruritus Injection site swelling

Symptomtext

Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2302079

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: SC
Alter: 84,0
Geschlecht: M
Eingang: 30.05.2022
Impfdatum: 13.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site erythema

Symptomtext

Redness to Left Deltoid. No pain, tenderness, temp at site. Resident started on Cephalaxin 500mg BID x3 days as a precaution.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298765

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NE
Alter: 69,0
Geschlecht: F
Eingang: 27.05.2022
Impfdatum: 28.04.2022
Beginn: 24.05.2022
Tage bis Beginn: 26,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Feeling abnormal Malaise Nasal congestion Oropharyngeal pain Pain Pulmonary pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Sneezing Throat irritation

Symptomtext

On May 24, 2022 I started to feel achy with a scratchy, sore throat and a dry cough. The next day I had malaise, and I didn't feel good. I didn't have much aching, but I still had a dry cough. My upper lungs were hurting. My nose started to be real stuffy and runny, and I started sneezing. I called my doctor and I was prescribed Paxlovid yesterday. Today I don't have much coughing and my congestion is cleared up. I do have diarrhea since taking Paxlovid. Throughout that entire time of having Covid I never ran a fever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Covid test negative (5/24/2022). Covid test positive (5/25/2022).
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure
Andere Medikamente: Amlodipine 5mg 1x day; irbesartan 150mg 1x day
Allergien: Ampicillin; penicillin; sulfa; erythromycin; chloromycetin; kiwi
Vorherige Impfungen: -

VAERS 2298595

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MS
Alter: 27,0
Geschlecht: F
Eingang: 27.05.2022
Impfdatum: 12.05.2022
Beginn: 13.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Urticaria

Symptomtext

ON 5/13/22 AROUND 8:30AM STAFF REPORTED HAVING "HIVES" IN THE UNDERARM AREA. STAFF NURSE VIEWED RED RAISED HIVE-LIKE WELPS ON THE UNDERSIDE/UNDER ARM AREA OF BOTH ARMS. CONDITION DID NOT WARRANT AN MD VISIT. TREATED WITH HYDROCORTISONE CREAM. UPON LEAVING AT END OF SHIFT AT 2PM, STAFF DENIED ANY ITCHING AND REPORTED THE AREA HAD NOT WORSENED. STAFF HAS QUIT.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: UNKNOWN
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: SEASONAL ALLERGIES - GRASS , POLLEN, MOLD, WASP PCN BENADRYL IRISH SPRING SOAP OKRA
Vorherige Impfungen: -

VAERS 2296514

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: WA
Alter: 55,0
Geschlecht: F
Eingang: 26.05.2022
Impfdatum: 04.05.2022
Beginn: 22.05.2022
Tage bis Beginn: 18,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Cough Fatigue Fear Feeling abnormal Headache Malaise Nausea Oropharyngeal pain Pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I did an at home COVID-19 test on 5/22/2022 that was negative. I started getting symptoms late at night with coughing that did not stop. On 5/23/2022 and 5/24/2022, I had sore throat, coughing, body aches, runny nose, headache, chills, possible fever, brain fog, nausea, and fatigue. I did an at home COVID-19 test on 5/23/2022 that was positive. I contacted my doctor on 5/24/2022 because my symptoms progressed so strong, I was scared due to being out of state. I did a virtual visit and was prescribed PAXLOVID. I never did take PAXLOVID due to bad side effects and wanted to wait and see how my symptoms went. On 5/25/2022 most all of the symptoms were gone except for runny nose and cough which is mild.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: At home COVID-19 test negative 5/22/2022. At home COVID-19 test positive 5/23/2022.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Claritin; multivitamins; fish oil
Allergien: Erythromycin; codeine
Vorherige Impfungen: -

VAERS 2295680

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MD
Alter: 80,0
Geschlecht: F
Eingang: 26.05.2022
Impfdatum: 16.04.2022
Beginn: 16.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chills Gait disturbance Inflammation Pain in extremity Pyrexia

Symptomtext

hurts to walk; inflammation in the body; pain in knees,pain in ankles,it is unusual for left knee to hurt; right arm pain,pain in bottom of feet and ankles; chills; fever; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (right arm pain,pain in bottom of feet and ankles), GAIT DISTURBANCE (hurts to walk), INFLAMMATION (inflammation in the body), ARTHRALGIA (pain in knees,pain in ankles,it is unusual for left knee to hurt) and CHILLS (chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 16-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2022, the patient experienced CHILLS (chills) and PYREXIA (fever). On 17-Apr-2022, the patient experienced PAIN IN EXTREMITY (right arm pain,pain in bottom of feet and ankles) and ARTHRALGIA (pain in knees,pain in ankles,it is unusual for left knee to hurt). On an unknown date, the patient experienced GAIT DISTURBANCE (hurts to walk) and INFLAMMATION (inflammation in the body). The patient was treated with PARACETAMOL (TYLENOL) for Arthritis, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (right arm pain,pain in bottom of feet and ankles), GAIT DISTURBANCE (hurts to walk), INFLAMMATION (inflammation in the body), ARTHRALGIA (pain in knees,pain in ankles,it is unusual for left knee to hurt), CHILLS (chills) and PYREXIA (fever) had not resolved. No concomitant medications reported. Treatment also included 15 minutes of exercise a day to help the pain and staying hydrated. Patient called the doctor who said that the vaccine attacks inflammatory system.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2294478

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 69,0
Geschlecht: F
Eingang: 25.05.2022
Impfdatum: 17.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

I started to have a lack of energy on Monday afternoon. On Tuesday I was so exhausted so my husband advised me to take a at home COVID-19 test that came back positive. I called the nurse. I was advised to quarantine for 5 days and wear a mask for the following 5 days. They did not prescribe any medication. I had a fever and I treated the fever with Dayquil.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Test -05-24-2022-Positive.
Aktuelle Erkrankungen: N/a
Vorgeschichte: N/a
Andere Medikamente: Vitamin C Airborne Metoprolol Simvastatin Nyquil
Allergien: Morphine; penicillin
Vorherige Impfungen: -

VAERS 2290602

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: FL
Alter: 69,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 18.04.2022
Beginn: 24.04.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Dizziness Headache Oropharyngeal pain Pain SARS-CoV-2 test positive Sinus congestion Upper respiratory tract congestion

Symptomtext

Tested Positive for Covid April 24-2022. Sore throat -body aches - headache- dizziness - head/facial congestion Received Monoclonal April 28th 2022. Dizziness and headache gave continued .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroid High Cholesterol
Andere Medikamente: Levothyroxine Motegrity Dexilant
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2290591

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: CT
Alter: 33,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 05.05.2022
Beginn: 09.05.2022
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash

Symptomtext

Rash on both legs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2290481

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: WI
Alter: 66,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 29.04.2022
Beginn: 16.05.2022
Tage bis Beginn: 17,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Oropharyngeal pain Pain SARS-CoV-2 test positive

Symptomtext

I had a sore throat, coughing, and body aches. I am still dealing with this at this time. I tested positive for COVID-19 on 5/18/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Rapid COVID-19 - 5/17/2022 - Negative. Rapid and PCR COVID-19 Test and 5/19/2022 - Positive
Aktuelle Erkrankungen: I had a sore throat and uvulitis and I was put on an antibiotic.
Vorgeschichte: Hypolipidemia, Chronic Neck Pain, Arthritis in my knees
Andere Medikamente: Vitamin D3, Krill Oil, COQ 10, Pravastatin, Gabapentin, Terbinafine, Sudafed
Allergien: N/A
Vorherige Impfungen: -

VAERS 2287139

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: PA
Alter: 70,0
Geschlecht: F
Eingang: 20.05.2022
Impfdatum: 10.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Neuralgia

Symptomtext

Lower back pain not muscular more nerve type.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Levothyroxine 75 mcg Rosuvastatin 5 mg M-W-F 1/2 tab Fish oil 2400 mg Fortifeye D3 1000 IU Calcium 600 mg Fluxone high dose quad 8/13/2021
Allergien: Tree nuts Bee stings
Vorherige Impfungen: -

VAERS 2286971

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NJ
Alter: 63,0
Geschlecht: F
Eingang: 20.05.2022
Impfdatum: 30.04.2022
Beginn: 16.05.2022
Tage bis Beginn: 16,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Feeling abnormal Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had severe sore throat and foggy head on 5/16. I went to the urgent center and got tested for covid and was positive and had runny nose. But I'm doing really well. Also I had a family member who had covid at the time. I got my 4th dose/booster, two weeks ago.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: PCR covid test - positive, rapid covid test - negative
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: Enablex
Allergien: no
Vorherige Impfungen: -

VAERS 2284639

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: CA
Alter: 55,0
Geschlecht: F
Eingang: 19.05.2022
Impfdatum: 15.05.2022
Beginn: 15.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Nausea

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Additional Details: After patient received vaccination she felt slightly dizzy and nauseous. Monitored pts bp and she was in the normal range. She sat for about 15 min and she felt better. She left after she came back to normal. Followed up with the patient 3 hours later and she is okay.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2281895

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 43,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 16.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chills Headache Pyrexia Somnolence

Symptomtext

Severe headache, aching joints, severe chills, "groggy" feeling, fever

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: A-fib
Andere Medikamente: Zyrtec
Allergien: None
Vorherige Impfungen: -

VAERS 2281399

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 74,0
Geschlecht: F
Eingang: 17.05.2022
Impfdatum: 15.04.2022
Beginn: 27.04.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatinine decreased Blood urea increased Electrophoresis Feeling abnormal Feeling hot Haematocrit increased Haemoglobin normal Hepatitis A virus test Hepatitis B virus test Hepatitis C virus test Immunoglobulins normal Monocyte count increased Platelet count increased Protein total Rash Red blood cell count increased White blood cell count increased

Symptomtext

I had my vaccine booster on 04/15/2022 I was fine until the morning of 04/27/2022 and woke up with a red rash starting to go all over my body. As the day progressed it got worse and I felt like I was totally on fire. I called my doctor who told me to go get my blood drawn. He prescribed me prednisone and said he didn't know what was wrong with me. He said my white blood cells were attacking my red blood cells and thought it may be Hepatis A. The next morning it was even worse. I thought I was going to die. My kids were doing conference calls to each other they were so worried I was going to die. I got all the anti-itch cremes and whatever I could take to get rid of it but nothing worked. In the meantime my doctor had already done a blood stat test and then sent me again a few days later but it was getting better. I'm having hip surgery coming up on 06/09/2022 and now it looks like my blood levels are almost normal again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: 04/28/2022 - Hepatitis Panel; Hepatitis AB Total - Nonreactive; Hepatitis B - Reactive; Hepatitis B Core - Nonreactive; Hepatitis C - Nonreactive; White Blood Cells - High; Red Blood Cells - High; Hempcrete - High; 05/05/2022 - Blood stat test; Protein total and electrophoresis - Everything in green except gamma globulin - 0.7; Creatinine - low - .50; BUN/creatinine - 26; White Blood Count - 10-20; Red Blood Count - 3-10; White Blood Count CBC - 9.6; Red Blood Count - 4.91; Hemoglobin - Normal; Hematocrit - 47.4; Platelet - 456; Absolute Monocyte - 1152
Aktuelle Erkrankungen: -
Vorgeschichte: Blood Pressure; Hyperthyroidism
Andere Medikamente: Hydrocortisone Prednisone 10mg CBD Roll On Levothyroxine 50mg Amlodipine 5mg tablet once a day Hydrochlorothiazide 25mg once a day
Allergien: -
Vorherige Impfungen: -

VAERS 2280713

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NJ
Alter: 56,0
Geschlecht: F
Eingang: 17.05.2022
Impfdatum: 14.05.2022
Beginn: 15.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site pain Injection site swelling Lip swelling Rash

Symptomtext

I got in the shower & I removed the bandage & about 2 inches from injection site I noticed a big round red bump & it was sore to the touch & then I washed my hair & I noticed my head had bumps in my scalp & also my lip started swelling & I knew something was wrong so I took 2 Benadryl & all bumps were gone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: Hypothyroidism
Andere Medikamente: Allegra, Levoxyl
Allergien: Tetracycline, All Shellfish
Vorherige Impfungen: -

VAERS 2280619

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 17.05.2022
Impfdatum: 11.05.2022
Beginn: 13.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Muscular weakness Pain Pain in extremity

Symptomtext

Pain and Muscle weakness in left arm and shoulder. Pulsating throbbing pain in left Deltoid and Shoulder. Aleve not effective for pain relief. Pain scale 7/10.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: Patient reported following up with PCP.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Unknown
Allergien: No
Vorherige Impfungen: -

VAERS 2280585

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: WV
Alter: 34,0
Geschlecht: F
Eingang: 17.05.2022
Impfdatum: 11.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blister Rash

Symptomtext

Systemic: Allergic: Rash Generalized-Medium, Systemic: "blistering all over the body"-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2278368

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: IL
Alter: 58,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 29.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Headache Lethargy

Symptomtext

I was very lethargic I had a severe headache & I was very fatigued.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes; Hypertension
Andere Medikamente: Aspirin Metformin Atorvastatin Vitamin D b-12 Complex Lisinopril
Allergien: None
Vorherige Impfungen: Pneumovax

VAERS 2278278

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: IL
Alter: 67,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 20.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Next day after vaccination, I had a very sore throat and a fever of 100.5 F. I thought this might be a reaction to the vaccine, but the sore throat and fever continued through the next day. I used in-home rapid covid test and it was positive for Covid. The sore throat continued into the next day (Saturday). Contacted our docto's office and talked to the on-call physician. He prescribed the antiviral Paxlovid. After 2 days of taking the antiviral, the sore throat subsided. After the completion of the 5 day course of medication, I felt better, but still tested positive for Covid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: In-home rapid Covid test
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multi=-vitamin, vitamin D
Allergien: None known
Vorherige Impfungen: -

VAERS 2277764

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: FL
Alter: 52,0
Geschlecht: M
Eingang: 14.05.2022
Impfdatum: 27.04.2022
Beginn: 02.05.2022
Tage bis Beginn: 5,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test normal Chest X-ray normal Dizziness Electrocardiogram normal Hyperhidrosis Nodule Respiratory rate increased

Symptomtext

symptoms: knot in chest around sternum area, profuse sweating, lightheadedness, increased breathing. called 911 went to local hospital. had cardiac workup (EKG, blood tests, chest x-ray) negative for heart attack. released in evening. follow-up scheduled with primary care doc.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: negative blood test, EKG and chest x-ray
Aktuelle Erkrankungen: degenerative disc disease emphysema
Vorgeschichte: degenerative disc disease emphysema
Andere Medikamente: mirtazipine morphine rosuvastatin hydroxyzine motrin vitamin d
Allergien: -
Vorherige Impfungen: -

VAERS 2275873

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 58,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 02.05.2022
Beginn: 09.05.2022
Tage bis Beginn: 7,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Body temperature increased COVID-19 Chills Diarrhoea Fatigue Headache Oropharyngeal pain SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case of COVID, high temp 103, chills, headache, sore throat, sore joints, diarrhea, fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: COVID test.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; Obesity; Hyperlipidemia.
Andere Medikamente: Amlodipine; atenolol; atorvastatin; candesartan; folic acid; metformin; Ozempic; spironolactone; aspirin; niacin; vitamin D; vitamin K; multivitamin.
Allergien: None
Vorherige Impfungen: -

VAERS 2273700

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: PA
Alter: 82,0
Geschlecht: F
Eingang: 12.05.2022
Impfdatum: 09.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Injection site erythema Injection site swelling Injection site warmth

Symptomtext

Patient's arm was slightly pink below the injection site, warm to the touch, and a bit swollen. She said that started the day after injection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2273546

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: AL
Alter: 82,0
Geschlecht: M
Eingang: 12.05.2022
Impfdatum: 25.04.2022
Beginn: 07.05.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dry skin Rash

Symptomtext

Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: dry rash

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2273506

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 63,0
Geschlecht: F
Eingang: 12.05.2022
Impfdatum: 27.04.2022
Beginn: 08.05.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Approximately after a few weeks after my 2nd booster shot (Dose 4) I tested positive for COVID and have the following symptoms: runny nose, fatigue but then I already have these symptoms prior to testing positive as part of my seasonal allergies. I was prescribed with Paxlovid but I haven't taken it because it will contradict to the existing medication that I'm taking.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Thyroid cancer; Atrial Fibrillation; Sleep Apnea; General Anxiety
Andere Medikamente: None
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2270600

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NY
Alter: 73,0
Geschlecht: F
Eingang: 11.05.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature Chills Pain in extremity Pyrexia SARS-CoV-2 test

Symptomtext

Fever/Low-grade fever about 99.8 to 101.2; Chills; A little sore in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever/Low-grade fever about 99.8 to 101.2), CHILLS (Chills) and PAIN IN EXTREMITY (A little sore in the arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. The patient had no food allergies. The patient's past medical history included COVID-19 (tested COVID positive) on 01-Apr-2022. Previously administered products included for COVID-19 vaccination: Pfizer (First dose) on 23-Feb-2021, Pfizer (Second dose) on 16-Mar-2021 and Pfizer (Third dose/1st booster dose) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Hypertension (high blood pressure started at age 55) and Drug allergy (Patient has allergies with high doses of Advil 800mg). On 06-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced PYREXIA (Fever/Low-grade fever about 99.8 to 101.2), CHILLS (Chills) and PAIN IN EXTREMITY (A little sore in the arm). At the time of the report, PYREXIA (Fever/Low-grade fever about 99.8 to 101.2) and PAIN IN EXTREMITY (A little sore in the arm) had not resolved and CHILLS (Chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2022, SARS-CoV-2 test: positive (Positive) Positive. On 06-May-2022, Body temperature: 99.8 to 101.2 (High) 99.8 to 101.2 (low grade fever). No concomitant medication information was provided. On 06-May-2022, the patient received the second booster dose of Moderna COVID-19 Vaccine. The reporter (patient's husband) wanted to know if the patient was contagious and if it was fine to have a COVID-19 test even if they got the vaccine. On the previous night of 06-May-2022, the patient developed fever and chills which the reporter read as being the general side effects of the Moderna vaccine. The patient also mentioned that the pharmacist had told the patient that the patient could get the vaccine after 2 weeks of testing positive with COVID-19. The patient had not received any medical care yet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Test Date: 20220506; Test Name: Body temperature; Result Unstructured Data: 99.8 to 101.2 (low grade fever); Test Date: 20220401; Test Name: COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Drug allergy (Patient has allergies with high doses of Advil 800mg); Hypertension (high blood pressure started at age 55)
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (tested COVID positive); Comments: The patient had no food allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2328524

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: -
Alter: 49,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Erythema Pruritus Rash Scratch Urticaria

Symptomtext

SkinRash, UrticariaPruritus, Itchiness Narrative: Patient has h/o of allergic reaction to Cipro and therefore was kept for a 30 minute observation period. Twenty minutes following vaccination with her first booster (she received a 3 dose primary series d/t immunocompromise), nurse who administered the vaccine noticed that the employee was scratching her skin around her watch. She asked the employee to remove her sweater. Her arms were red. The redness progressed to her back. She developed hives on her back only. She was given 25 mg of Benadryl. The rash spread to abdomen before starting to respond to the Benadryl. Employee denied difficulty breathing, SOB or swelling of her airway.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2328524

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: -
Alter: 49,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Erythema Pruritus Rash Scratch Urticaria

Symptomtext

SkinRash, UrticariaPruritus, Itchiness Narrative: Patient has h/o of allergic reaction to Cipro and therefore was kept for a 30 minute observation period. Twenty minutes following vaccination with her first booster (she received a 3 dose primary series d/t immunocompromise), nurse who administered the vaccine noticed that the employee was scratching her skin around her watch. She asked the employee to remove her sweater. Her arms were red. The redness progressed to her back. She developed hives on her back only. She was given 25 mg of Benadryl. The rash spread to abdomen before starting to respond to the Benadryl. Employee denied difficulty breathing, SOB or swelling of her airway.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2269160

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: FL
Alter: 66,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 22.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Rash Rash pruritic

Symptomtext

I experienced a painful and itchy rash on my neck, and it spread to both sides of my neck. The rash lasted for 7 to 8 days. I was prescribed Methylprednisolone 4mg cream, an over-the-counter anti-itch cream, Diphenhydramine HCI 25mg, and Tagamet. It has fully resolved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: No
Vorgeschichte: 5 Stints in 2009 Thyroid Disease
Andere Medikamente: Levothyroxine Calcium Multivitamin Glucosamine Lodine Vitamin D3 Fish Oil
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2269054

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 04.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Fatigue Headache

Symptomtext

Intermittent left shoulder ache, head ache, and fatigue began at about 48 hours after vaccination, duration was for days 3 thru 5, or approximately 72 hours. No adverse effects noted today which is day 6. Overall significant adverse effects days 2-5 but completely resolved. The vaccination was the second Moderna booster after the initial two dose Pfizer series. Adverse effects more than experienced before in a retired health professional who has had very minimal effects or no side effects with approximately 12 vaccinations from age 64 to 66, and close to 100 vaccinations lifetime.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: none
Vorgeschichte: environmental allergies (mold, seasonal grass and trees, dust mites)
Andere Medikamente: 1/2 multivitamin daily, fish oil 1000mg daily, glucosamine SO4 500mg daily, fexofenadine 180 mg daily, olopatadine eye drop each eye daily
Allergien: hazelnut, tamsulosin
Vorherige Impfungen: -

VAERS 2268967

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: IL
Alter: 55,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 06.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Immediate post-injection reaction Injection site discolouration Injection site oedema Injection site pain Injection site swelling

Symptomtext

Site: Swelling at Injection Site-Medium, Additional Details: Patient showed up prior to pharmacy close, seen by opening pharmacists at around 8:10 am. Patient experienced pain at injection site immediately after vaccination. woke up to a large fluid filled sac around injection site in the morning with continued pain. Note: Pt had applied biofreeze the night before. Also, there seemed to be some discoloration of the skin surrounding injection site, not sure if due to biofreeze or vaccine. Pt will be going to a nearby minute clinic for further evaluation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site discolouration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2268531

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 67,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Asthenia Body temperature Decreased appetite Diarrhoea Hangover Lethargy Pyrexia

Symptomtext

Hasn't had much of an apatite; No energy; Had diarrhea a couple of times; Felt like I had a bad hangover/then woke up the next morning hungover/it feels like I had a lot of drinks the night before; lethargic/still lethargic; Temperature of 101 degrees F; First he had pain in the shoulder that night; This spontaneous case was reported by a consumer and describes the occurrence of HANGOVER (Felt like I had a bad hangover/then woke up the next morning hungover/it feels like I had a lot of drinks the night before), LETHARGY (lethargic/still lethargic), DECREASED APPETITE (Hasn't had much of an apatite), ASTHENIA (No energy) and DIARRHOEA (Had diarrhea a couple of times) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient had no allergies and no medical History. Previously administered products included for COVID-19 vaccination: PFIZER BIONTECH COVID-19 VACCINE (First dose Batch number: EL3246 Route of administration: Intramuscular) on 17-Jan-2021; for Product used for unknown indication: Pfizer COVID-19 vaccine (Second dose Batch no. EL9262 lost his eye sight for 3 months) on 06-Feb-2021 and Pfizer COVID-19 vaccine (First booster dose Batch no. 301348A Blew a blood vessel in the left eye after this) on 26-Sep-2021. Past adverse reactions to the above products included Broken blood vessel in eye with Pfizer COVID-19 vaccine; No adverse event with PFIZER BIONTECH COVID-19 VACCINE; and Temporary vision loss with Pfizer COVID-19 vaccine. Concomitant products included ZOLPIDEM, AMITRIPTYLINE, LISINOPRIL, METOPROLOL, MONTELUKAST, ACETYLSALICYLIC ACID (ASPIRIN 81) and NICOTINAMIDE (VITAMIN B3) for an unknown indication. On 03-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced ARTHRALGIA (First he had pain in the shoulder that night). On 04-May-2022, the patient experienced HANGOVER (Felt like I had a bad hangover/then woke up the next morning hungover/it feels like I had a lot of drinks the night before), LETHARGY (lethargic/still lethargic) and PYREXIA (Temperature of 101 degrees F). On an unknown date, the patient experienced DECREASED APPETITE (Hasn't had much of an apatite), ASTHENIA (No energy) and DIARRHOEA (Had diarrhea a couple of times). The patient was treated with ACETAMINOPHEN at a dose of 325 mg x 2. At the time of the report, HANGOVER (Felt like I had a bad hangover/then woke up the next morning hungover/it feels like I had a lot of drinks the night before), LETHARGY (lethargic/still lethargic), DECREASED APPETITE (Hasn't had much of an apatite), ASTHENIA (No energy), DIARRHOEA (Had diarrhea a couple of times), ARTHRALGIA (First he had pain in the shoulder that night) and PYREXIA (Temperature of 101 degrees F) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2022, Body temperature: 101 (High) Had a temperature of 101 degrees F. Concomitant medication information reported included senna for unknown indication and unspecified lubricant for eyes. It was reported that the patient had the first Pfizer COVID-19 vaccine on 17-Jan-2021. The patient had the second Pfizer COVID-19 vaccine on 06-Feb-2021 and stated that the patient lost their eyesight for 3 months. The patient had their first Pfizer COVID-19 booster vaccine on 26-Sep-2021 and stated the patient blew a blood vessel in the left eye after this. The patient had the second Moderna COVID-19 booster vaccine on 03-May-2022 and the patient first had pain in the shoulder that night. The next day the patient felt like they had a bad hangover, lethargic, and had a temperature of 101 degrees F. The patient took two acetaminophen 325 mg, but it didn't help. Yesterday the patient was still lethargic and hasn't had much of an appetite. The patient had diarrhea a couple of times and had no energy. The patient said it felt like the patient had a lot of drinks the night before and got plastered then woke up the next morning hungover. It was also reported that the patient had not touched alcohol the last 3-4 years. The patient's height reported as 5 feet 11 inch.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Test Date: 20220504; Test Name: Body temperature; Result Unstructured Data: Had a temperature of 101 degrees F
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no allergies and no medical History.
Andere Medikamente: ZOLPIDEM; AMITRIPTYLINE; LISINOPRIL; METOPROLOL; MONTELUKAST; ASPIRIN 81; VITAMIN B3
Allergien: -
Vorherige Impfungen: -

VAERS 2268077

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NY
Alter: 70,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 15.04.2022
Beginn: 24.04.2022
Tage bis Beginn: 9,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Feeling abnormal Headache Listless SARS-CoV-2 test positive

Symptomtext

I was not feeling right on 04/26/2022, I did 2 home tests one tested positive and one negative. On 04/25/2022 I did a PCR. The results came back on 04/26/2022 as positive. My symptoms were a real bad headache and very tired and listless. Once my doctor put me on Paxlovid I felt better the following day. I feel great now and I tested myself on 05/05/2022 thru 05/7/2022 came back negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home tests and PCR - 1 negative, 2 positive including PCR
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Verapamil 150mg OD Asmanex 200mcg QD Atorvastatin 20mg QD Lisinopril 20mg QD Bayer aspirin 81mg Multivitamin Vitamin B Vitamin D Areds2 Turmeric
Allergien: Shell Fish Hay Fever Dogs Cats Horses
Vorherige Impfungen: Flu shot 5-6 years ago I got a real bad cold and tired which cleared up with in a few days. That is the only time a vaccine ever

VAERS 2267249

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: VA
Alter: 21,0
Geschlecht: F
Eingang: 09.05.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Dizziness Fatigue Feeling hot Lethargy Nausea Visual impairment

Symptomtext

Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: pt was lightheaded, felt warm, and had chills after vaccine w/in 15 min.-Mild, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: Pt experienced sympotoms within the 15 min observation period. Was monitored and vitals checked. Pt was placed in a supine position with feet elevated until symptoms passed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2267168

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NC
Alter: 59,0
Geschlecht: F
Eingang: 08.05.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Fatigue Headache Hyperhidrosis Myalgia Oropharyngeal pain

Symptomtext

Sore throat headache muscle aches extreme fatigue chills sweats

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure
Andere Medikamente: Vit c vit d
Allergien: Amoxicillin, sulfa
Vorherige Impfungen: -

VAERS 2267136

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 08.05.2022
Impfdatum: 22.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered Injection site pain

Symptomtext

Patient was given Prevnar-20 vaccine outside of CDC guidelines. Patient had completed series of Pneumonia vaccinations with PPSV23 in 2013 and PCV13 in 2015. Patient only had soreness at the injection site for 1-2 days. There were no major/severe side effects observed per patient. Patient was notified upon the discovery of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2267096

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: TX
Alter: 84,0
Geschlecht: F
Eingang: 08.05.2022
Impfdatum: 02.05.2022
Beginn: 02.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site erythema Injection site pain Injection site pruritus Pruritus Rash

Symptomtext

Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash Generalized-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266956

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21A

mild

Staat: NY
Alter: 45,0
Geschlecht: M
Eingang: 07.05.2022
Impfdatum: 01.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoaesthesia oral Pain in extremity Peripheral swelling

Symptomtext

Pain to upper arm, numbness to the tip of left hand?s fingers, numbness to mouth lower lips and swollen /pain to left arm armpit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2266105

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MN
Alter: 62,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 04.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Injection site erythema Injection site pain Injection site swelling Injection site warmth Rash

Symptomtext

Around 12-24 hours post vaccination, symptoms developed at injection site: redness, warmth, swelling, and pain. The redness was rash like in appearance and extended from the shoulder area to the elbow. The area continues to have redness, warmth, swelling, and pain today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: Staff member encouraged to follow up with her PCP, urgent care/ER for appropriate follow-up and diagnostics. She was instructed to inform them that she had received her 4th dose of Moderna COVID-19 vaccine on Wednesday.
Aktuelle Erkrankungen: None.
Vorgeschichte: Unknown.
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2265779

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: WI
Alter: 48,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 29.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site bruising Injection site erythema Injection site pain Nausea

Symptomtext

Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Systemic: Nausea-Severe

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2264818

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: AL
Alter: 70,0
Geschlecht: M
Eingang: 05.05.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Hyperhidrosis Impaired work ability Myalgia

Symptomtext

Sweated all night long. Muscles and joints ached. Did not go to work.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Tamoxylin, Fuexitine
Allergien: None
Vorherige Impfungen: -

VAERS 2264702

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 63,0
Geschlecht: M
Eingang: 05.05.2022
Impfdatum: 28.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site swelling

Symptomtext

Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2264330

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: FL
Alter: 62,0
Geschlecht: M
Eingang: 05.05.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Cough Neck mass Osteitis

Symptomtext

Coughing after 2nd booster/He was coughing as he was speaking; He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting; He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting; He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing after 2nd booster/He was coughing as he was speaking), OSTEITIS (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting), NECK MASS (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting) and ARTHRALGIA (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2022, the patient experienced COUGH (Coughing after 2nd booster/He was coughing as he was speaking), OSTEITIS (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting), NECK MASS (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting) and ARTHRALGIA (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting). At the time of the report, COUGH (Coughing after 2nd booster/He was coughing as he was speaking) had not resolved and OSTEITIS (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting), NECK MASS (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting) and ARTHRALGIA (He states that his shoulder collar bone towards the neck has a knot, Inflamed, and it is hurting) outcome was unknown. No concomitant medications were reported. The patient was reluctant to provide information and was irritated with the questions. No treatment medications were reported. This case was linked to MOD-2022-556083 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2263478

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 43,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 04.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Discomfort Dry throat Inappropriate schedule of product administration Injection site pruritus Throat irritation

Symptomtext

Patient said they had an itchy arm the first they had the Moderna vaccine, as well as general itchiness. After she received the 2nd dose on 5/4, about 15-20 minutes later she complained on itchiness around the area as well as a dry and itchy throat. Patient did not have any difficulty breathing but was uncomfortable and anxious. Patient was given intramuscular Benadryl and the itchiness subsidized. 9-1-1 was called and patient refused to go with them and was picked up by her daughter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Response to the first Moderna shot - itchy arm
Vorherige Impfungen: Moderna COVID vaccine 3/17/22 - itchy arm and swelling, 43 years old at vaccination

VAERS 2263397

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NC
Alter: 65,0
Geschlecht: M
Eingang: 04.05.2022
Impfdatum: 30.04.2022
Beginn: 03.05.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Cough Decreased appetite Diarrhoea Myalgia Pain Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test negative

Symptomtext

I am a teacher. When I was at school one day I started to feel feverish with a runny nose and cough. I went to the school nurse and got my temperature checked. The nurse said I had a little bit of a fever. She did a rapid COVID-19 test at school, and it was negative. She said that I could go home. Yesterday my symptoms started to get worse and worse. My temperature was at 101.7 degrees. I had bad coughing, congestion, feeling very weak, achy, horrible diarrhea, and a loss of appetite. I took some OTC Tylenol and Imodium. The Imodium seems to be working. I've been drinking a lot of ginger ale. The fever is gone now. I still have some weakness and muscles aches, but the coughing, congestion, and diarrhea is better now. I do plan on possibly taking the rest of the school week off.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: Rapid COVID-19 Test- negative
Aktuelle Erkrankungen: Cold
Vorgeschichte: Type 2 diabetes Cancer Survivor
Andere Medikamente: Atorvastatin 40mg Zolpidem 10mg Iron 325mg Descovy 225mg Magnesium 500mg Vitamin C 1000mg Zyrtec 10mg Vitamin D3 2000mg 4 Fiber capsules Pantoprazole 40mg Bupropion 500mg Viberzi 100mg Probiotic Generic for Glucosamine
Allergien: None
Vorherige Impfungen: -

VAERS 2263214

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 64,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 02.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Injection site mass Injection site pain Injection site rash Pain Pyrexia

Symptomtext

fever of 100.1 aches, acute dizziness, achy and a rash and lump around injection site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: gerd
Vorgeschichte: IBS/Barrett's esophagus
Andere Medikamente: none
Allergien: sulfa
Vorherige Impfungen: -

VAERS 2263017

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: GA
Alter: 72,0
Geschlecht: M
Eingang: 04.05.2022
Impfdatum: 27.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Atrial fibrillation Cardiac disorder Cardiac monitoring Discomfort Electrocardiogram abnormal Influenza like illness Pain Somnolence

Symptomtext

Injection given Wednesday 4/27/22. Thursday 4/28/22 light flu type symptoms. Body ache all over. Spent most of day sleeping or resting took tylenol for discomfort . Friday 4/29/22 3:45 AM felt heart issue. Checked twice with Watch EKG. Indicated Atrial fibrillation. Drove to hospital, EKG confirmed Atrial Fibrillation. Received two medications, heart rhythm returned to normal. Sent home with heart monitor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: 1,0
Labordaten: 4/29/22 EKG indicated Atrial fibrillation
Aktuelle Erkrankungen: high blood pressure, heart disease 4/1/22 Dizzyness, unstable walking, Possible reaction to medicine for treating inner ear problem. spent two days in hospital
Vorgeschichte: high blood pressure, hearth disease, Celiac disease
Andere Medikamente: Flecainide, Ezetimbe, Amlodipine, Temisartin, Silodosin, Vitamin D3
Allergien: Penicillin, Z-Pac (Asithromycin), Gluten, Cialis
Vorherige Impfungen: -

VAERS 2260570

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 52,0
Geschlecht: F
Eingang: 02.05.2022
Impfdatum: 27.04.2022
Beginn: 27.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity Rash Urticaria

Symptomtext

The patient stated she developed a rash after receiving her vaccines on 4/27 that has persisted to 5/1/22 without treatment of any kind. She had one vaccine in each arm with both arms being equally sore and no distinct difference in injection site reactions, just full body rash/hives

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2259825

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: IN
Alter: 78,0
Geschlecht: F
Eingang: 30.04.2022
Impfdatum: 28.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Induration Inflammation Pruritus Skin warm Swelling

Symptomtext

I received my second covid-19 booster of Moderna at 4:00 p.m. Thursday, April 28th, 2022 At 7:00 a.m. I woke up with a three and a half inch diameter circle right beside the band-aid that was covering the injection site. It was swollen, raised, hard, hot, (765) 832-3622 red, and itching intensely. There is no pain or soreness involved, just horrible itching.This morning it had increased to a diameter of 5 in. My initial vaccination took 11 days before the exact same thing occurred. The following three occurred within 12 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: None It has resolved on its own the last three times.
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure and high cholesterol both being controlled.
Andere Medikamente: Valsartan-HCTZ 320-12.5 mg tab - 1 everyday Amlodipine 5 mg tab - 1 everyday Pravastatin Sodium 40 mg tab - 1 everyday at bedtime Meloxicam 15 mg tab - 1 everyday Fish Oil 1,000 - 2 e
Allergien: Penicillin and Tetracycline
Vorherige Impfungen: With all three of Moderna's previous vaccines I had the same reaction. Site reaction only.

VAERS 2257088

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MI
Alter: 82,0
Geschlecht: F
Eingang: 28.04.2022
Impfdatum: 25.04.2022
Beginn: 26.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Computerised tomogram Dizziness Immunisation reaction Injection site mass Joint warmth Pyrexia Vertigo X-ray

Symptomtext

The patient report dizziness (spinning), lemon size lump at the injection size, fever, and "hot joints". She called for an ambulance around 3 in the morning and was taken to the hospital. There, they ran tests including an Xray and CT scan. Patient reports that it was determined she had a reaction to the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2257002

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: OH
Alter: 68,0
Geschlecht: F
Eingang: 28.04.2022
Impfdatum: 21.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Pain in extremity Pruritus

Symptomtext

My arm is really red and itchy, little pain and it was really painful but it has went down a lot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: Type 2 Diabetes; COPD
Andere Medikamente: No
Allergien: Sulfa form drugs; Morphine
Vorherige Impfungen: Shingles, dry hiving and stomach issue, body aches and fever.

VAERS 2255078

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 72,0
Geschlecht: M
Eingang: 27.04.2022
Impfdatum: 24.04.2022
Beginn: 24.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Back pain Injection site erythema Injection site pain Loss of personal independence in daily activities Pain in extremity Skin reaction

Symptomtext

Received 2nd dose of Moderna CoVid19 Booster shot on left arm on April 24, 2022 at 12:55pm. Sore pain on poke area started to be felt together with back muscle pain, joint area and lower legs areas by about 8:00pm of April2 24, 2022. Took 1-cap Acetaminophen at bedtime 10:30pm. The next day, April 25, 2022 more severe pain was felt on the same areas restricting usual daily home activities. Took 1-cap of Acetaminophen at 11:00am. Towards the evening, pain still existed, took another 1-cap Acetaminophen at 6pm. Reddish spots were starting to appear along neckline, armpits, groin, legs and poke areas. Upon wakeup of April 26, 2022, noticed more red spots on skin and muscle pains gone except with poke area, took 1-cap Benadryl Antihistamine. at bedtime. Upon Wakeup on Apri27, 2022, more red spots appear on skin below arms, legs (upper and lower), took 1-cap Benadryl for allergy. As of this writing reddish spots become more prominent on areas mentioned.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes. Hypertension, High Cholesteroland Glaucoma.
Andere Medikamente: Daily : Atenolol, 50mg ; Lisinopril 20mg ; Metformin 500mg twice daily; Vitamin D 25mcg; Rosuvastatin 5mg; Centrum Silver; Fish Oil; Turmeric; Zinc; Aspirin 81 mg; Vitamin C; Vitamin E.
Allergien: Penicillin Injection.
Vorherige Impfungen: Similar Adverse reactions were experienced and reported to VAERS on 1st regular Moderna Covid19 dose in February 25, 2021, then

VAERS 2252790

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: FL
Alter: 59,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 26.04.2022
Beginn: 26.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Flushing Rash

Symptomtext

Patient reported flushing of the ears and face with bumpiness on the face also, I advised her to take benadryl and seek medical attention if her condition worsened. She reported that this started about 40 minutes after the vaccine was administered. I called her back 1 hour after instructing her to take the Benadryl and she reported that the bumpiness and flushing was subsiding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Patient reported that she had flushing of ears with her 1st booster dose of Moderna.

VAERS 2250163

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: IL
Alter: 57,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 21.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pruritus Injection site swelling Injection site warmth

Symptomtext

Patient stated that her entire upper left arm was swollen and hot to the touch starting on Friday April 22, 2022. She said she applied ice but used no other treatment. Her arm was swollen today Monday April 25, 2022 when she presented back at the pharmacy. I suggested she try taking some Benadryl, Tylenol, and use hydrocortisone cream for the itching and to follow up with a medical provider if no relief. Patient was from out of town and did not want to see a provider.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pruritus
Hospital-Tage: -
Labordaten: Patient had not seen a medical provider.
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: no known allergies
Vorherige Impfungen: Patient stated that she had a reaction to her second Moderna vaccine (10/19/21) but "not as severe" when she returned to the pha

VAERS 2250153

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: IL
Alter: 71,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 23.04.2022
Beginn: 25.04.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site swelling Injection site warmth

Symptomtext

Red, raised, hot, swollen injection site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: leukemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249680

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MA
Alter: 62,0
Geschlecht: M
Eingang: 24.04.2022
Impfdatum: 22.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pyrexia

Symptomtext

Fever of 101 lasting about12 hours

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: none
Vorgeschichte: Hashimoto's thyroiditis
Andere Medikamente: Multivitamins, Levoxyl, chlorthalidone, pravastatin, 81 mg aspirin
Allergien: Penicillin
Vorherige Impfungen: Pfizer

VAERS 2249502

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: NH
Alter: 61,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 22.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Pain Pyrexia

Symptomtext

Headache, body aches and fever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes
Andere Medikamente: Simvastatin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2247732

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: FL
Alter: 60,0
Geschlecht: M
Eingang: 22.04.2022
Impfdatum: 19.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site pain Injection site swelling

Symptomtext

Notable swelling, soreness, tenderness, and mild redness at injection site lasting three days (so far)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Testosterone, multivitamins
Allergien: None
Vorherige Impfungen: -

VAERS 2247651

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: IL
Alter: 73,0
Geschlecht: M
Eingang: 22.04.2022
Impfdatum: 18.04.2022
Beginn: 18.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Fatigue Heart rate Oxygen saturation Pyrexia

Symptomtext

fatigue; diarrhea; little of fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), DIARRHOEA (diarrhea) and PYREXIA (little of fever) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Concurrent medical conditions included Kidney stone and Blood pressure increased. On 18-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2022, the patient experienced FATIGUE (fatigue), DIARRHOEA (diarrhea) and PYREXIA (little of fever). At the time of the report, FATIGUE (fatigue), DIARRHOEA (diarrhea) and PYREXIA (little of fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Apr-2022, Heart rate: 96 (normal) 96. On 18-Apr-2022, Oxygen saturation: 96 (normal) 96. No concomitant medication were provided. Patient reported no allergy. No treatment medication were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: Test Date: 20220418; Test Name: heart rate; Result Unstructured Data: 96; Test Date: 20220418; Test Name: O2 saturation; Result Unstructured Data: 96
Aktuelle Erkrankungen: Blood pressure increased; Kidney stone
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2246049

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: TX
Alter: 57,0
Geschlecht: F
Eingang: 21.04.2022
Impfdatum: 19.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Pain

Symptomtext

patient reported sudden pain upon insertion of needle that has been constant since administration of vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: n/a
Vorgeschichte: unknown
Andere Medikamente: lisinopril,omeprazole,valacyclovir,gabapentin,ubrelvy,montelukast,albuterol inhaler
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2238863

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

mild

Staat: TN
Alter: 70,0
Geschlecht: F
Eingang: 18.04.2022
Impfdatum: 18.04.2022
Beginn: 18.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site pruritus

Symptomtext

itching at injection site, pt reported slight itch after about 4 minutes. gave 12.5ml of liquid benedryl. pt didnt want a larger dose. no redness or visible signs of reaction. called pt 45 min later after waiting 30 min and she was fine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no sickness
Vorgeschichte: blood pressure
Andere Medikamente: none reported
Allergien: vioxx
Vorherige Impfungen: -

VAERS 2238118

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: MO
Alter: 46,0
Geschlecht: F
Eingang: 16.04.2022
Impfdatum: 16.04.2022
Beginn: 16.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness

Symptomtext

Patient felt faint and dizzy for >1 hour.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2054371

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

mild

Staat: CA
Alter: 30,0
Geschlecht: F
Eingang: 21.01.2022
Impfdatum: 08.01.2022
Beginn: 12.01.2022
Tage bis Beginn: 4,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Histamine intolerance Urticaria

Symptomtext

Significant hives and histamine response lasting 8 days

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Keflex, penicillin
Vorherige Impfungen: -

VAERS 2700875

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: FL
Alter: -
Geschlecht: F
Eingang: 24.10.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Positive airway pressure therapy

Symptomtext

Patient admitted to the hospital Continue BiPAP support Continue remdesivir IV Will start the patient on Decadron 6 mg IV daily Will start the patient IV fluid normal saline at 75 mL/hour Will start the patient on budesonide nebulizer breathing treatment Will start the patient on formoterol nebulizer breathing treatment Will continue cefepime IV Will start the patient on Protonix 40 mg p.o. daily 11/7/2022 VACCINE DOSE 4, 4/29/2022 (3), 11/242021 (2), 3/15/2021 (1)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Positive airway pressure therapy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: diabetes mellitus, hypothyroidism, coronary artery disease status post stent placement, hypertension CKD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2647881

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 21.06.2023
Impfdatum: 19.06.2022
Beginn: 10.01.2023
Tage bis Beginn: 205,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bronchitis Chest X-ray Cough Loss of personal independence in daily activities Sleep disorder

Symptomtext

I have a dry cough no product or nothing comes up but it is enough to interrupt conversation , sleep, and daily activities. I was prescribed Cefdinir.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bronchitis
Hospital-Tage: -
Labordaten: Chest xray no results. Bronchitis was dagnosed.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Atenelol; Atorvastain; Omeprazole; Vitamin D; Sertraline
Allergien: None
Vorherige Impfungen: -

VAERS 2638390

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: OH
Alter: 71,0
Geschlecht: F
Eingang: 30.05.2023
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Deafness unilateral Hypoacusis Tinnitus

Symptomtext

About 6 hours after being vaccinated I started having ringing in my ears. I actually lost hearing in my left ear for about 12 hours. It is still kind of muffled at this time and the ringing continues. I am still dealing with this at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deafness unilateral
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Fibromyalgia; Previous Heart Attack; Asthma; COPD; Chronic Sinusitis.
Andere Medikamente: Levothyroxine; Atenolol; Rosuvastatin; Duloxetine; Tizanidine; Buspirone; Inhaler; Flonase; Multivitamin; Vitamin C; Probiotics; Magnesium Maleate
Allergien: Penicillin; Sulfa; Keflex; Azithromycin; Tetracycline; Cipro; Trees; Molds
Vorherige Impfungen: I had a reaction to a Shingles vaccine in 2016. This lasted for about 3 weeks. My doctor decided it wouldn't be a good idea for

VAERS 2626225

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 71,0
Geschlecht: F
Eingang: 02.05.2023
Impfdatum: 14.05.2022
Beginn: 14.10.2022
Tage bis Beginn: 153,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Cough and runny nose one day then tested (Home Covid ted) - tested positive

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: -
Andere Medikamente: Atorvastatin, Famotidine, Multi vitamin, Calcium Citrate, Vita
Allergien: none that I know of
Vorherige Impfungen: -

VAERS 2624844

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 94,0
Geschlecht: F
Eingang: 02.05.2023
Impfdatum: 09.05.2022
Beginn: 07.07.2022
Tage bis Beginn: 59,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 1/18/21 Lot# 012L20A; Moderna 2/15/21 Lot# 010M20A; Moderna 11/12/21 Lot# 022J21A; Moderna 5/9/22 LOt# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2623159

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 61,0
Geschlecht: F
Eingang: 28.04.2023
Impfdatum: 04.05.2022
Beginn: 14.09.2022
Tage bis Beginn: 133,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Facial paresis Hemiparesis Transient ischaemic attack

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE TRANSIENT CEREBRAL ISCHEMIA LEFT FACIAL MUSCLE WEAKNESS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paresis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2621123

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 057M21A

gering

Staat: MA
Alter: 57,0
Geschlecht: F
Eingang: 25.04.2023
Impfdatum: 13.05.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 58-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13May2022 as dose 4 (booster), single (Lot number: 057M21A) at the age of 57 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Mild seasonal allergies (rhinitis)" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11Apr2023) Negative; (15Apr2023) Positive, notes: tested (strongly) positive again on 15Apr2023; (20Apr2023) Positive, notes: (20Apr2023), still testing (faint-to-moderate) positive. Clinical information: Tested negative on 11Apr2023 after increasingly faint readings (one week after starting Paxlovid course); tested (strongly) positive again on 15Apr2023. As of today (20Apr2023), still testing (faint-to-moderate) positive. (All testing using at-home antigen tests.) Symptoms since rebound positive test were minor to nonexistent (congestion and mild fatigue, could have been due to allergies and lack of sleep from worry about the positive test). Other medication in 2weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230411; Test Name: antigen tests; Test Result: Negative ; Test Date: 20230415; Test Name: antigen tests; Test Result: Positive ; Comments: tested (strongly) positive again on 15Apr2023; Test Date: 20230420; Test Name: antigen tests; Test Result: Positive ; Comments: (20Apr2023), still testing (faint-to-moderate) positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Rhinitis allergic
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2618353

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: TX
Alter: 69,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 17.04.2022
Beginn: 11.05.2022
Tage bis Beginn: 24,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Drug hypersensitivity Feeling abnormal Laboratory test

Symptomtext

In May 2022, I got COVID-19, I was given the monoclonial infusion and I recovered from the virus and was doing good. In December 2022, I don't recall calling my neighbors at 4:00am in the morning asking them to take me to the emergency room. I was recovering from COVID-19, my doctor had given my Paxlovid. I had been given Jardiance, that we have discovered I am allergic to. I cannot remember the test they ran on me as I was in and out of it for days. I felt like I was going to die, I did not flat line but was close to it, my son pushed for me to be put on a dialysis machine. I was released from the hospital after seven days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 7,0
Labordaten: N/A
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes Type 2; Bells Palsy
Andere Medikamente: Triamterene; Procardia; Metformin; Potassium Chloride; Cymbalta; Breo; Montelukast: Albuterol Inhaler as need; Promethazine as needed; Diazepam
Allergien: Dust; Mold; IV Contrast Dye; Cat Dander; Dog Dander
Vorherige Impfungen: -

VAERS 2599533

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IA
Alter: 80,0
Geschlecht: M
Eingang: 20.03.2023
Impfdatum: 26.04.2022
Beginn: 10.10.2022
Tage bis Beginn: 167,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dry skin

Symptomtext

dry skin on stomach, chest, right leg, buttocks, back, neck

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dry skin
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Overactive bladder
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2596866

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 057M21A

gering

Staat: NJ
Alter: -
Geschlecht: M
Eingang: 15.03.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19

Symptomtext

husband contracted Covid after receiving the Moderna vaccine lot 057M21A; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (husband contracted Covid after receiving the Moderna vaccine lot 057M21A) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (husband contracted Covid after receiving the Moderna vaccine lot 057M21A). At the time of the report, COVID-19 (husband contracted Covid after receiving the Moderna vaccine lot 057M21A) outcome was unknown. The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown. No treatment medications were reported No concomitant medications were reported This case was linked to US-MODERNATX, INC.-MOD-2023-714020 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-714020:Wife case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2588660

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 76,0
Geschlecht: F
Eingang: 28.02.2023
Impfdatum: 05.05.2022
Beginn: 02.11.2022
Tage bis Beginn: 181,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 2/26/21 Lot# 010A21A; Moderna 3/26/21 Lot# 018B21A; Moderna 11/29/21 Lot# 012H21B; Moderna 5/5/22 Lot# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2574463

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CA
Alter: 70,0
Geschlecht: M
Eingang: 02.02.2023
Impfdatum: 29.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site swelling

Symptomtext

Swelling in the left arm of about 2 cm. Same arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling in the left arm of about 2 cm. Same arm of the injection) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE SWELLING (Swelling in the left arm of about 2 cm. Same arm of the injection). At the time of the report, VACCINATION SITE SWELLING (Swelling in the left arm of about 2 cm. Same arm of the injection) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient had no allergy or diseases. No concomitant product was reported. The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site swelling
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2574264

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 89,0
Geschlecht: F
Eingang: 02.02.2023
Impfdatum: 02.05.2022
Beginn: 24.01.2023
Tage bis Beginn: 267,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after three vaccines Moderna 1/11/21 Lot# 012L20A; Moderna 11/12/21 Lot# 033F21A; Moderan 5/2/22 Lot# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2564923

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: -
Geschlecht: F
Eingang: 21.01.2023
Impfdatum: 11.05.2022
Beginn: 19.01.2023
Tage bis Beginn: 253,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hot flush

Symptomtext

Hot flushes; This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (Hot flushes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 11-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2023, the patient experienced HOT FLUSH (Hot flushes). At the time of the report, HOT FLUSH (Hot flushes) outcome was unknown. No concomitant medications were reported. Caller was 99 percentage sure that patient hot flashes which had been experiencing from the time caused by the second booster on 11-May-2022 with 24/7 and the vaccine was administered from vial. This event not reported previously with Moderna or another agency. No treatment medications were reported. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hot flush
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544891

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 24.06.2022
Beginn: 21.12.2022
Tage bis Beginn: 180,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 2/25/2 Lot# 002A21A; Moderna 3/25/21 Lot# 017B21A; Moderna 11/30/2 Lot# 057M21A; Moderna 6/24/22 Lot# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2542349

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 36,0
Geschlecht: F
Eingang: 23.12.2022
Impfdatum: 27.04.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product administration interrupted

Symptomtext

looking to receive her second dose of the monovalent vaccine in her primary series; No adverse event; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (looking to receive her second dose of the monovalent vaccine in her primary series) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Apr-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (looking to receive her second dose of the monovalent vaccine in her primary series) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (looking to receive her second dose of the monovalent vaccine in her primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Patient reported no disease state and no medication history . No concomitant medications were reported. Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. The Patient does not report any other adverse reactions. It was reported that it was more than 35 days between the patients first and second dose of the Moderna Covid-19 primary vaccination series. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2539112

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 68,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 12.01.2021
Beginn: 06.10.2022
Tage bis Beginn: 632,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatinine increased Blood sodium decreased Brain natriuretic peptide increased COVID-19 Chemotherapy Chest X-ray normal Haemoglobin normal Laboratory test abnormal SARS-CoV-2 test positive Vulval cancer

Symptomtext

Patient is hypertension, hyperlipidemia, asthma, paroxysmal atrial fibrillation, sleep apnea, obesity who presented to the hospital on 5/6/2022 due to abnormal labs outpatient. Recently diagnosed with valvular cancer and started chemotherapy recently. She had labs done outpatient by oncologist which displayed a sodium level of 120. Denies any chest pain, shortness of breath, fevers or chills, lesions or syncope no extremity edema. Vital signs in the ER were stable. Chest x-ray displayed no acute findings. Na 116. Cr 2.4. BNP 179. Globin stable. Tested positive for COVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood creatinine increased
Hospital-Tage: -
Labordaten: 10/6 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2527685

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: FL
Alter: 84,0
Geschlecht: M
Eingang: 09.12.2022
Impfdatum: 25.04.2022
Beginn: 29.11.2022
Tage bis Beginn: 218,0
Dosis: 3
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19

Symptomtext

Hospitalization for COVID-19 on dates 11/29/2022- 12/4/2022. Treated with dexamethasone, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2523125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: KY
Alter: 65,0
Geschlecht: F
Eingang: 05.12.2022
Impfdatum: 16.06.2022
Beginn: 28.11.2022
Tage bis Beginn: 165,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

Admitted to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2522944

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 79,0
Geschlecht: F
Eingang: 05.12.2022
Impfdatum: 04.05.2022
Beginn: 02.12.2022
Tage bis Beginn: 212,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case. Moderna 2/26/21 010A21A, 3/26/21 018B21A and boosted 11/24/21 005C21A and 5/4/22 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Positive COVID test 12/2/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2518651

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IN
Alter: 60,0
Geschlecht: M
Eingang: 29.11.2022
Impfdatum: 25.03.2021
Beginn: 28.11.2022
Tage bis Beginn: 613,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient COVID + after completing vaccine series

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID + on 11/28/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Kidney and pancreas transplant, CKD, DM, CAD
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2495392

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NJ
Alter: 42,0
Geschlecht: F
Eingang: 01.11.2022
Impfdatum: 23.05.2022
Beginn: 01.05.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Skin burning sensation

Symptomtext

Severe burning under skin

Weitere VAERSDATA-Felder

Praegender Schweregrund: Skin burning sensation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Mastocytosis, numerous vascular compressions, crps, Ehlers danlos hypermobile, narcolepsy, tremors.
Andere Medikamente: Wakix, xolair, methotrexate
Allergien: Sulfa meds, quinolones, sulfites
Vorherige Impfungen: -

VAERS 2495155

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NY
Alter: 32,0
Geschlecht: F
Eingang: 01.11.2022
Impfdatum: 04.05.2022
Beginn: 07.08.2022
Tage bis Beginn: 95,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Heavy menstrual bleeding Iron deficiency anaemia Menstruation irregular Ultrasound scan vagina

Symptomtext

Iron deficiency anemia, Iron deficiency anemia due to chronic blood loss, Other iron deficiency anemia Menses, irregular, Menorrhagia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood test
Hospital-Tage: -
Labordaten: Intravaginal Ultrasound 9/21/22, Bloodwork 10/6/2022, 10/10/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Ulcertaive Colitis, Anxiety with Depressive Qualities, Arthritis associated with inflammatory bowel disease
Andere Medikamente: Lialda 1.2gm (4) Escitalopram 20 mg Claritin 10 mg Vitamin D 4000 IU Visbiome (2) Folic Acid 1 mg Methotrexate 2.5 gm (8) Simponi 50 mg/0.5 ml SOAJ (Once a month Last shot before vaccine April 8th, 2022) Calcium Citrate with Magnesium & Bor
Allergien: At time of vaccine- Sulfa Drugs, Asacol, 6MP( Six Mercaptualpurine) Sensitivity to TNF Blockers. Currently adding Iron Sucrose aka Venofer to the list.
Vorherige Impfungen: -

VAERS 2494744

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: FL
Alter: 82,0
Geschlecht: F
Eingang: 31.10.2022
Impfdatum: 20.04.2022
Beginn: 17.10.2022
Tage bis Beginn: 180,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Hip fracture SARS-CoV-2 test positive

Symptomtext

Hospitalization: 10/17/2022 - 10/24/2022 Presentation to the ED: R HIP FRACTURE. COVID + date: 10/17/22 Treatment: Decadron & hydrochlorothiazide, SUPPLEMENTAL 02. Discharge to: REHAB FACILITY.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: hypertension, hyperlipidemia, paroxysmal atrial fibrillation, COPD.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2493886

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 69,0
Geschlecht: F
Eingang: 31.10.2022
Impfdatum: 26.04.2022
Beginn: 27.10.2022
Tage bis Beginn: 184,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

dose 1 3/9/21 Moderna 023M320A dose 2 4/8/21 Moderna 047A21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: covid+ test on 10/27/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2488549

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 82,0
Geschlecht: F
Eingang: 25.10.2022
Impfdatum: 12.01.2021
Beginn: 03.09.2022
Tage bis Beginn: 599,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

09/03/22 presents to ED for "coronavirus concern". PMHx of "A. fib on Eliquis, hypertension, CAD"

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 09/03/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485435

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 55,0
Geschlecht: M
Eingang: 21.10.2022
Impfdatum: 18.05.2022
Beginn: 19.10.2022
Tage bis Beginn: 154,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

covid vaccine breakthrough case dose 1 Moderna 3/13/21 002B21A dose 2 Moderna 4/10/21 025B21A dose 3 Moderna 11/24/21 012H21B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: covid+ test on 10/19/22
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485408

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MA
Alter: 69,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 21.04.2022
Beginn: 22.08.2022
Tage bis Beginn: 123,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Balance disorder Magnetic resonance imaging head Vertigo positional Vestibular function test

Symptomtext

I was diagnosed as Benign paroxysmal positional vertigo, BPPV. I received physical therapy for it. The acute symptoms are gone, and the crystals are back where they belong. I still have ongoing balance issues but not the vertigo.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Balance disorder
Hospital-Tage: -
Labordaten: Brain MRI; Vestibular testing
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Calcium; potassium
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2658655

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2460761

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 26.09.2022
Impfdatum: 28.04.2022
Beginn: 25.09.2022
Tage bis Beginn: 150,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 2/14/21 Lot# 015M20A; Moderna 3/14/21 Lot# 044A21A; Moderna 9/15/21 Lot# 005C21A; Moderna 4/28/22 Lot# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: external COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2460625

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 26.09.2022
Impfdatum: 10.05.2022
Beginn: 22.09.2022
Tage bis Beginn: 135,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 2/18/21 Lot# 007M20A; Moderna 3/16/21 Lot# 015M20A; Moderna 9/27/21 Lot# 005C21A; Moderna 5/10/22 Lot# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452187

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 26.04.2022
Beginn: 17.09.2022
Tage bis Beginn: 144,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 3/6/21 Lot# 029A21A; Moderna 4/3/21 Lot# 016B21A; Moderna 11/4/21 Lot# 017F1A; Moderna 4/26/22 Lot# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2451831

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 66,0
Geschlecht: U
Eingang: 20.09.2022
Impfdatum: 16.08.2022
Beginn: 16.08.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 16-Aug-2022; No adverse event; We gave expired Moderna Covid-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We gave expired Moderna Covid-19 vaccine), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 16-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 (Dose 1). Past adverse reactions to the above products included No adverse event with COVID-19. On 16-Aug-2022 at 4:14 PM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 16-Aug-2022 at 4:14 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (We gave expired Moderna Covid-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 16-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We gave expired Moderna Covid-19 vaccine), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 16-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (We gave expired Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 16-Aug-2022). Concomitant medication information was not provided by the reporter. The vaccine was delivered and placed into the freezer on 18-Apr-2022. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). The vial did not undergo any temperature excursion. Treatment information was not provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449962

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 79,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 06-Sep-2022; No adverse event; Expired Moderna Covid-19 vaccine (Monovalent) to 27 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine (Monovalent) to 27 patients.), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 06-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 VACCINE (Unspecified COVID-19 Vaccine, Dose 1), COVID-19 VACCINE (Unspecified COVID-19 Vaccine, Booster Dose 1), COVID-19 VACCINE (Unspecified COVID-19 Vaccine and Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE, COVID-19 VACCINE and COVID-19 VACCINE. On 06-Sep-2022 at 3:18 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Sep-2022 at 3:18 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine (Monovalent) to 27 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 06-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine (Monovalent) to 27 patients.), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 06-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine (Monovalent) to 27 patients.) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 06-Sep-2022). No concomitant medication was reported. On 18-Apr-2022 the vial was delivered and stored in the refrigerator on same date. The vial size is of 5.5mL. The vial did not undergo any temperature excursions. Vaccines were only offered on Tuesdays from March-2022 forward to the patient. For each Tuesday vaccine date, only removed one vial from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449960

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 71,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022, initially stored on 05-Sep-2022 and administered to the patient on 06-Sep-2022; No adverse event; Patient administered expired Moderna COVID-19 vaccine (Monovalent); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered expired Moderna COVID-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 05-Sep-2022 and administered to the patient on 06-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (Unspecified COVID-19 Vaccine Dose 1), COVID-19 Vaccine (Unspecified COVID-19 Vaccine, First Booster Dose) and COVID-19 Vaccine (Unspecified COVID-19 Vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine, COVID-19 Vaccine and COVID-19 Vaccine. On 06-Sep-2022 at 3:17 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Sep-2022 at 3:17 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered expired Moderna COVID-19 vaccine (Monovalent)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 05-Sep-2022 and administered to the patient on 06-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered expired Moderna COVID-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 05-Sep-2022 and administered to the patient on 06-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered expired Moderna COVID-19 vaccine (Monovalent)) and PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 05-Sep-2022 and administered to the patient on 06-Sep-2022). No concomitant medications were reported. Vial size was reported as 5.5 ml. The vaccine was delivered and placed into the freezer on 18-Apr-2022 and the vial did not undergo any temperature excursion. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 06-Sep-2022 vial was placed into refrigerator on 05-Sep-2022. NDC of vial was 8077727310. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449955

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 58,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration; No adverse event; Vaccine was expired on 13-Aug-2022 and was administered on 06-Sep-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration), EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 06-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 VACCINE (unspecified COVID-19 vaccine Dose 1), COVID-19 Vaccine (unspecified COVID-19 vaccine Dose 3, 1st Booster) and COVID-19 Vaccine (unspecified COVID-19 vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE, COVID-19 Vaccine and COVID-19 Vaccine. On 06-Sep-2022 at 2:34 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Sep-2022 at 2:34 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 06-Sep-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration), EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 06-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration) and EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 06-Sep-2022). No concomitant medications were reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. The vial size was reported as 5.5 ml. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 30-Aug-2022 vial was placed into refrigerator on 29-Aug-2022. The vial did not undergo any temperature excursion. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449954

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 69,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental overdose Expired product administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022; No adverse event; Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient; Patient received 0.5 ml as second booster dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022), ACCIDENTAL OVERDOSE (Patient received 0.5 ml as second booster dose) and NO ADVERSE EVENT (No adverse event) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Sep-2022 at 10:08 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Sep-2022 at 10:08 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient) and ACCIDENTAL OVERDOSE (Patient received 0.5 ml as second booster dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022), ACCIDENTAL OVERDOSE (Patient received 0.5 ml as second booster dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and ACCIDENTAL OVERDOSE (Patient received 0.5 ml as second booster dose). No concomitant medications were reported. Reported that patient received 2 COVID doses and 2 booster dose. The vaccine was delivered and placed into the freezer on 18-Apr-2022. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 13-Sep-2022, vial was removed from the freezer and placed into the refrigerator on 12-Sep-2022. The vial did not undergo any temperature excursion. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental overdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449953

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 56,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-SeBC p-2022/Expired vaccine stored in refrigerator; No adverse event; Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022/Expired vaccine stored in refrigerator) and NO ADVERSE EVENT (No adverse event) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (First dose), COVID-19 vaccine (First booster dose), COVID-19 vaccine (Third dose) and COVID-19 vaccine (Second dose). Past adverse reactions to the above products included No adverse event with COVID-19 vaccine, COVID-19 vaccine, COVID-19 vaccine and COVID-19 vaccine. On 13-Sep-2022 at 9:24 AM, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 13-Sep-2022 at 9:24 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022/Expired vaccine stored in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022/Expired vaccine stored in refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022) and PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022/Expired vaccine stored in refrigerator). No concomitant medications were reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. Therefore, for administration on 13-Sep-2022, vial was removed from the freezer and placed into the refrigerator on 12-Sep-2022. The vial did not undergo any temperature excursion. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449950

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 53,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Expired vaccine was stored in refrigerator; No adverse event; gave expired Moderna Covid-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine), PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Covid-19 vaccine (Dose 1), Covid-19 vaccine (1st booster dose), Covid-19 vaccine (Dose 3) and Covid-19 vaccine (Dose 2). Past adverse reactions to the above products included No adverse event with Covid-19 vaccine, Covid-19 vaccine, Covid-19 vaccine and Covid-19 vaccine. On 06-Sep-2022 at 2:33 PM, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Sep-2022 at 2:33 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine), PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator). No concomitant medications were reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. The vial size was reported as 5.5 ml. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). The vial did not undergo any temperature excursion. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449949

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 47,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 30.08.2022
Beginn: 30.08.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient 30-Aug-2022/Expired vaccine stored in refrigerator; No adverse event; Vial was expired on 13-Aug-2022, and administered to the patient on 30-Aug-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient 30-Aug-2022/Expired vaccine stored in refrigerator), EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 47-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (first dose), COVID-19 Vaccine (First booster dose) and COVID-19 Vaccine (second dose). Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine, COVID-19 Vaccine and COVID-19 Vaccine. On 30-Aug-2022 at 11:54 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 30-Aug-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient 30-Aug-2022/Expired vaccine stored in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient 30-Aug-2022/Expired vaccine stored in refrigerator), EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient 30-Aug-2022/Expired vaccine stored in refrigerator) and EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 30-Aug-2022). No relevant concomitant medications were reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 13-Sep-2022, vial was removed from the freezer and placed into the refrigerator on 12-Sep-2022. The vial did not undergo any temperature excursion. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449947

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 60,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 30.08.2022
Beginn: 30.08.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Eexpired vaccine was stored in refrigerator; No adverse event; gave expired Moderna Covid-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine), PRODUCT STORAGE ERROR (Eexpired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (unspecified COVID-19 vaccine Dose 1), COVID-19 vaccine (unspecified COVID-19 vaccine Booster dose) and COVID-19 vaccine (unspecified COVID-19 vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 vaccine, COVID-19 vaccine and COVID-19 vaccine. On 30-Aug-2022 at 3:16 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Aug-2022 at 3:16 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Eexpired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine), PRODUCT STORAGE ERROR (Eexpired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Eexpired vaccine was stored in refrigerator). No concomitant medications were reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. The vial size was reported as 5.5 ml. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 30-Aug-2022 vial was placed into refrigerator on 29-Aug-2022. The vial did not undergo any temperature excursion. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449946

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 62,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 13.09.2022
Beginn: 13.08.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Extra dose administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022; No adverse event; Vaccine expired on 13-Aug-2022 and administered on 13-Sep-2022/Patient administered expired Moderna COVID-19 vaccine (Monovalent); Patient received second booster dose as 0.5 milliliter; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 13-Aug-2022 and administered on 13-Sep-2022/Patient administered expired Moderna COVID-19 vaccine (Monovalent)), EXTRA DOSE ADMINISTERED (Patient received second booster dose as 0.5 milliliter), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 1), COVID-19 vaccine (Unspecified COVID-19 vaccine, first booster dose), COVID-19 VACCINE (Unspecified COVID-19 vaccine Dose 3) and COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE, COVID-19 vaccine, COVID-19 vaccine and COVID-19 vaccine. On 13-Sep-2022 at 2:33 PM, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Aug-2022 at 2:33 PM, the patient experienced EXTRA DOSE ADMINISTERED (Patient received second booster dose as 0.5 milliliter). On 13-Sep-2022 at 2:33 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 13-Aug-2022 and administered on 13-Sep-2022/Patient administered expired Moderna COVID-19 vaccine (Monovalent)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 13-Aug-2022 and administered on 13-Sep-2022/Patient administered expired Moderna COVID-19 vaccine (Monovalent)), EXTRA DOSE ADMINISTERED (Patient received second booster dose as 0.5 milliliter), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 13-Aug-2022 and administered on 13-Sep-2022/Patient administered expired Moderna COVID-19 vaccine (Monovalent)), EXTRA DOSE ADMINISTERED (Patient received second booster dose as 0.5 milliliter) and PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022). No concomitant medications were reported. Vial size was reported as 5.5 ml. The vaccine was delivered and placed into the freezer on 18-Apr-2022 and the vial did not undergo any temperature excursion. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 13-Sep-2022 vial was placed into refrigerator on 12-Sep-2022. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449944

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 61,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 23.08.2022
Beginn: 23.08.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22; No adverse event; The patient received dose after 30 day use date or after manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 1), COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 3) and COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 vaccine, COVID-19 vaccine and COVID-19 vaccine. On 23-Aug-2022 at 3:46 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Aug-2022 at 3:46 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22). No concomitant medications was reported. On 18-Apr-2022 the vial was delivered and stored in the refrigerator on same date. The vial size is of 5.5mL. The vial did not undergo any temperature excursions. Vaccines were only offered from March-2022 forward to the patient. For each vaccine date, only removed one vial from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). No treatment drug details was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 57,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 30.08.2022
Beginn: 30.08.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient on 30-Aug-2022; No adverse event; Patient administerd expired Moderna Covid-19 vaccine (Monovalent); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administerd expired Moderna Covid-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Aug-2022 at 11:56 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Aug-2022 at 11:56 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administerd expired Moderna Covid-19 vaccine (Monovalent)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administerd expired Moderna Covid-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administerd expired Moderna Covid-19 vaccine (Monovalent)) and PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 29-Aug-2022 and administered to the patient on 30-Aug-2022). No concomitant medications were reported. Patient received 2 doses of unknown manufacture and 1 booster dose. Vial size was reported as 5.5 ml. The vaccine was delivered and placed into the freezer on 18-Apr-2022 and the vial did not undergo any temperature excursion. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 30-Aug-2022 vial was placed into refrigerator on 29-Aug-2022. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449942

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 79,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 16.08.2022
Beginn: 16.08.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was moved from the freezer to place in the refrigerator the day before it was used; No adverse event; Patient was administered with expired Moderna Covid-19 vaccine (Monovalent); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna Covid-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Aug-2022 at 10:07 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Aug-2022 at 10:07 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna Covid-19 vaccine (Monovalent)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna Covid-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna Covid-19 vaccine (Monovalent)) and PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used). No concomitant medication were reported. The patient had received 2 covid doses plus one booster dose. Only one vial was removed from the freezer to place in the refrigerator the day before it was used i.e on 15-Aug-2022 the vial was removed from the freezer and placed in the refrigerator. The vial was initially stored in the freezer on 18-Apr-2022. The size of the vial was reported as 5.5ml. The vial had not undergone any temperature excursions. No treatment medication were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449941

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 30,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Expired vaccine was stored in refrigerator; No adverse event; expired Moderna Covid-19 vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered), PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (Dose 1). Past adverse reactions to the above products included No adverse event with COVID-19 vaccine. On 06-Sep-2022 at 10:30 AM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 06-Sep-2022 at 10:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered), PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine administered) and PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator). No concomitant medications were reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. The vial size was reported as 5.5 ml. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). The vial did not undergo any temperature excursion. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449940

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 74,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 23.08.2022
Beginn: 23.08.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Expired vaccine was stored in refrigerator; No adverse event; gave expired Moderna Covid-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine), PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (Unspecified COVID-19 vaccine dose 2) and COVID-19 vaccine (Unspecified COVID-19 vaccine dose 1). Past adverse reactions to the above products included No adverse event with COVID-19 vaccine and COVID-19 vaccine. On 23-Aug-2022 at 2:27 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Aug-2022 at 2:27 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine), PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (gave expired Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator). No concomitant medications were reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration 23-Aug-2022, vial was removed from the freezer and placed into the refrigerator on 22-Aug-2022. The vial did not undergo any temperature excursion. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449939

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 89,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 23.08.2022
Beginn: 23.08.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Overdose Product storage error

Symptomtext

Vaccine was expired on 13-Aug-2022 and was was stored in refrigerator after expiration; No adverse event; Vaccine was expired on 13-Aug-2022 and was administered on 23-Aug-2022; Patient received second booster dose of 0.5ml; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was was stored in refrigerator after expiration), EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 23-Aug-2022), OVERDOSE (Patient received second booster dose of 0.5ml) and NO ADVERSE EVENT (No adverse event) in an 89-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (unspecified COVID-19 vaccine Dose 1), COVID-19 Vaccine (unspecified COVID-19 vaccine Dose 4, 1st Booster), COVID-19 Vaccine (unspecified COVID-19 vaccine Dose 3) and COVID-19 Vaccine (unspecified COVID-19 vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine, COVID-19 Vaccine, COVID-19 Vaccine and COVID-19 Vaccine. On 23-Aug-2022 at 11:36 AM, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 23-Aug-2022 at 11:36 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 23-Aug-2022) and OVERDOSE (Patient received second booster dose of 0.5ml). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was was stored in refrigerator after expiration) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was was stored in refrigerator after expiration), EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 23-Aug-2022), OVERDOSE (Patient received second booster dose of 0.5ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was was stored in refrigerator after expiration), EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 23-Aug-2022) and OVERDOSE (Patient received second booster dose of 0.5ml). No concomitant medications were reported. It was reported that patient received Second booster dose. The vaccine was delivered and placed into the freezer on 18-Apr-2022. The vial size was reported as 5.5 ml. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 30-Aug-2022 vial was placed into refrigerator on 29-Aug-2022. The vial did not undergo any temperature excursion. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449938

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 56,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 30.08.2022
Beginn: 30.08.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was moved from the freezer to place in the refrigerator the day before it was used; No adverse event; Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient), PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Aug-2022 at 4:26 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Aug-2022 at 4:26 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient), PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Second booster dose of expired Moderna Covid-19 vaccine (Monovalent) administered to patient) and PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used). No concomitant medications were reported. Reported that patient received 2 COVID dose and 2 booster dose. The vaccine was delivered and placed into the freezer on 18-Apr-2022. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 30-Aug-2022, vial was removed from the freezer and placed into the refrigerator on 29-Aug-2022. The size of the vial was reported as 5.5ml. The vial did not undergo any temperature excursion. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449937

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 58,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 23.08.2022
Beginn: 23.08.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 23-Aug-2022; No adverse event; expired Moderna Covid-19 vaccine (Monovalent) to 27 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine (Monovalent) to 27 patients), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 23-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 VACCINE (Unspecified COVID-19 Vaccine Dose 1), COVID-19 VACCINE (Unspecified COVID-19 Vaccine booster dose 1), COVID-19 VACCINE (Unspecified COVID-19 Vaccine Dose 3) and COVID-19 VACCINE (Unspecified COVID-19 Vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE, COVID-19 VACCINE, COVID-19 VACCINE and COVID-19 VACCINE. On 23-Aug-2022 at 1:57 PM, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 23-Aug-2022 at 1:57 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine (Monovalent) to 27 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 23-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine (Monovalent) to 27 patients), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 23-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine (Monovalent) to 27 patients) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 23-Aug-2022). No concomitant medications was reported. On 18-Apr-2022 the vial was delivered and stored in the refrigerator on same date. The vial size is of 5.5mL. The vial did not undergo any temperature excursions. Vaccines were only offered on Tuesdays from March-2022 forward to the patient. For each Tuesday vaccine date, only removed one vial from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). No treatment drug details was reported. Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2022: Follow-up received: Patient details updated, dosage regimen updated (vaccination date, dose number and batch number).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449936

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 45,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 06-Sep-22.; No adverse event; The patient received dose after 30 day use date or after manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 06-Sep-22.) and NO ADVERSE EVENT (No adverse event) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Sep-2022 at 12:19 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Sep-2022 at 12:19 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 06-Sep-22.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 06-Sep-22.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 06-Sep-22.). No concomitant medications was reported. On 18-Apr-2022 the vial was delivered and stored in the refrigerator on same date. The vial size is of 5.5mL. The vial did not undergo any temperature excursions. Vaccines were only offered on Tuesdays from March-2022 forward to the patient. For each Tuesday vaccine date, only removed one vial from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). No treatment drug details was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449935

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 86,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 23.08.2022
Beginn: 23.08.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22; No adverse event; The patient received dose after 30 day use date or after manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (Unspecified vaccine, Dose 1), COVID-19 Vaccine (Unspecified vaccine, Dose 3 (First booster dose).), COVID-19 Vaccine (Unspecified vaccine and Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine, COVID-19 Vaccine and COVID-19 Vaccine. On 23-Aug-2022 at 11:36 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Aug-2022 at 11:36 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22). No concomitant medications was reported. On 18-Apr-2022 the vial was delivered and stored in the refrigerator on same date. The vial size is of 5.5mL. The vial did not undergo any temperature excursions. Vaccines were only offered on Tuesdays from March-2022 forward to the patient. For each Tuesday vaccine date, only removed one vial from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). No treatment medication was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449934

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 43,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 16.08.2022
Beginn: 16.08.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022, initially stored on 15-Aug-2022 and administered to the patient on 16-Aug-2022/Expired vaccine stored in refrigerator; No adverse event; Vial was expired on 13-Aug-2022, and administered to the patient on 16-Aug-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 15-Aug-2022 and administered to the patient on 16-Aug-2022/Expired vaccine stored in refrigerator), EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 16-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 VACCINE (First booster dose), COVID-19 VACCINE (second dose) and COVID-19 VACCINE (first dose). Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE, COVID-19 VACCINE and COVID-19 VACCINE. On 16-Aug-2022 at 10:28 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 16-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 16-Aug-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 15-Aug-2022 and administered to the patient on 16-Aug-2022/Expired vaccine stored in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 15-Aug-2022 and administered to the patient on 16-Aug-2022/Expired vaccine stored in refrigerator), EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 16-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 15-Aug-2022 and administered to the patient on 16-Aug-2022/Expired vaccine stored in refrigerator) and EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 16-Aug-2022). No relevant concomitant medications were reported. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449933

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 59,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022; No adverse event; Patient administered expired Moderna COVID-19 vaccine (Monovalent); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered expired Moderna COVID-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 1), COVID-19 vaccine (Unspecified COVID-19 vaccine, first booster dose), COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 3) and COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 vaccine, COVID-19 vaccine, COVID-19 vaccine and COVID-19 vaccine. On 13-Sep-2022 at 2:34 AM, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 13-Sep-2022 at 2:34 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered expired Moderna COVID-19 vaccine (Monovalent)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered expired Moderna COVID-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered expired Moderna COVID-19 vaccine (Monovalent)) and PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022, initially stored on 12-Sep-2022 and administered to the patient on 13-Sep-2022). No concomitant medications were reported. Vial size was reported as 5.5 ml. The vaccine was delivered and placed into the freezer on 18-Apr-2022 and the vial did not undergo any temperature excursion. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 13-Sep-2022 vial was placed into refrigerator on 12-Sep-2022. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449932

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 76,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 30.08.2022
Beginn: 30.08.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration; No adverse event; Vaccine was expired on 13-Aug-2022 and was administered on 30-Aug-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration), EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (unspecified COVID-19 vaccine Dose 2) and COVID-19 Vaccine (unspecified COVID-19 vaccine Dose 1). Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine and COVID-19 Vaccine. On 30-Aug-2022 at 4:14 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Aug-2022 at 4:14 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 30-Aug-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration), EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (Vaccine was expired on 13-Aug-2022 and was stored in refrigerator after expiration) and EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 13-Aug-2022 and was administered on 30-Aug-2022). No concomitant medications were reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. The vial size was reported as 5.5 ml. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 30-Aug-2022 vial was placed into refrigerator on 29-Aug-2022. The vial did not undergo any temperature excursion. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449931

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 74,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022; No adverse event; Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Sep-2022 at 10:52 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022), PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vial was expired on 13-Aug-2022, and administered to the patient on 13-Sep-2022) and PRODUCT STORAGE ERROR (Vial was expired on 13-Aug-2022 and stored in refrigerator on 12-Sep-2022 and administered to the patient on 13-Sep-2022). Concomitant medication information was not provided by the reporter. The vaccine was delivered and placed into the freezer on 18-Apr-2022. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 13-Sep-2022, vial was removed from the freezer and placed into the refrigerator on 12-Sep-2022. The vial did not undergo any temperature excursion. Treatment information was not provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449930

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 66,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 30.08.2022
Beginn: 30.08.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 30-Aug-2022; No adverse event; The patient received dose after 30 day use date or after manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (Dose 01), COVID-19 Vaccine (Dose 03 (Booster dose)) and COVID-19 Vaccine (Dose 02). Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine, COVID-19 Vaccine and COVID-19 Vaccine. On 30-Aug-2022 at 3:41 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Aug-2022 at 3:41 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 30-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 30-Aug-2022). No concomitant medications was reported. The vaccine was delivered and placed into the freezer on 18-Apr-2022. Vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date, only one vial was removed from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). Therefore, for administration on 13-Sep-2022, vial was removed from the freezer and placed into the refrigerator on 12-Sep-2022. The vial did not undergo any temperature excursion. No treatment drug details was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449929

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 69,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 16.08.2022
Beginn: 16.08.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was moved from the freezer to place in the refrigerator the day before it was used; No adverse event; Patient was administered with expired Moderna Covid-19 vaccine (Monovalent); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna Covid-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: COVID-19 (Dose 1.), COVID-19 (Dose 3 (First booster).) and COVID-19 (Dose 2.). Past adverse reactions to the above products included No adverse event with COVID-19, COVID-19 and COVID-19. On 16-Aug-2022 at 2:20 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Aug-2022 at 2:20 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna Covid-19 vaccine (Monovalent)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna Covid-19 vaccine (Monovalent)), PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with expired Moderna Covid-19 vaccine (Monovalent)) and PRODUCT STORAGE ERROR (The vial was moved from the freezer to place in the refrigerator the day before it was used). No concomitant medication were reported. It was reported that the (Clinic) provided scheduled vaccines, no walk-ins. At this location, vaccines were only offered on Tuesdays from Mar-2022 forward. For each Tuesday vaccine date. Only removed one vial from the freezer to place in the refrigerator the day before it was used i.e on 15-AUG-2022 the vial was removed from the freezer and placed in the refrigerator. The vial was initially stored in the freezer on 18-Apr-2022. The size of the vial was reported as 5.5ml. The vial had not undergone any temperature excursions. No treatment medication were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449918

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 80,0
Geschlecht: U
Eingang: 17.09.2022
Impfdatum: 16.08.2022
Beginn: 16.08.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 18-Aug-2022; No adverse event; expired Moderna Covid-19 vaccine (Monovalent) to 27 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine (Monovalent) to 27 patients), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 18-Aug-2022) and NO ADVERSE EVENT (No adverse event) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Aug-2022 at 8:47 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2022 at 8:47 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine (Monovalent) to 27 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 18-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine (Monovalent) to 27 patients), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 18-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (expired Moderna Covid-19 vaccine (Monovalent) to 27 patients) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administred on 18-Aug-2022). No concomitant medications was reported. On 18-Apr-2022 the vial was delivered and stored in the refrigerator on same date. The vial size is of 5.5mL. The vial did not undergo any temperature excursions. Vaccines were only offered on Tuesdays from March-2022 forward to the patient. For each Tuesday vaccine date, only removed one vial from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator). No treatment drug details was reported. Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2022: Follow-up received contains significant information accepted as patient details updated and dosage regimen updated (vaccination date, dose number and batch number).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2447683

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: WV
Alter: 73,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 02.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Lymphadenopathy

Symptomtext

Lymph nodes under injection arm swelled up significantly and lasted 1 or 2 weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymphadenopathy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2429366

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 94,0
Geschlecht: M
Eingang: 02.09.2022
Impfdatum: 02.05.2022
Beginn: 08.05.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2424048

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: OH
Alter: 88,0
Geschlecht: M
Eingang: 30.08.2022
Impfdatum: 26.07.2022
Beginn: 27.07.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Depression Insomnia Restlessness

Symptomtext

Patient states that around 2am (approximately 12 hours after vaccination) he woke up feeling very anxious and restless. He states he was unable to go back to sleep and he just walked all night. He has followed up with his family physician who has prescribed him Xanax and another medication he cannot remember to treat new onset anxiety and depression. He states his doctor advised him to let the health department know about his reaction so that it could be reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anxiety
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2422067

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: AZ
Alter: 59,0
Geschlecht: F
Eingang: 27.08.2022
Impfdatum: 23.08.2022
Beginn: 23.08.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to a patient after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-Aug-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to a patient after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to a patient after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to a patient after manufacturer date of expiry). Concomitant product use was not provided by the reporter. The vial was initially stored in the refrigerator on 15-Aug-2022. The vial did not undergo any temperature excursions. The pharmacy buyer stated that they gave a first booster dose of the Moderna COVID-19 vaccine to a patient from a vial after the manufacturer's expiry date. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2419096

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MO
Alter: 69,0
Geschlecht: M
Eingang: 24.08.2022
Impfdatum: 18.08.2022
Beginn: 18.08.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Vaccine vial sent to facility after expiration for booster dose. Vaccine expired 8/13/22. Sent 8/17/22. Vaccine administered 8/18/22. Patient not having adverse events at this time

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2418128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NY
Alter: 81,0
Geschlecht: F
Eingang: 23.08.2022
Impfdatum: 19.08.2022
Beginn: 19.08.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Patient received an expired vaccine; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) and NO ADVERSE EVENT (No adverse event) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 19-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine). No concomitant medications were reported. Reporter stated that she still had vaccine that have been expired and she wanted to know how to dispose of it. She stated that it was their 1st booster and the vaccine had expired a few days ago and a patient receiving it did not make a difference. That the patient was still getting the benefit from the vaccine. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2417350

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 22.08.2022
Impfdatum: 05.05.2022
Beginn: 14.08.2022
Tage bis Beginn: 101,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Cough

Symptomtext

Cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2417194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NJ
Alter: 66,0
Geschlecht: M
Eingang: 22.08.2022
Impfdatum: 20.05.2022
Beginn: 07.08.2022
Tage bis Beginn: 79,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Nasopharyngitis Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I thought I had a cold because I was in a hotel and felt it was drafty. In the morning I had a cough and congestion. I traveled out of state and felt an oncoming head cold while driving. On the 7th I got home and it was a little worse but not real bad so I started taking cold medication. I took the test on the 16th and by then it was mostly past but like a mild cold and tested positive that day. I had a tele med appointment on the 17th and was already past the day since I think I got it on the 8th.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID-19 at home test on the 16th, positive, then negative on the 19th.
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma
Andere Medikamente: Propranolol; doxycycline; ROGAINE; losartan potassium; HCTZ; biotin; ACTAPRIL; fish oil; goat weed; glucosamine chondroitin; AGELESS MALE max; extreme 2000; baby aspirin; alfa alfa; magnesium; garcinia cambogia; MEMOTENZ
Allergien: No
Vorherige Impfungen: -

VAERS 2415825

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: KY
Alter: 61,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 13.06.2022
Beginn: 13.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

VACCINE ADIMINSTERED BEYOND STORAGE EXPIRATION DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2415815

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: KY
Alter: 44,0
Geschlecht: M
Eingang: 19.08.2022
Impfdatum: 13.06.2022
Beginn: 13.06.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine administered beyond storage expiration date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2415808

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: KY
Alter: 58,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 10.06.2022
Beginn: 10.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

VACCINE ADMINISTERED AFTER STORAGE EXPIRATION DATE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HYPOTHYROID, ASTHMA, HYPOKALEMIA, SEASONAL ALLERGIES
Andere Medikamente: MONTELUKAST 10, ASMANEX, LEVOTHYROXINE 112, POTASSIUM 20, LEVOCETIRIZINE 5
Allergien: NONE
Vorherige Impfungen: -

VAERS 2415798

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: KY
Alter: 70,0
Geschlecht: M
Eingang: 19.08.2022
Impfdatum: 13.06.2022
Beginn: 13.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

VACCINE ADMINISTERED BEYOND STORAGE EXPIRATION DATE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HBP, GOUT, HYPERCHOLESTEROLEMIA, DIABETES.
Andere Medikamente: MIRTAZAPINE 15, JARDIANCE 10, ALLOPURINOL 100, METFORMIN 50, NIFEDIPINE 90, ATORVASTATIN 20, BENAZAPRIL 5, COLCHICINE 0.6, ATENOLOL 50.
Allergien: NONE
Vorherige Impfungen: -

VAERS 2415788

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: KY
Alter: 80,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 13.06.2022
Beginn: 13.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Vaccine administered beyond storage expiration date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HBP, osteoporosis, hypercholesterolemia
Andere Medikamente: Alendronate 70mg, Atenolol 50mg, Pravastatin 40mg, Amlodipine 5mg
Allergien: Aspirin
Vorherige Impfungen: -

VAERS 2415786

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: KY
Alter: 31,0
Geschlecht: M
Eingang: 19.08.2022
Impfdatum: 10.06.2022
Beginn: 10.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine administered beyond storage expiration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2413178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 057M21A

gering

Staat: IL
Alter: 66,0
Geschlecht: F
Eingang: 17.08.2022
Impfdatum: 29.09.2021
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient. A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Jan2021 as dose 1, single (Lot number: EL3249), in right arm, on 09Feb2021 as dose 2, single (Lot number: EM9810), in right arm and on 29Sep2021 as dose 3 (booster), single (Lot number: FC3183) at the age of 66 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 03May2022 as dose 4 (booster), single (Lot number: 057M21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "mild coronary artery disease" (unspecified if ongoing). The patient had no known allergies. Concomitant medication(s) included: IMDUR; PRAVACHOL. The patient received other medication in two weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative, notes: treatment I test negative for Covid on Day 11 and 12; (2022) Positive, notes: I tested positive with an antigen test. Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient received anti-viral treatment for COVID-19, treatment start date 24Jul2022 and treatment stop date 28Jul2022. Clinical course: After completing Paxlovid 5-day treatment the patient test negative for Covid on Day 11 and 12. On Day 13, the patient began feeling achy, very tired, return of sore throat and runny nose. The patient tested positive with an antigen test and resumed second period of isolation and quarantine. Adverse event start date reported as 04Aug2022 at 17:00. The adverse event was not resulted in physician office or emergency room visit. Sender's Comments: Based on the information given in narrative, the causal relationship between the events vaccination failure and COVID-19 and the suspect drug BNT162B2 cannot be excluded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 2022; Test Name: antigen test; Test Result: Negative ; Comments: treatment I test negative for covid on Day 11 and 12.; Test Date: 2022; Test Name: antigen test; Test Result: Positive ; Comments: I tested positive with an antigen test
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Coronary artery disease; Obesity
Andere Medikamente: Imdur; Pravachol
Allergien: -
Vorherige Impfungen: -

VAERS 2410001

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: WA
Alter: 71,0
Geschlecht: M
Eingang: 12.08.2022
Impfdatum: 11.08.2022
Beginn: 11.08.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered

Symptomtext

I delivered a Moderna booster to this individual and after doing so, recognized he had received four vaccinations already. He had no adverse effects at the time of vaccination. I notified the patient and staff at the adult family home that it occurred and advised them that no action was necessary unless he developed concerning symptoms. Our process is to verify doses at time of registration before the day of vaccination. We also check the cards at the site. None of our staff caught that he was already up to date until after I administered the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: none reported
Vorherige Impfungen: -

VAERS 2404376

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge #057M21A

gering

Staat: NC
Alter: 60,0
Geschlecht: F
Eingang: 08.08.2022
Impfdatum: 05.05.2022
Beginn: 09.06.2022
Tage bis Beginn: 35,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaemia Blood chloride decreased Blood creatinine normal Blood folate normal Blood iron normal Blood sodium decreased Blood urea nitrogen/creatinine ratio Chapped lips Haematocrit decreased Haemoglobin decreased Iron binding capacity total normal Laboratory test Lymphocyte count normal Neutrophil count normal Red blood cell count decreased Serum ferritin normal Transferrin saturation White blood cell count increased

Symptomtext

Anemia diagnosed by routine lab test Symptoms: none except cracked lips at corner of mouth Added iron supplement daily Awaiting results of colonoscopy/endoscopy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaemia
Hospital-Tage: -
Labordaten: Lab test results (annual physical) 6/9/2022 Hemoglobin 10.8 Hematocrit 33.6 Creatnine 1.06 BUN/Creatinine Ratio 11 Lymphs (Absolute) 3.8 Sodium 133 Chloride 95 Anemia Profile B (6/13/2022) Ferritin 11 Iron Bind.Cap.(TIBC) 410 Iron 69 Iron saturation 17 WBC 11.5 RBC 4.06 Hemoglobin 11.3 Hematocrit 34.3 Folate (Folic Acid), Serum 18.2 Neutrophils (Absolute) 7.3 Lymphs (Absolute) 3.3
Aktuelle Erkrankungen: none
Vorgeschichte: kidney disease back, hip, neck pain (from a fall - compressed discs) high blood pressure high cholesterol depression anxiety GERD
Andere Medikamente: Omeprazole, delayed release Clonazepam Lamotrigine Buproprion SR Hydrocodone/APAP Cyclobenzaprine Rosuvastatin Olmesartan Anxiety Control (GABA, passion flower, vit B6) CoQ10 Cinnamon (Cinnulin) Omega-3 Glucosamin/Chondroitin Multivitamin C
Allergien: chlorpheniramine
Vorherige Impfungen: -

VAERS 2401643

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 48,0
Geschlecht: M
Eingang: 04.08.2022
Impfdatum: 28.06.2022
Beginn: 28.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Moderna was past it's 30 day shelf life from being transferred from the freezer to the refrigerator and given to this patient. The manfacturer was contacted and given the scenario. The manufacturer stated that vaccine would be considered invalid and would need to be repeated. Patient declines a repeat dose at this time. Patient has been informed and did not report any physical reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2401275

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 69,0
Geschlecht: M
Eingang: 04.08.2022
Impfdatum: 28.06.2022
Beginn: 28.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Moderna was past it's 30 day shelf life from being transferred from the freezer to the refrigerator and given to this patient. The manufacturer was contacted and given the scenario. The manufacturer stated that vaccine would be considered invalid and would need to be repeated. Patient has been informed and did not report any physical reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2396404

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: FL
Alter: 97,0
Geschlecht: F
Eingang: 29.07.2022
Impfdatum: 12.05.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asymptomatic COVID-19 Osteomyelitis SARS-CoV-2 test positive Wound

Symptomtext

Pt presented with wounds positive for osteomyelitis which rocephin was given. Pt also tested for covid asymptomatic,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Asymptomatic COVID-19
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: MRSA in wound, tibia fracture
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2395071

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: VA
Alter: 67,0
Geschlecht: F
Eingang: 28.07.2022
Impfdatum: 27.04.2022
Beginn: 25.07.2022
Tage bis Beginn: 89,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ocular hyperaemia Vitreous detachment

Symptomtext

On July 25th, Suddenly, I got a spider web in my right eye, no pain. It happened Saturday but I waited until Monday July 27th to go to the doctor, but I called an emergency doctor and I described what happen and he said to wait to Monday and then on Monday at 3:00PM I went to the eye center and the doctor said that it was a "Posterior vitreous detachment"; now the doctor has to monitor the eye, it is a possibility that my retina is damaged. It was a blood in my eye and probably that was the reason of the vitreous detachment. My next appointment is next Monday August 1st.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ocular hyperaemia
Hospital-Tage: -
Labordaten: 27July2022 eye pressure normal.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Depression
Andere Medikamente: Bupropion XL; vitamin D3; lisinopril; vitamin B12; probiotic
Allergien: Beer; wine; body heat
Vorherige Impfungen: 15May 2022 COVID-19 3rd dose, 67 years, skin rash.

VAERS 2391200

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: HI
Alter: 75,0
Geschlecht: F
Eingang: 26.07.2022
Impfdatum: 22.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac flutter Cardioversion Computerised tomogram Heart rate increased X-ray

Symptomtext

I experienced increased heart rate that would not lower even after medications, which has been occurring daily. I went to the ER the following Monday after my dose, and was diagnosed with a heart flutter. The cardiologist confirmed my diagnosis of a heart flutter, and performed electrical cardioversion to treat the heart flutter on 07/25/2022 while today 07/26/2022 is my follow up appointment. I have not recovered, and the treatment has not been successful.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac flutter
Hospital-Tage: -
Labordaten: X-Ray and CAT Scan showed no damage to my heart.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Atrial Fibrillation
Andere Medikamente: COREG; TAMBOCOR; XARELTO; simvastatin; calcium; vitamin C; magnesium; coQ10; glucosamine
Allergien: CIPRO
Vorherige Impfungen: -

VAERS 2388532

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21-A

gering

Staat: CA
Alter: 78,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 23.04.2022
Beginn: 28.06.2022
Tage bis Beginn: 66,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac monitoring Heart rate irregular Laboratory test Ventricular extrasystoles

Symptomtext

04/23/2022 Vaccination. 05/28/2022 I just started getting more of the PVC's; benign irregular heartbeat. I have a history but never prevalent. This was about 5 weeks after the vacation and it was a lot. 07/25/2022 I am still having them more then I have had in a long time. I am seeing a cardiologist regarding this but no medication as this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac monitoring
Hospital-Tage: -
Labordaten: Cardiogram; Carotid Artery test
Aktuelle Erkrankungen: N/A
Vorgeschichte: chronic cough - the breathing in of stuff like mold and other things in the air - it's kind of like an allergic type reaction - like a lung inflammation that has been checked and scanned some arthritis - some aches and pains
Andere Medikamente: Cholesterol medication - Lipitor; Famotidine; Multi Vitamin; Calcium with D; CoQ10; Biotin; Probiotic; Baby aspirin; Prilosec
Allergien: Sulfa; Strong pain Medication
Vorherige Impfungen: COVID-19; all of them. Flushed, weak in legs, chills, malaise

VAERS 2387019

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: AZ
Alter: -
Geschlecht: U
Eingang: 23.07.2022
Impfdatum: 12.07.2022
Beginn: 27.05.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

administer the vaccine after the beyond use date, it was on the refrigerator for more than 30 days; it was on the refrigerator for more than 30 days then used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer the vaccine after the beyond use date, it was on the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (it was on the refrigerator for more than 30 days then used) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 27-May-2022, the patient experienced PRODUCT STORAGE ERROR (it was on the refrigerator for more than 30 days then used). On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer the vaccine after the beyond use date, it was on the refrigerator for more than 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer the vaccine after the beyond use date, it was on the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (it was on the refrigerator for more than 30 days then used) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Number of doses was 1 vial 1 dose. The vial was initially stored in the refrigerator was on 27-May-2022. The vial did not undergo any temperature excursions. No treatment drug detail was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2379357

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 83,0
Geschlecht: M
Eingang: 22.07.2022
Impfdatum: 28.04.2022
Beginn: 16.07.2022
Tage bis Beginn: 79,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case after four vaccines 4/22/21 Moderna Lot# 045B21A; Moderna 5/20/21 Lot# 041C212A; Moderna 11/22/21 Lot# 067F21A; Moderna 4/28/22 Lot# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: external COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2379183

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NC
Alter: 60,0
Geschlecht: F
Eingang: 22.07.2022
Impfdatum: 18.03.2021
Beginn: 13.07.2022
Tage bis Beginn: 482,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough Covid infection 3 months after 2nd booster

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 7/13/2022 positive for Covid via rapid antigen test
Aktuelle Erkrankungen: Sjogren?s disease Hypertension
Vorgeschichte: Sjogren?s disease Hypertension
Andere Medikamente: Hydroxychloroquine Cymbalta Metoprolol Lisinopril
Allergien: Crab
Vorherige Impfungen: -

VAERS 2376820

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NC
Alter: 54,0
Geschlecht: F
Eingang: 21.07.2022
Impfdatum: 21.07.2022
Beginn: 21.07.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Patient in for her third Moderna shot. Nurse looked at the immunocompromised chart and gave the patient a 0.5 3rd primary dose. Determine the patient was not immunocompromised and should have gotten a 0.25 booster dose instead. Contacted immunization nurse consultant for instructions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: Unkown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2371392

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: -
Geschlecht: U
Eingang: 16.07.2022
Impfdatum: 12.07.2022
Beginn: 12.07.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

a dose given from a vial with the lot # 057M21A today 7/12/22 when the BUD sticker was 7/9/22 of 30 days in the fridge; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (a dose given from a vial with the lot # 057M21A today 7/12/22 when the BUD sticker was 7/9/22 of 30 days in the fridge) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (a dose given from a vial with the lot # 057M21A today 7/12/22 when the BUD sticker was 7/9/22 of 30 days in the fridge). At the time of the report, EXPIRED PRODUCT ADMINISTERED (a dose given from a vial with the lot # 057M21A today 7/12/22 when the BUD sticker was 7/9/22 of 30 days in the fridge) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. A dose given from a vial with the lot (057M21A) today 7/12/22 when the BUD sticker was 7/9/22 of 30 days in the fridge. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2370141

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 83,0
Geschlecht: U
Eingang: 15.07.2022
Impfdatum: 12.07.2022
Beginn: 12.07.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

A dose of Moderna Covid-19 vaccine was given after the 30-day beyond use by date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given after the 30-day beyond use by date.) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given after the 30-day beyond use by date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A dose of Moderna Covid-19 vaccine was given after the 30-day beyond use by date.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient was administered first dose, second dose and first booster dose of unknown manufacturer on an unknown date. On 09-Jun-2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. Treatment information was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2365834

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 69,0
Geschlecht: M
Eingang: 12.07.2022
Impfdatum: 28.06.2022
Beginn: 28.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 22-Apr-2022 and the vaccine was administered on 28-Jun-2022/Has been in the refrigerator after 30 days; Moderna COVID booster was given and the vaccine was expired; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 22-Apr-2022 and the vaccine was administered on 28-Jun-2022/Has been in the refrigerator after 30 days) and EXPIRED PRODUCT ADMINISTERED (Moderna COVID booster was given and the vaccine was expired) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID booster was given and the vaccine was expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 22-Apr-2022 and the vaccine was administered on 28-Jun-2022/Has been in the refrigerator after 30 days). At the time of the report, PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 22-Apr-2022 and the vaccine was administered on 28-Jun-2022/Has been in the refrigerator after 30 days) and EXPIRED PRODUCT ADMINISTERED (Moderna COVID booster was given and the vaccine was expired) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The vaccine was expired, not from the manufactured date. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2022: Follow-up information received contains no significant information.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2365832

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 48,0
Geschlecht: M
Eingang: 12.07.2022
Impfdatum: 28.06.2022
Beginn: 28.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Patient was administered with the vaccine after 30 days use by date; Patient was administered with the vaccine after 30 days use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with the vaccine after 30 days use by date) and PRODUCT STORAGE ERROR (Patient was administered with the vaccine after 30 days use by date) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with the vaccine after 30 days use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient was administered with the vaccine after 30 days use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with the vaccine after 30 days use by date) and PRODUCT STORAGE ERROR (Patient was administered with the vaccine after 30 days use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. It was reported the date the vial was initially stored in the refrigerator was on 22 Apr 2022. And the vial had not undergone any temperature excursions. No treatment medication were reported. Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2022: Follow up received contains non significant information.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2364662

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: AZ
Alter: 35,0
Geschlecht: F
Eingang: 11.07.2022
Impfdatum: 17.05.2022
Beginn: 11.07.2022
Tage bis Beginn: 55,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Medical assistant vaccinated this patient on there 21 day when it should have been on there 28th day for there 2nd dose of Moderna.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361090

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: IL
Alter: 44,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 30.06.2022
Beginn: 30.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361087

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: IL
Alter: 57,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361086

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: IL
Alter: 53,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered No adverse event Product storage error

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361082

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: IL
Alter: 55,0
Geschlecht: M
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361080

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: IL
Alter: 55,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361052

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: IL
Alter: 83,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361045

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: IL
Alter: 61,0
Geschlecht: M
Eingang: 07.07.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361041

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361020

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 80,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361017

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

No adverse reaction reported, vaccine administered after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2361006

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 69,0
Geschlecht: M
Eingang: 07.07.2022
Impfdatum: 23.06.2022
Beginn: 23.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

no symptoms reported, vaccine administered after 30 days or refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2360993

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 54,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

no symptoms reported, vaccine administered after 30 days or refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2360983

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 50,0
Geschlecht: M
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

no symptoms reported, vaccine administered after 30 days or refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2360974

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 70,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

no symptoms reported, administered vaccine after 30 days of refrigeration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2357683

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 81,0
Geschlecht: M
Eingang: 05.07.2022
Impfdatum: 13.05.2022
Beginn: 28.06.2022
Tage bis Beginn: 46,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after three doses. Moderna 2/6/21 Lot# 013M20A; Moderna 3/6/21 Lot# 030A21A; Moderna 5/13/22 Lot# 057M21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356077

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 80,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Circumstance or information capable of leading to medication error Poor quality product administered Product measured potency issue Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Possible freezer temperature excursion but unknown; Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses; Potential subpotent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible freezer temperature excursion but unknown), POOR QUALITY PRODUCT ADMINISTERED (Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses) and PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses) and PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses) outcome was unknown and PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) had resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses). Concomitant medications details were not reported by the reporter. patient ever been diagnosed with/ tested positive for COVID-19 was reported as unknown. It was reported that vaccines was stored, there was no monitoring of the freezer temperature and those vaccines was administered to patients. Vaccination site has a data logger, but it was not set up to record. The HCP stated that there is no freezer minimum and maximum temperatures to report as the temperatures are not recorded by the site. There were no adverse event, only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. Treatment details were not reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Follow up received contain Non-significant information, Quality complaint number was updated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Circumstance or information capable of leading to medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356076

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 67,0
Geschlecht: M
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product measured potency issue Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Potential subpotent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. It was unknown patient had ever been diagnosed with or tested positive for COVID-19. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). Concomitant medications details were not reported by the reporter. It was reported that vaccines were stored, there was no monitoring of the freezer temperature, and those vaccines was administered to patients. Vaccination site has a data logger, but it was not set up to record. The HCP stated that there was no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. There was no adverse event, only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. Treatment details were not reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Follow up received and Quality Complaint number added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product measured potency issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was unknown patient had ever been diagnosed with or tested positive for COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356075

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 57,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover.) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover.) outcome was unknown. Not provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover.) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). No concomitant medications information was reported. Reporter stated that a site that administers the Moderna COVID-19 vaccine did not monitor the freezer temperatures where the Moderna vaccine is stored. The site had a data logger, but it was not set up to record. The HCP stated there is no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. Therefore, it was unknown if a freezer temperature excursion actually occurred. There were no adverse events. Only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover was reported. No treatment medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Quality complaint no. added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356074

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 68,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Circumstance or information capable of leading to medication error Poor quality product administered Product measured potency issue Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Possible freezer temperature excursion but unknown; Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses; Potential subpotent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible freezer temperature excursion but unknown), POOR QUALITY PRODUCT ADMINISTERED (Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses) and PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses) and PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses) outcome was unknown and PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) had resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PRODUCT MEASURED POTENCY ISSUE (Potential subpotent dose) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Multiple patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover./potential subpotent doses). No concomitant medications were reported No treatment medications were reported It was unknown if the patient ever been diagnosed with or tested positive for COVID-19 It was reported that vaccines was stored, there was no monitoring of the freezer temperature and those vaccines was administered to patients. Vaccination site has a data logger, but it was not set up to record. The HCP stated that there is no freezer minimum and maximum temperatures to report as the temperatures are not recorded by the site. There were no adverse event, only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Follow up received contains Non significant, quality complaint number added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Circumstance or information capable of leading to medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356073

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 59,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. It was unknown if the patient had ever been diagnosed with/ tested positive for COVID-19. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). No concomitant medications information was reported. Reporter stated that a site that administers the Moderna COVID-19 vaccine did not monitor the freezer temperatures where the Moderna vaccine is stored. The site had a data logger, but it was not set up to record. The HCP stated there is no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site.Therefore, it was unknown if a freezer temperature excursion actually occurred. There were no adverse events. Only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover was reported. The event did not cause the patient to seek medical care. No treatment information were reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Live follow-up: Quality complaint no. only added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was unknown if the patient had ever been diagnosed with/ tested positive for COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356072

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 64,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) and PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. It was unknown if the patient had ever been diagnosed or tested positive for COVID-19. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) and PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). Concomitant medications details were not reported by the reporter. Reporter stated that a site that administers the Moderna COVID-19 vaccine did not monitor the freezer temperatures where the Moderna vaccine is stored. The site had a data logger, but it was not set up to record. The HCP stated there was no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. Therefore, it was unknown if a freezer temperature excursion actually occurred. There were no adverse events. Potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover was reported. The event did not cause the patient to seek medical care. Treatment details were not reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-586994 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Follow up received contain non significant information, quality complaint number was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2022-586994:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was unknown if the patient had ever been diagnosed or tested positive for COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356071

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 60,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). No concomitant medications were reported. The patient administered the Moderna COVID-19 vaccine which was stored in freezer for which temperature was not monitor. The site had a data logger, but it was not set up to record. The health care professional (HCP) stated there was no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. Therefore, it was unknown if a freezer temperature excursion actually occurred. The event potential sub potent dose did not cause patient to seek medical care. There were no adverse events reported. Only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Live follow up received quality complaint number added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356070

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 82,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion; Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/Potential sub potent dose.; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/Potential sub potent dose.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/Potential sub potent dose.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/Potential sub potent dose.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/Potential sub potent dose.) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion). Concomitant medications details were not reported by the reporter. It was reported that vaccines were stored, there were no monitoring of the freezer temperature and those vaccines were administered to patients. Vaccination site had a data logger, but it was not set up to record. The HCP stated that there were no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. There were no adverse event, only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. Treatment details were not reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Live follow-up: Quality complaint number received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356069

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 76,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover/Potential sub potent dose.; Does not monitor freezer temperatures/Possible freezer temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover/Potential sub potent dose.) and POOR QUALITY PRODUCT ADMINISTERED (Does not monitor freezer temperatures/Possible freezer temperature excursion) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. It was unknown if patient had ever been diagnosed with/ tested positive for COVID-19. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Does not monitor freezer temperatures/Possible freezer temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover/Potential sub potent dose.). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover/Potential sub potent dose.) and POOR QUALITY PRODUCT ADMINISTERED (Does not monitor freezer temperatures/Possible freezer temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Does not monitor freezer temperatures/Possible freezer temperature excursion) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover/Potential sub potent dose.). No concomitant medications were reported It was reported that vaccines was stored, there was no monitoring of the freezer temperature and those vaccines was administered to patients. Vaccination site has a data logger, but it was not set up to record. The HCP stated that there is no freezer minimum and maximum temperatures to report as the temperatures are not recorded by the site. There were no adverse event, only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. The event did not cause the patient to seek medical care. No treatment medications were reported Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Live Follow-up received contain non significant information Quality complaint number received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was unknown if patient had ever been diagnosed with/ tested positive for COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356068

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 82,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Did not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) and PRODUCT TEMPERATURE EXCURSION ISSUE (Did not monitor freezer temperatures/Possible freezer temperature excursion but unknown) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. It was unknown if the patient had ever been diagnosed with or tested positive for COVID-19. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Did not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) and PRODUCT TEMPERATURE EXCURSION ISSUE (Did not monitor freezer temperatures/Possible freezer temperature excursion but unknown) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential subpotent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Did not monitor freezer temperatures/Possible freezer temperature excursion but unknown). Concomitant medications details were not reported by the reporter. Reporter stated that a site that administers the Moderna COVID-19 vaccine did not monitor the freezer temperatures where the Moderna vaccine is stored. The site had a data logger, but it was not set up to record. The HCP stated there was no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. Therefore, it was unknown if a freezer temperature excursion actually occurred. There were no adverse events. Only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover was reported. It was also reported that the event did not cause the patient to seek medical care. Treatment details were not reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-586994 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Live Follow-up was received: Quality complaint number was added.; Sender's Comments: US-MODERNATX, INC.-MOD-2022-586994:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was unknown if the patient had ever been diagnosed with or tested positive for COVID-19.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356067

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 69,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential sub potent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential sub potent dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential sub potent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential sub potent dose) outcome was unknown. Not provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Patient vaccinated from vials originally stored in freezer / administered the Moderna COVID-19 vaccine does not monitor the freezer temperatures/Potential sub potent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). No concomitant medications were reported. The patient administered the Moderna COVID-19 vaccine which was stored in freezer for which temperatures was not monitor. The site had a data logger, but it was not set up to record. The health care professional (HCP) stated there was no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. Therefore, it was unknown if a freezer temperature excursion actually occurred. The event potential sub potent dose did not cause patient to seek medical care. There were no adverse events reported. Only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Live follow-up received contain Quality complaint number.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356066

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 63,0
Geschlecht: M
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion; Patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/potential sub potent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/potential sub potent dose) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/potential sub potent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/potential sub potent dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Patients vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/potential sub potent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion). Concomitant medications details were not reported by the reporter. It was reported that vaccines were stored, there were no monitoring of the freezer temperature and those vaccines were administered to patients. Vaccination site had a data logger, but it was not set up to record. The HCP stated that there were no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. There were no adverse event, only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. Treatment details were not reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Live follow up : Quality complaint no. added

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356065

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 66,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. It was unknown if the patient had ever been diagnosed with/ tested positive for COVID-19. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover/ Potential subpotent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). No concomitant medications information was reported. Reporter stated that a site that administers the Moderna COVID-19 vaccine did not monitor the freezer temperatures where the Moderna vaccine is stored. The site had a data logger, but it was not set up to record. The HCP stated there is no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site.Therefore, it was unknown if a freezer temperature excursion actually occurred. There were no adverse events. Only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover was reported. The event did not cause the patient to seek medical care. No treatment medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Quality complaint number added

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was unknown if the patient had ever been diagnosed with/ tested positive for COVID-19
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356064

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 74,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature; Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover//potential sub potent dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature) and POOR QUALITY PRODUCT ADMINISTERED (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover//potential sub potent dose) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover//potential sub potent dose). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature) and POOR QUALITY PRODUCT ADMINISTERED (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover//potential sub potent dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Patient was vaccinated from vials originally stored in freezer / potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover//potential sub potent dose) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature). Concomitant medications details were not reported by the reporter. It was reported that vaccines were stored, there were no monitoring of the freezer temperature and those vaccines were administered to patients. Vaccination site had a data logger, but it was not set up to record. The HCP stated that there were no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. There were no adverse event, only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover. Treatment details were not reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Quality complaint number added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2356063

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 79,0
Geschlecht: M
Eingang: 03.07.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown; Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover.) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 17-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 17-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown) and POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover.) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (Potential of a subtherapeutic dose due to poor frezer documentation following a freezer changeover.) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Does not monitor freezer temperatures/Possible freezer temperature excursion but unknown). No concomitant medications information was reported. Reporter stated that a site that administers the Moderna COVID-19 vaccine did not monitor the freezer temperatures where the Moderna vaccine is stored. The site had a data logger, but it was not set up to record. The HCP stated there is no freezer minimum and maximum temperatures to report as the temperatures were not recorded by the site. Therefore, it was unknown if a freezer temperature excursion actually occurred. There were no adverse events. Only the potential of a subtherapeutic dose due to poor freezer documentation following a freezer changeover was reported. No treatment medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2022: Quality complaint number added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 71,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was first punctured on 06-JUN-2022, post punctured stored at fridge and administered on 24-JUN-2022; Dose administered >12(hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered >12(hours post puncture) and PRODUCT STORAGE ERROR (Vial was first punctured on 06-JUN-2022, post punctured stored at fridge and administered on 24-JUN-2022) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Jun-2022 at 7:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2022 at 7:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered >12(US hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was first punctured on 06-JUN-2022, post punctured stored at fridge and administered on 24-JUN-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered >12(hours post puncture) and PRODUCT STORAGE ERROR (Vial was first punctured on 06-JUN-2022, post punctured stored at fridge and administered on 24-JUN-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient received second booster dose of Moderna COVID-19 vaccine. No concomitant information was reported by the reporter. On 01-JUN-2022 vial was initially stored in refrigerator, on 06-JUN-2022 at 10:00AM vial was first punctured and on 24-JUN-2022 at 7:00 A vial was administered to patient .It is also reported that vial after punctured stored in fridge and the vial doesn't go under temperature excursions. No treatment information was provided by the reporter. This case was linked to MOD-2022-594660.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2355941

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 54,0
Geschlecht: F
Eingang: 03.07.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

product storage error; Dose administered more than 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture) and PRODUCT STORAGE ERROR (product storage error) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Jun-2022 at 7:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2022 at 7:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture) and PRODUCT STORAGE ERROR (product storage error) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. It was reported that patient had taken second booster dose. The number of doses per vial was 2 doses which was booster doses. On 01June 2022 the vial was initially stored in the refrigerator. On 06June2022 at 10:00AM the vial was first punctured. The vial was stored in fridge post puncture. The vial did not undergo any temperature excursions Total amount of time the vial was exposed to room temperature range was for more than 24 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335781

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 64,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product measured potency issue

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product measured potency issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335779

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 67,0
Geschlecht: M
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product measured potency issue

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product measured potency issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335773

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 66,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335770

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 82,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335768

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 74,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335766

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 79,0
Geschlecht: M
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335765

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 80,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335764

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 76,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335762

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 69,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335761

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 63,0
Geschlecht: M
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335760

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 61,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335759

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 57,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335576

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 82,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335574

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 59,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered

Symptomtext

POTENTIAL SUBPOTENT VACCINE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335573

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 68,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered

Symptomtext

POTENTIAL SUBPOTENT VACCINE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 79,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered

Symptomtext

POTENTIAL SUBPOTENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335571

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: ME
Alter: 59,0
Geschlecht: F
Eingang: 27.06.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

POTENTIALLY SUBPOTENT VACCINE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335410

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 55,0
Geschlecht: M
Eingang: 26.06.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

Patient was administered vaccine one day outside the use by date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335408

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 60,0
Geschlecht: M
Eingang: 26.06.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Patient was administered vaccine one day outside the use by date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335407

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 61,0
Geschlecht: M
Eingang: 26.06.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Patient was administered vaccine one day outside the use by date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335403

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 58,0
Geschlecht: M
Eingang: 26.06.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

Patient was administered vaccine one day outside the use by date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335402

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 64,0
Geschlecht: M
Eingang: 26.06.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Patient was administered vaccine one day outside the use by date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335401

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 61,0
Geschlecht: F
Eingang: 26.06.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

Patient was administered vaccine one day outside the use by date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335400

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CO
Alter: 65,0
Geschlecht: F
Eingang: 26.06.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

Patient was administered vaccine one day outside the use by date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2335398

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: FL
Alter: 71,0
Geschlecht: M
Eingang: 26.06.2022
Impfdatum: 24.06.2022
Beginn: 24.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product use issue

Symptomtext

Patient was administered vaccine one day outside the use by date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2328951

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IA
Alter: 69,0
Geschlecht: M
Eingang: 23.06.2022
Impfdatum: 09.05.2022
Beginn: 13.06.2022
Tage bis Beginn: 35,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Tested positive for Covid-19 on June 14, 2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: At-home Antigen Test 6/14/2022
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure
Andere Medikamente: Diltiazem XR 180 mg
Allergien: None
Vorherige Impfungen: -

VAERS 2327417

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: OH
Alter: 64,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 19.05.2022
Beginn: 08.06.2022
Tage bis Beginn: 20,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Joint swelling Peripheral swelling

Symptomtext

My ankle and leg started swell. I was seen by a doctor and discovered my lung and heart was fine. My doctor stated my age cause with vaccine caused my legs and ankle to swell.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood test
Hospital-Tage: -
Labordaten: Blood work
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Advil; Ibuprofen
Allergien: None
Vorherige Impfungen: -

VAERS 2320266

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 15.06.2022
Impfdatum: 12.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320212

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 15.06.2022
Impfdatum: 06.06.2022
Beginn: 02.06.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product storage error

Symptomtext

Narrative: Syringe was drawn up from the vial on 6/1, 0.5 ml. It was not utilized or disposed of on 6/1 as would be appropriate for a 12 hour BUD. Since it was not disposed of per procedure and left in the vaccine prep area, the 6/2 staff did note the 6/1 date and utilized this syringe to split and make two 0.25 ml booster vaccine doses. These were administered. No adverse outcome identified.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2318425

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MD
Alter: 66,0
Geschlecht: F
Eingang: 14.06.2022
Impfdatum: 10.06.2022
Beginn: 10.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

the vial had been open for more than 24h; A patient was administered a dose from a vial that had been open for more 24h; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose from a vial that had been open for more 24h) and PRODUCT STORAGE ERROR (the vial had been open for more than 24h) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 10-Jun-2022 at 9:50 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose from a vial that had been open for more 24h). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial had been open for more than 24h). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose from a vial that had been open for more 24h) and PRODUCT STORAGE ERROR (the vial had been open for more than 24h) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment reported. It was reported that there were no other AEs as a result of this misadministration. 1 dose expired after the 12h. On Monday 6 Jun 2022 the vial was initially stored in the refrigerator. On 9 June 2022 9:30 am vial was first punctured. The vial was stored post puncture in a fridge. The vial did not undergo any temperature excursions. The vial was exposed to room temperature range for 15 mins before administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2314174

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 82,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 03.06.2022
Beginn: 06.06.2022
Tage bis Beginn: 3,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered No adverse event

Symptomtext

The patient was inadvertently given a 3rd booster of the Moderna Covid-19 vaccine. Patient has not experienced any adverse events to date. Patient continues to be monitored regularly for any side effects from receipt of the extra booster dose. 2nd booster dose was administered on 05/25/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: None at this time have been needed.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Dementia
Andere Medikamente: Unknown
Allergien: Unknown-no severe allergies noted
Vorherige Impfungen: -

VAERS 2313969

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NY
Alter: 50,0
Geschlecht: M
Eingang: 09.06.2022
Impfdatum: 26.04.2022
Beginn: 15.05.2022
Tage bis Beginn: 19,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

Covid positive on 5/15/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Covid rapid test positive on 5/15/2022 Monoclonal antibodies administered on 5/15/2022
Aktuelle Erkrankungen: None
Vorgeschichte: Sleep apnea, asthma
Andere Medikamente: Crestor, CoQ10, fish oil, mutivitamin, vitamin D, probiotics, vitamin C, Singulair, Finesteride,
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2313715

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 64,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 12.05.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

After testing negative, symptoms returned and received positive result; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (After testing negative, symptoms returned and received positive result) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. The patient had no known allergies. Concomitant products included CALCIUM, COLECALCIFEROL (CALCIUM +VIT D) for an unknown indication. On 12-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (After testing negative, symptoms returned and received positive result). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 25-May-2022 to 30-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (After testing negative, symptoms returned and received positive result) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jun-2022, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive and negative (Negative) Negative. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient had reported after testing negative, symptoms had returned and patient had received positive result on 04-Jun-2022. Company Comment: This spontaneous case reported by a patient concerns a 64-year-old female patient, with no relevant medical history, who experienced unexpected, non-serious AESI Covid19 on an unknown date after receiving a fourth dose of mRNA-1273. She was treated with Nirmatrelvir/Ritonavir (Paxlovid), after which she tested negative for Covid19. However, around 5 days later the symptoms returned, and she tested positive again. The ongoing Covid19 pandemic could be a contributory factor. The benefit risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case reported by a patient concerns a 64-year-old female patient, with no relevant medical history, who experienced unexpected, non-serious AESI Covid19 on an unknown date after receiving a fourth dose of mRNA-1273. She was treated with Nirmatrelvir/Ritonavir (Paxlovid), after which she tested negative for Covid19. However, around 5 days later the symptoms returned, and she tested positive again. The ongoing Covid19 pandemic could be a contributory factor. The benefit risk relationship of mRNA-1273 is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive; Test Name: COVID-19 virus test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20220604; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known allergies.
Andere Medikamente: CALCIUM +VIT D
Allergien: -
Vorherige Impfungen: -

VAERS 2633951

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NY
Alter: 16,0
Geschlecht: F
Eingang: 08.06.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administered to patient of inappropriate age

Symptomtext

Patient was given Moderna vaccine on 5/5/2022 on this date she was only 15 years 7 months old and Moderna is not FDA approved for children under the age of 18. No harm noted to patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: no
Vorgeschichte: Allergic rhinitis
Andere Medikamente: Mupi4odin ointemtn, famotidine 20 mg, docusate sodium 100 mg
Allergien: None Known
Vorherige Impfungen: -

VAERS 2313130

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: OH
Alter: 70,0
Geschlecht: F
Eingang: 08.06.2022
Impfdatum: 10.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 8,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Infusion SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough Case of COVID-19: Tested positive for COVID-19, I had a severe sore throat. I had a virtual health appointment and was given the antibody infusion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: N/a
Vorgeschichte: Hypertension; Obesity; Hypercholesterolemia
Andere Medikamente: Crestor Toprol ER Hygroton Albuterol Zyrtec Aspirin Centrical
Allergien: Allopurinol
Vorherige Impfungen: -

VAERS 2312787

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days; Expired vaccine administered to 2 patients/Doses administered to patients after beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 2 patients/Doses administered to patients after beyond use date) and PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 26-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 26-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 2 patients/Doses administered to patients after beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 2 patients/Doses administered to patients after beyond use date) and PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. On 25-Apr-2022 vial stored in refrigerator product BUD is 25-May-2022 No concomitant medication information provided. No treatment medication information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2312548

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days; dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days) and PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 27-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 27-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days) and PRODUCT STORAGE ERROR (dose was administered to patient after the beyond use date after the vaccine was thawed out in the refrigeraor after 30 days) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the vial was initially stored in refrigerator on 25-Apr-2022. The vial did not undergo any temperature excursion. It was reported patients were administered from 2 separate vials of same lot number. Dose administered on 27MAY2022 with beyond use date being on 25MAY2022 as per HCP from 2 separate vials from the same lot number. Treatment was reported as unknown. This case was linked to MOD-2022-583974 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 07.06.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Expired product administered Multiple use of single-use product No adverse event Product storage error

Symptomtext

Narrative: Syringe was drawn up from the vial on 6/1, 0.5 ml. It was not utilized or disposed of on 6/1 as would be appropriate for a 12 hour BUD. Since it was not disposed of per procedure and left in the vaccine prep area, the 6/2 staff did not note the 6/1 date and utilized this syringe to split and make two 0.25 ml booster vaccine doses. These were administered. No adverse outcome identified.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2311490

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NJ
Alter: -
Geschlecht: U
Eingang: 07.06.2022
Impfdatum: 01.06.2022
Beginn: 12.05.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

1 patient received doses from vial that went to 6.6 F; 1 patient received doses from vial that went to 6.6 F/ freezer excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (1 patient received doses from vial that went to 6.6 F/ freezer excursion) and POOR QUALITY PRODUCT ADMINISTERED (1 patient received doses from vial that went to 6.6 F) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-May-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (1 patient received doses from vial that went to 6.6 F/ freezer excursion). On 01-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (1 patient received doses from vial that went to 6.6 F). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (1 patient received doses from vial that went to 6.6 F/ freezer excursion) and POOR QUALITY PRODUCT ADMINISTERED (1 patient received doses from vial that went to 6.6 F) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Freezer excursion was reported, and the data log said it happened on 12-May 2022. There was a loss of power close to midnight. Maximum temperatures reached was 6.6 F with the excursion duration of 5 minutes. Vials were moved from freezer to refrigerator on 31-May-2022 and were stored in fridge, quarantined in a separate bag. Vaccine was still frozen upon visual inspection on 16-May-2022. Proposed desired use by date was reported as 03-Jun-2022 and 09-Jun-2022 to 10-Jun-2022. 8 vials were impacted in the excursion, three were used, there were 5 left. Remaining 5 vials were not punctured with no previous excursions. It was also reported that patient received Spikevax on 01-Jun-2022. The vial was initially stored in the refrigerator on 31-May-2022 and the vial did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2309615

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MO
Alter: 63,0
Geschlecht: F
Eingang: 04.06.2022
Impfdatum: 04.06.2002
Beginn: 04.06.2022
Tage bis Beginn: 7.305,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered No adverse event

Symptomtext

NO adverse event(s) or treatment noted at this time. 0.5ml dose given vs 0.25 ml dose for 1st Booster.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: none at this time.
Aktuelle Erkrankungen: #5 FOR WEAKENED IMMUNE SYSTEM no
Vorgeschichte: N/A
Andere Medikamente: N/A- AT THIS TIME
Allergien: #4: no ON CONSENT FORM
Vorherige Impfungen: -

VAERS 2309492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 04.06.2022
Impfdatum: 27.05.2022
Beginn: 27.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Administered 2 days past the beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered 2 days past the beyond use date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 27-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered 2 days past the beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered 2 days past the beyond use date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Beyond Use date was reported as 25 May 2022. It was reported that the product did not experienced any other temperature excursions and no particulates or discoloration noted. Suspect product was transported and maintained between 36-46F. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2022-581911 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2309491

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 04.06.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

administered 2 days past the beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 2 days past the beyond use date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 26-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 2 days past the beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 2 days past the beyond use date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Beyond Use date was reported as 25-May-2022. It was reported that the product did not experienced any other temperature excursions and no particulates or discoloration noted. Suspect product was transported and maintained between 36-46F. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2022-582105 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2307049

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: OH
Alter: 64,0
Geschlecht: M
Eingang: 02.06.2022
Impfdatum: 12.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

11 days after my 4th vaccine I tested positive for COVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Heart stents; Heart disease; Obesity; Chronic kidney stones
Andere Medikamente: Lipitor 80mg, Niaspan 1000mg, Prasugrel 10mg, Alfuzosin 10mg, Aspirin 81mg,
Allergien: FLOMAX
Vorherige Impfungen: -

VAERS 2306971

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MO
Alter: 76,0
Geschlecht: F
Eingang: 02.06.2022
Impfdatum: 01.03.2021
Beginn: 27.05.2022
Tage bis Beginn: 452,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Interchange of vaccine products

Symptomtext

unknown

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2306183

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 02.06.2022
Impfdatum: 29.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

I was recovering from COVID19 and had two negative tests then a few days later started having symptoms again (mostly congestion). I retested and was positive.; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I was recovering from COVID19 and had two negative tests then a few days later started having symptoms again (mostly congestion). I retested and was positive.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Drug use for unknown indication: Pfizer / BioNTech (Dose Number: 1 Batch/Lot No: EN6200 Location of injection: Arm Left) on 23-Feb-2021, Pfizer / BioNTech (Dose Number: 2 Batch/Lot No: EN6208 Location of injection: Arm Right) on 16-Mar-2021 and Pfizer / BioNTech (Dose Number: 3 Batch/Lot No: FF2593 Location of injection: Arm Left) on 25-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer / BioNTech, Pfizer / BioNTech and Pfizer / BioNTech. Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN for an unknown indication. On 29-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced COVID-19 (I was recovering from COVID19 and had two negative tests then a few days later started having symptoms again (mostly congestion). I retested and was positive.). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 13-May-2022 to 17-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (I was recovering from COVID19 and had two negative tests then a few days later started having symptoms again (mostly congestion). I retested and was positive.) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2022, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative and negative (Negative) Negative. Patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. Patient previously received COVID-19 vaccine. The patient was recovering from COVID19 and had two negative tests then a few days later started having symptoms again mostly congestion 24-MAY-2022 21:00. The patient retested and was positive. Treatment medications were not reported. Company comment: This spontaneous case concerns a patient of an unknown age and gender, with no relevant medical history, who experienced the unexpected, non-serious AESI of COVID-19, approximately a month after the fourth dose of mRNA-1273 vaccine, considered as the fourth dose of the vaccine schedule. Previously the patient received three doses of Pfizer/BioNTech vaccine. As per source document, the patient was recovering from COVID-19 and had two negative tests but a few days later started having symptoms again and had a positive retested. Concomitant PAXLOVID remains as a confounder for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a patient of an unknown age and gender, with no relevant medical history, who experienced the unexpected, non-serious AESI of COVID-19, approximately a month after the fourth dose of mRNA-1273 vaccine, considered as the fourth dose of the vaccine schedule. Previously the patient received three doses of Pfizer/BioNTech vaccine. As per source document, the patient was recovering from COVID-19 and had two negative tests but a few days later started having symptoms again and had a positive retested. Concomitant PAXLOVID remains as a confounder for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19 Test; Test Result: Negative ; Result Unstructured Data: Negative; Test Name: COVID-19 Test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 202205; Test Name: COVID-19 Test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Hypertension
Vorgeschichte: -
Andere Medikamente: LOSARTAN
Allergien: -
Vorherige Impfungen: -

VAERS 2303145

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: HI
Alter: -
Geschlecht: U
Eingang: 31.05.2022
Impfdatum: 29.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Interchange of vaccine products SARS-CoV-2 test

Symptomtext

I was recovering from COVID-19"; Patient received 3 Pfizer vaccine and 4th dose as moderna; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I was recovering from COVID-19") and INTERCHANGE OF VACCINE PRODUCTS (Patient received 3 Pfizer vaccine and 4th dose as moderna) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. Previously administered products included for Drug use for unknown indication: Pfizer / BioNTech (Dose Number: 1 Batch/Lot No: EN6200 Location of injection: Arm Left) on 23-Feb-2021, Pfizer / BioNTech (Dose Number: 2 Batch/Lot No: EN6208 Location of injection: Arm Right) on 16-Mar-2021 and Pfizer / BioNTech (Dose Number: 3 Batch/Lot No: FF2593 Location of injection: Arm Left) on 25-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer / BioNTech, Pfizer / BioNTech and Pfizer / BioNTech. Concurrent medical conditions included Hypertension and Drug allergy (unknown historical drug). Concomitant products included LOSARTAN for Heart disorder. On 29-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2022, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received 3 Pfizer vaccine and 4th dose as moderna). On an unknown date, the patient experienced COVID-19 (I was recovering from COVID-19"). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 13-May-2022 to 17-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (I was recovering from COVID-19") had not resolved and INTERCHANGE OF VACCINE PRODUCTS (Patient received 3 Pfizer vaccine and 4th dose as moderna) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-May-2022, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative and negative (Negative) Negative. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment and the patient previously received a COVID-19 vaccine. The patient was recovering from COVID-19 and had two negative tests then a few days later started experiencing symptoms again (mostly congestion). The patient retested and was positive. Treatment information was not provided. Company comment: This is a spontaneous case concerning a patient of unknown age and gender with no relevant medical history and with vaccine history of receiving first, second and third dose of Covid-19 BioNTech, who experienced the unexpected non-serious AESI event of Covid-19. The event occurrence was unknown with respect to the fourth dose of mRNA-1273 vaccine administration in Covid-19 vaccination in series. The event was described as, on unknown date patient experienced Covid-19. Approximately 14 days after the fourth dose of mRNA-1273 vaccine administration, patient and took Nirmatrelvir + Ritonavir (Paxlovid). On unknown date, patient was recovering from Covid-19 with 2 negative tests. However, few days later patient started having symptoms again mostly congestion. Patient retested with positive result. No other information surrounding the event was reported. The outcome of the event was reported as not resolved. The current Covid-19 pandemic remain confounder for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient of unknown age and gender with no relevant medical history and with vaccine history of receiving first, second and third dose of Covid-19 BioNTech, who experienced the unexpected non-serious AESI event of Covid-19. The event occurrence was unknown with respect to the fourth dose of mRNA-1273 vaccine administration in Covid-19 vaccination in series. The event was described as, on unknown date patient experienced Covid-19. Approximately 14 days after the fourth dose of mRNA-1273 vaccine administration, patient and took Nirmatrelvir + Ritonavir (Paxlovid). On unknown date, patient was recovering from Covid-19 with 2 negative tests. However, few days later patient started having symptoms again mostly congestion. Patient retested with positive result. No other information surrounding the event was reported. The outcome of the event was reported as not resolved. The current Covid-19 pandemic remain confounder for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19 Test; Test Result: Negative ; Result Unstructured Data: Negative; Test Name: COVID-19 Test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20220524; Test Name: COVID-19 Test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Hypertension
Vorgeschichte: Medical History/Concurrent Conditions: Drug allergy (unknown historical drug)
Andere Medikamente: LOSARTAN
Allergien: -
Vorherige Impfungen: -

VAERS 2299599

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 28.05.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product temperature excursion issue

Symptomtext

Freezer temperature never reached an acceptable range and was always warm by at least 2 degree C; possible administration of invalid dose to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Freezer temperature never reached an acceptable range and was always warm by at least 2 degree C) and PRODUCT TEMPERATURE EXCURSION ISSUE (possible administration of invalid dose to patient) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Freezer temperature never reached an acceptable range and was always warm by at least 2 degree C) and PRODUCT TEMPERATURE EXCURSION ISSUE (possible administration of invalid dose to patient). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Freezer temperature never reached an acceptable range and was always warm by at least 2 degree C) and PRODUCT TEMPERATURE EXCURSION ISSUE (possible administration of invalid dose to patient) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. It was reported that there are 4 days temperature data (between 4/1/2022 and 4/4/2022) for the freezer storage unit, however it never reached an acceptable range and was always warm by at least 2 degree C. Between 2/22/21 to 4/26/22 there is no other temperature data available. Total 6640 doses of COVID-19 Moderna Vaccine were received by this facility during this time period and LOT numbers were provided(057M21A, 025L21B, 066H21A, 069H21A, 027H21B, 032F21A, 011F21A, 004F21A, 025C21A, 017C21A, 002C21A, 042B21A, 031B21A, 027B21A, 026B21A, 016B21A, 008B21A, 045A21A, 001B21A, 029A21A, 025A21A, 001A21A).Some vials may have been moved to a refrigerator at some point. There is no temperature data for that storage unit. Treatment information was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product temperature excursion issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2296809

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CA
Alter: 61,0
Geschlecht: F
Eingang: 26.05.2022
Impfdatum: 19.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 5,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypoacusis Tinnitus

Symptomtext

Tinnitus experienced twice lasting 20 min. Some slight ringing also. Diminished hearing on L ear.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypoacusis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Glaucoma Hypertension
Andere Medikamente: Latanaprost eye drops for glaucoma ExForge for Hypertension Vit D3 q day
Allergien: Fish like salmon, red snapper
Vorherige Impfungen: Moderna

VAERS 2296600

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: PA
Alter: 66,0
Geschlecht: M
Eingang: 26.05.2022
Impfdatum: 12.05.2022
Beginn: 22.05.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

I contracted COVID 19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Home administered BinaxNow
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure High cholesterol Benign enlarged prostate
Andere Medikamente: Atenolol Lipitor Lisinopril Flomax Phentermine Baby aspirin Famotidine Vitamin D
Allergien: Allergy to raw potatoes Environmental allergies
Vorherige Impfungen: 1 day of feeling bad after 1st and 2nd dose of Moderna vaccine

VAERS 2295678

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: SC
Alter: 72,0
Geschlecht: M
Eingang: 26.05.2022
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

the vial was initially stored in the refrigerator on 22Apr2022 and administered after 30 days beyond use date on 23May2022; gave a 2nd booster dose today of the Moderna Covid-19 Vaccine that was past the beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave a 2nd booster dose today of the Moderna Covid-19 Vaccine that was past the beyond use date) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 22Apr2022 and administered after 30 days beyond use date on 23May2022) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 23-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave a 2nd booster dose today of the Moderna Covid-19 Vaccine that was past the beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 22Apr2022 and administered after 30 days beyond use date on 23May2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (gave a 2nd booster dose today of the Moderna Covid-19 Vaccine that was past the beyond use date) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 22Apr2022 and administered after 30 days beyond use date on 23May2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vials were initially stored in the refrigerator on 22-Apr-2022. It was states that gave a 2nd booster dose of the Moderna Covid-19 Vaccine that was past the beyond use date. Vial did not undergo any temperature excursion. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2294624

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NY
Alter: 27,0
Geschlecht: F
Eingang: 25.05.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Lip swelling Throat irritation

Symptomtext

After patient received her 2nd COVID booster this afternoon, patient was asked to wait in recovery for 15 minutes. At approximately 3:15 this patient reported a swelling of her bottom lip and a "scratchy" throat. The nurse manager was notified, patient was assessed, and 25mg Benadryl PO were given to the patient. Patient's family member/caretaker and patient verbalized understanding of education and plan: Patient is to go home with escort, patient understands that she may feel drowsy but the medication will help with the reaction, and patient is to call us back if any questions or concerns. Patient will be called in one hour from leaving vaccine clinic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lip swelling
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: none that are noted in chart
Vorgeschichte: Chronic Medical Conditions: Asthma, Cerebral Palsy, GERD.
Andere Medikamente: n/a
Allergien: Macrobid, Pencillin
Vorherige Impfungen: -

VAERS 2320171

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: 58,0
Geschlecht: M
Eingang: 24.05.2022
Impfdatum: 18.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2292916

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IL
Alter: 95,0
Geschlecht: M
Eingang: 24.05.2022
Impfdatum: 17.05.2022
Beginn: 17.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered

Symptomtext

Pt was looked up in the registry on May 11th to see if they were due for their 4th dose of vaccine at the request of the the facility he resides in. Pt was due and scheduled for onsite vaccine clinic on 5/17/22. Pts daughter picked him on the 18th and took him a doctors appointment. They gave him a booster dose of Moderna at this visit. Neither the pt or the daughter informed the facility of the vaccine given. On 5/17/22 pt was asked questions by the facility nurse from the IAC prevacination checklist. Pt stated he has had 3 doses of thus far of Covid vaccine. Pt was given a booster dose of Moderna vaccine at this vaccine clinic day. Daughter called an informed pharmacy of incident on 5/20/22. Daughter reported no adverse reactions. Pharmacy called PCP to inform them and they also notified local health office. Nurse at pcp stated as long as the pt doesn't show any adverse reaction there is no reason report anything back to them. Pt was put on 2 hours checks by the Facilty nurse. The pharmacist followed up with nurse and the patient still showing no adverse reaction on this date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2290670

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: KY
Alter: 51,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 18.04.2022
Beginn: 18.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect route of product administration Wrong technique in product usage process

Symptomtext

Please note that the administration of the 4th vaccine was given at the pharmacy location being reported. We do not have detailed information regarding the vaccine series 1-3. An intern used the incorrect size needle to administer the Covid vaccine to the patients listed on this report. The needle size used was a 5/8 inch needle, when the correct size that should have been used was a 1 inch needle. The correct dose was given to all patients. Based on CDC recommendations, there is no need to revaccinate any patient that was administered the dose in the wrong location; in this case the vaccine was given SubQ rather than intramuscular, based on the length of the needle. All patients were notified of this error and were given advise on what to expect. All patients were informed that no harm was done, the vaccine was still effective, and no additional dose is required based on CDC guidelines. As a result of these errors, reeducation was given to the pharmacy student, and the area within the pharmacy that contains all vaccination related supplied were relabeled to make it more clear for everyone administering vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes E11.9 Medium 4/15/2019 Essential hypertension I10 Medium 4/16/2019 HLD (hyperlipidemia) E78.5 Medium 10/16/2020 Morbid obesity E66.01 Medium 8/27/2021 Hypothyroidism E03.9 Medium 4/15/2019 Gastroesophageal reflux disease K21.9 Medium 8/27/2021 Liver disease K76.9 Medium 8/27/2021 Anterolisthesis M43.10 Medium 5/18/2020 Anxiety disorder F41.9 Medium 11/22/2020 More... Arthritis M19.90 Medium 11/13/2020 Bilateral myopia H52.13 Medium 6/23/2020 Bilateral presbyopia H52.4 Medium 6/23/2020 Knee pain M25.569 Medium 3/10/2021 Diabetes mellitus type 2 without retinopathy E11.9 Medium 6/23/2020 Osteoarthritis of lower back M47.9 Medium 5/18/2020 Facet arthritis of lumbar region M47.816 Medium 6/22/2020 Facet arthropathy M47.819 Medium 5/18/2020 Low back pain M54.50 Medium 4/15/2019 Nuclear sclerosis of both eyes H25.13 Medium 6/23/2020 S/P total knee arthroplasty Z96.659 Medium 3/12/2021 Vitamin D deficiency E55.9 Medium 4/15/2019 Painful knee M25.569 Medium 10/14/2021 Failed total left knee replacement T84.093A Medium Unknown Psychophysiological insomnia F51.04 Medium 12/26/2021 Seborrheic dermatitis L21.9 Medium 12/26/2021
Andere Medikamente: lamotrigine levothyroxine acetaminophen alprazolam Lotrel atorvastatin duloxetine ergocalciferol bydureon meloxicam metformin methocarbamol
Allergien: empagliflozin
Vorherige Impfungen: -

VAERS 2290426

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: OH
Alter: 50,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Medication error No adverse event Underdose

Symptomtext

MED ERROR RN gave 0.25 mL to the patient, and then gave another 0.25mL to equal the full .50mL dose. Patient waited 15 minutes for any adverse reaction. None was noted. The vaccination was the second in the patient's series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289887

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NM
Alter: 94,0
Geschlecht: F
Eingang: 22.05.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Error: Dose in Series Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289192

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OK
Alter: 58,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289191

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OK
Alter: 66,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289190

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OK
Alter: 63,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289189

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OK
Alter: 69,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289188

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OK
Alter: 79,0
Geschlecht: F
Eingang: 21.05.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2289187

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OK
Alter: 71,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2287137

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NJ
Alter: 65,0
Geschlecht: M
Eingang: 20.05.2022
Impfdatum: 04.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vision blurred

Symptomtext

left eye became blurry all of sudden , went to see Dr - opthalmalogist, NOthing seen on exam, As of today, blurriness has improved but has not gone away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vision blurred
Hospital-Tage: -
Labordaten: none , just eye exam.
Aktuelle Erkrankungen: n o
Vorgeschichte: no
Andere Medikamente: lisinopril adlodopine metformin gabopentin
Allergien: no
Vorherige Impfungen: -

VAERS 2278397

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: NY
Alter: 36,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

patient came in for a booster dose and was given a second booster though she did not meet current guidance for a 2nd booster

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2278395

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 70,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 28.04.2022
Beginn: 13.05.2022
Tage bis Beginn: 15,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

COVID +

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2278357

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CA
Alter: 77,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 02.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

I did not have an adverse reaction to the Dose 4. I tested positive for Covid 19 on 05/06/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Home test (numerous test) for Covid 19.
Aktuelle Erkrankungen: None
Vorgeschichte: Blood pressure problems.
Andere Medikamente: Blood pressure medication
Allergien: Severe reaction to many blood pressure medications
Vorherige Impfungen: -

VAERS 2275887

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: OH
Alter: 43,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration

Symptomtext

PATIENT'S FIRST COVID BOOSTER DOSE WAS ADMINISTERED AT THE INCORRECT INTERVAL OF 14 DAYS INSTEAD OF 4 MONTHS. DOSE 1 WAS GIVEN 3/3/22 (PFIZER) AND DOSE 2 WAS GIVEN 4/28/22 (PFIZER).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275812

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NC
Alter: 67,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275809

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NC
Alter: 63,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275614

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OH
Alter: 72,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered Incorrect dose administered

Symptomtext

patient presented to pharmacy for 2nd booster shot. 0.5ml was administered instead of 0.25ml. At this time patient is not experiencing any side effects

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275592

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NJ
Alter: 62,0
Geschlecht: M
Eingang: 13.05.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Patient received booster dose of Moderna in error should have received full Moderna dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2275534

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OH
Alter: 71,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event

Symptomtext

Patient came to pharmacy to get 2nd booster. Patient was administered 0.5ml instead of 0.25ml of vaccine. At this time patient is not experiencing any out of sorts side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2275533

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MO
Alter: 31,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Wrong route

Symptomtext

Error: Wrong Route (SC, IM, etc.)-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong route
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2273244

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: OH
Alter: 43,0
Geschlecht: M
Eingang: 12.05.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too Low-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2269306

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21a

gering

Staat: OH
Alter: 66,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Interchange of vaccine products

Symptomtext

No adverse event-- Patient received J&J vaccine 5-14-2021. She presented today for booster vaccine and was given 0.5ml Moderna vaccine instead of typical 0.25ml booster. Patient did not answer the immunocompromised question on her form-- if immunocompromised the 0.5ml dose would be correct. We called patient to clarify but had to leave a message. Submitting as incident until we hear from patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2266818

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: AZ
Alter: 81,0
Geschlecht: F
Eingang: 07.05.2022
Impfdatum: 04.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

A patient received the 2nd booster from a vial that had been open for more than 12 hours.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient received the 2nd booster from a vial that had been open for more than 12 hours.) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient received the 2nd booster from a vial that had been open for more than 12 hours.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A patient received the 2nd booster from a vial that had been open for more than 12 hours.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was provided by the reporter. No treatment medications was provided by the reporter. The vial was initially stored in the refrigerator 2May 2022, the vial was first punctured 3 may 2022 at 11:00 am and at time of administration of vaccine was 4 may 2022, around 9 am. The vial stored post puncture was in Room temperature. Vial did not undergo any temperature excursions. The vial was exposed to room temperature range (8 to 25 degree Celsius 46? to 77?F) was for 22 hours. No Adverse event were reported. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2022: Follow-up received contain no significant information

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266079

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: AL
Alter: 26,0
Geschlecht: M
Eingang: 06.05.2022
Impfdatum: 05.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Interchange of vaccine products

Symptomtext

Patient thought they had received the Moderna covid vaccine for their first dose, received Moderna covid shot for their second shot in the series. We soon found out that the patient had received the Pfizer covid vaccine for their first shot. Patient not experiencing any adverse events at this time

Weitere VAERSDATA-Felder

Praegender Schweregrund: Interchange of vaccine products
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2266050

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CA
Alter: 20,0
Geschlecht: M
Eingang: 06.05.2022
Impfdatum: 04.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

PHARMACIST ADMINISTERED 0.25ML INTRAMUSCULAR TO THE LEFT ARM MODERNA COVID-19 VACCINE AS SECOND DOSE INSTEAD OF 0.5ML DOSAGE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2265956

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 83,0
Geschlecht: M
Eingang: 06.05.2022
Impfdatum: 04.05.2022
Beginn: 04.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

vaccine given past use date, reached out to patient

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2264506

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057m21A

gering

Staat: MO
Alter: 47,0
Geschlecht: F
Eingang: 05.05.2022
Impfdatum: 01.05.2022
Beginn: 01.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Error: Dose in Series Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2263475

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge #057M21A

gering

Staat: MA
Alter: 72,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 19.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Herpes zoster

Symptomtext

Don't know if related but developed mild shingles on 4/29/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Herpes zoster
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Amitryptolene, verapamil, ecotrin, omeprazole, multivitamin, vitamin d
Allergien: minocyclene, estrogen, codeine
Vorherige Impfungen: -

VAERS 2263437

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: TX
Alter: 28,0
Geschlecht: M
Eingang: 04.05.2022
Impfdatum: 26.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Lip swelling Scab Tenderness Throat irritation

Symptomtext

On 4/26/2022, patient received his first MODERNA vaccination (0.5mL, Part 1). Two days after, patient reported swelling of his upper right lips and itchiness in his throat. Patient took Benadryl, which helped with patient's swelling and itchiness. Patient denies having issues with breathing during the event, which might be partially due to patient ingesting Benadryl during the event. Patient reported and showed that swelling of lips has subsided for patient to where the lips has mostly returned to regular size. Patient reports today (5/4/2022) that currently there is still itchiness in his upper right lip region, his lips still feel tender. Crusting(?) in upper lip region was observed among the patient's moustache hairs. Patient denies any follow up reactions similar to initial adverse event. Patient denies having any previous vaccinations prior to his first MODERNA vaccine and reports that this is not only his first MODERNA vaccination, but also his first ever vaccine in his life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lip swelling
Hospital-Tage: -
Labordaten: Patient reported no additional medical tests or laboratory results so far.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2263159

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: CA
Alter: 53,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 02.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Breast tenderness Eye swelling Lymphadenopathy

Symptomtext

I had filler injections in my whole face in June 2021. This Injection has given me swelling under my right eye. My prior injections gave me no adverse reactions to my face. Also, I have swollen lymph nodes under my right arm and my right breast is tender. Not worried about the lymph nodes as this happened after the first booster shot. I am concerned about the swelling under my eye. Will take Benadryl and call Dr.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Breast tenderness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: None
Vorgeschichte: Crohn's disease. Hashimoto's disease. Left Bionic, Titanium Knee
Andere Medikamente: Had my 6th Lupron injection in the morning of my vaccination. Take Mesalamine daily for Crohn's disease. Also Levothyroxine for Hashimoto's disease. Wellbutrin 150mg daily.
Allergien: None
Vorherige Impfungen: I have had 4 Moderna vaccinations and have had some adverse reactions including fever, fatigue, swollen lymph nodes, extreme joi

VAERS 2261455

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MI
Alter: 30,0
Geschlecht: F
Eingang: 03.05.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Circumstance or information capable of leading to medication error Maternal exposure during pregnancy

Symptomtext

concerned and was pregnant; There was a paperwork error when she gave the patient 0.25 mL and the paperwork was incorrect; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (concerned and was pregnant) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (There was a paperwork error when she gave the patient 0.25 mL and the paperwork was incorrect) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. Last menstrual period and estimated date of delivery were not provided. On 28-Apr-2022, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (concerned and was pregnant) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (There was a paperwork error when she gave the patient 0.25 mL and the paperwork was incorrect). On 28-Apr-2022, MATERNAL EXPOSURE DURING PREGNANCY (concerned and was pregnant) had resolved. At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (There was a paperwork error when she gave the patient 0.25 mL and the paperwork was incorrect) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication and treatment information were not reported by the reporter. The pharmacist gave the patient 0.25 mL and the paperwork was incorrect and said 0.5mL. HCP said the concern was that the patient might have got a full dose instead of the half dose. Company comment-This spontaneous case concerns a 30-year-old, female patient with no medical history reported, who was with noted an unexpected non-serious event of Maternal exposure during pregnancy in association with third dose of mRNA-1273 vaccine. Additionally, an event of Circumstance or information capable of leading to medication error was also reported. It was reported that there was a paperwork error wherein the patient received 0.25 mL and the paperwork incorrectly mentioned 0.5 mL; however, the concern here is that the patient may have got a full dose instead of the half dose. Outcome of the event was not known at the time of report. No further details regarding primary dosage schedule and period of gestation available. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2022: Follow-up received on 28-APR-2022 contains no new information.; Sender's Comments: This spontaneous case concerns a 30-year-old, female patient with no medical history reported, who was with noted an unexpected non-serious event of Maternal exposure during pregnancy in association with third dose of mRNA-1273 vaccine. Additionally, an event of Circumstance or information capable of leading to medication error was also reported. It was reported that there was a paperwork error wherein the patient received 0.25 mL and the paperwork incorrectly mentioned 0.5 mL; however, the concern here is that the patient may have got a full dose instead of the half dose. Outcome of the event was not known at the time of report. No further details regarding primary dosage schedule and period of gestation available. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Circumstance or information capable of leading to medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2259646

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: AL
Alter: 92,0
Geschlecht: F
Eingang: 30.04.2022
Impfdatum: 26.04.2022
Beginn: 26.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage.; Administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage.) and PRODUCT STORAGE ERROR (Administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage.) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Apr-2022 at 12:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2022 at 12:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage.) and PRODUCT STORAGE ERROR (Administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication information was not provided by the reporter. Date the vial was initially stored in the refrigerator 24-Apr-2022. The vial was first punctured on 25-Apr-2022 at 10:15 am, left out at room temperature all day and overnight and then administered a 2nd booster dose of the Moderna Covid-19 Vaccine from a vial that was 25 hours and 45 minutes post puncture and after 25 hours 45 minutes of room temperature storage. Vial did not undergo any temperature excursions. Treatment information was not provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2258482

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: MD
Alter: 62,0
Geschlecht: F
Eingang: 29.04.2022
Impfdatum: 29.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

Patient received a Moderna COVID19 booster dose that was drawn from a Moderna vial that was stored at room temperature for >20 hours after 1st puncture.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2256234

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 28.04.2022
Impfdatum: 25.04.2022
Beginn: 25.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered to the patient after exposure to room temperature for more than 24 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to the patient after exposure to room temperature for more than 24 hours) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Apr-2022 at 4:00 PM, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 25-Apr-2022 at 4:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to the patient after exposure to room temperature for more than 24 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to the patient after exposure to room temperature for more than 24 hours) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. A vial was taken out of the freezer on 23-Apr-2022 and was punctured at 24-Apr-2022, 11 A.M. The vial was left out in room temperature until a dose was given from the vial to the patient at 25-Apr-2022 4 P.M. The pharmacist would urgently like to know if the dose was appropriate that was administered. The vial was initially stored in the refrigerator on 23-Apr-2022. The vial did not undergo any temperature excursions. The total amount of time for which the vial was exposed to room temperature range (8 degree Celsius to 25 degree Celsius/46 degree Fahrenheit to 77 degree Fahrenheit) was 29 hours. No treatment information was reported. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2252100

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: IN
Alter: 77,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 26.04.2022
Beginn: 26.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Haemorrhage Vaccination site mass

Symptomtext

vaccine was administered and the patient had some bleeding, then a small lump form where the vaccine was administered. Bleeding stopped and patient said dr was monitoring his platelets since his bloodwork 6 months ago. Referred patient to PCP and recommended new bloodwork

Weitere VAERSDATA-Felder

Praegender Schweregrund: Haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2250140

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: NC
Alter: 79,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 22.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Resuscitation Unresponsive to stimuli

Symptomtext

pt found saturday 4/23/22 at 410am unresponsive, CPR initiated, emergency responded, was unable to resuscitate patient

Weitere VAERSDATA-Felder

Praegender Schweregrund: Resuscitation
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: diabetes type 2, hypertension, dementia
Andere Medikamente: -
Allergien: none
Vorherige Impfungen: -

VAERS 2249624

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: TX
Alter: 54,0
Geschlecht: M
Eingang: 24.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Error: Wrong Dose of Vaccine - Too High-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249305

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: TX
Alter: -
Geschlecht: U
Eingang: 23.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 patients received booster doses of Moderna COVID-19 vaccine from a vial that had been punctured for more than 12 hours) and PRODUCT STORAGE ERROR (3 patients received booster doses from a vial that had been punctured for more than 12 hours/the vial was exposed to room temperature range for 24 hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 patients received booster doses of Moderna COVID-19 vaccine from a vial that had been punctured for more than 12 hours). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (3 patients received booster doses from a vial that had been punctured for more than 12 hours/the vial was exposed to room temperature range for 24 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (3 patients received booster doses of Moderna COVID-19 vaccine from a vial that had been punctured for more than 12 hours) and PRODUCT STORAGE ERROR (3 patients received booster doses from a vial that had been punctured for more than 12 hours/the vial was exposed to room temperature range for 24 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that patient was administered with first booster dose of the vaccine around 11:51 A.M or after that time. It was reported that the number of doses/vials that were affected and administered were 3 doses. The vial was initially stored in the refrigerator on 15-Apr-2022. The vial was first punctured at 11:50 A.M. on 19-Apr-2022. The vial was stored at room temperature post puncture. It was reported that the vial was left on counter top overnight. The total amount of time during which the vial was exposed to room temperature range (8 degree Celsius to 25 degree Celsius/46 degree Fahrenheit to 77 degree Fahrenheit) was 24 hours. No concomitant medications were reported. No treatment information was reported. This case was linked to MOD-2022-546072, MOD-2022-545341 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249284

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: TX
Alter: -
Geschlecht: U
Eingang: 23.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered with a dose of Moderna from a vial that had been punctured for more than 12 hours) and PRODUCT STORAGE ERROR (patient was administered with a dose of Moderna from a vial that had been punctured for more than 12 hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered with a dose of Moderna from a vial that had been punctured for more than 12 hours). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (patient was administered with a dose of Moderna from a vial that had been punctured for more than 12 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was administered with a dose of Moderna from a vial that had been punctured for more than 12 hours) and PRODUCT STORAGE ERROR (patient was administered with a dose of Moderna from a vial that had been punctured for more than 12 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that patient was administered with second booster dose. It was reported that Number of doses/vials administered were 3 doses. The vial was initially stored in the refrigerator on 15-Apr-2022. The vial was first punctured at 11:50AM on 19-Apr-2022. The vial was stored at room temperature post puncture. It was reported that the vial was left on countertop overnight. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) was 24 hours. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2022-546072, MOD-2022-546074 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2241016

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 057M21A

gering

Staat: TN
Alter: 73,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 19.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Needle issue Vaccination complication

Symptomtext

Technician went to give vaccine to shot and when inserted needle she hit the bone and was worried and pulled the needle all the way out. we drew up a new vaccine with a new needle and was given without any problems. patient does not report any issues or discomfort

Weitere VAERSDATA-Felder

Praegender Schweregrund: Needle issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -